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Paracetamol-induced acute liver failure causes disruption of normal hepatic
architecture and function, and where there is massive cellular necrosis, resulting in
poor prognosis heralded by hepatic coma, liver transplantation is the only effective
treatment. This procedure is however limited by a shortage of donor organs.
Alternative treatment strategies under development include hepatocyte-based
bioartficial liver systems (BALS) which may allow time for temporary support of the
failing liver until a donor organ becomes available. This approach, may even allow
regeneration of the native liver and full recovery. Primary porcine hepatocytes
(PPHs) are the preferred biological component for BALS as they have similar
morphology and biochemical functionality to human hepatocytes. Conventional in
vivo isolation of PPHs can give high yield and viability required of BALS, although
such methods are time-consuming, expensive and require specialist surgical
facilities. The consensus view is that PPH-based BALS should retain synthetic,
detoxifying, metabolic and excretory functions. Despite this, systematic studies on
the optimisation and characterisation of different in vitro culture conditions
following high yield extraction of PPHs, is lacking.
Principal Aims of Thesis
The principal aims of this thesis were to develop a high viability, high yield,
reproducible ex vivo method for obtaining PPHs and to characterise, using functional
and morphological criteria, PPHs under different fully-defined culture conditions, for
use in BAL devices.
xxviii
Methods
PPH isolation was optimised using a novel 5-step ex vivo retrograde collagenase
perfusion method. Purified cells were subsequently cultured in four separate serum-
free chemically-defined medium (SFCD) formulations (Medium 199 (Ml99),
Williams Medium E (WE), RPMI 1640 (Ml 640), and Hepatocyte Medium (HM))
for 6 days on biomatrix-free, unmodified tissue culture plastic, or in a rotary cell
culture simulated microgravity system (RCCS) in WE for 12 days. Differentiated
characteristics of morphology and function were then assessed. Functional assays of
urea synthesis rates (USR) and galactose elimination (GE) of medium-conditioned
cultures, and assays of total cellular protein content (TP), total P450 content (tP450)
and lactate dehydrogenase activity (cell viability) were measured using
spectrophotometry. Albumin synthesis rates (ASR) in test media, were determined
by a novel fluorimetric albumin 580 dye-binding assay.
Statistics:
For each biochemical measurement, and for image analysis, multiple comparisons
were made of: 1) between-media evaluations on each day of culture and 2) between-
day evaluations for each medium formulation using one-way single factor ANOVA
(assuming equal variances) and Post Hoc tests of least significant differences.
Results are expressed as mean±SEM (n=x, experiments).
In order to define an index of global functional capacity, a scoring system
(hepatocyte biological acitivity index; HBAI) was devised as an integrated measure
of overall functional capability of cell cultures, on each day or cumulatively. Gross
morphology and ultrastructure were assessed using phase contrast and both scanning
and transmission electron microscopy, and by image analysis techniques. Integrin
expression, bile functionality, and viability of RCCS spheroids were detected by
immunofluorescent (IF) staining using confocal and IF microscopy.
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Results
Cell Isolation A yield of 2.4+0.5 x 1010 cells from 12+1 kg piglets (n=20), with a
viability of 85+6% was obtained in <2 hours. Isolate purity was 97+3 %
hepatocytes (n=4). Image analysis data proved more discriminatory, in assessment of
plating efficiencies (PE), than assessment of total protein, or LDH activity. Between-
media comparisons: PE (n=3) on dl for WE, HM, Ml99, and, Ml640 maintained
cells were 71+14, 38+3, 78+5, and 55+10 %, respectively; PE was significantly
greater in both WE (p<0.05) and Ml99 (p<0.01) cells vs HM cells, up to d4. HM was
significantly lower than all test media on d2 (p<0.05) and d4 (p<0.01). USR of
cultures conditioned in test media (n=3): d2 was significantly greater at
147±21nmol/hour/mg TP for M1640 vs WE (104+11), but not M199 (115+17) or
HM (126+20) cells. By d4, USR of HM (221+25) and M1640 (176+31) cells was
significantly higher (p<0.01), than WE (93+14) or M199 (79+4) cultures. USR was
attenuated in all media by d6. GE of cultures conditioned in test media (n=3): GE for
WE, HM, M199 and RPMI 1640 on culture day 2 (420+66, 436+54, 416+33, 516+44
nmoi/h/mg TP, respectively) was significantly greater (p<0.05) v.v day 4 (266+56,
298+78, 231+41, 277+101) cultures. GE remained stable up to day 6. tP450
decreased significantly (p<0.001), from 120 pmol/mg TP for fresh cells, to «40
pmol/mg TP in all media tested on d2. Specifically, tP450 was maintained at 36+3 in
HM (n=3), significantly greater (p<0.05) than WE (24+3) or Ml640 (25+5) at d2,
and declining most significantly in WE (17+1, p<0.05) by d6. Between-day
comparisons: PE was significantly greater (p<0.05) in all media by d4 («95%) vs dl
(«70%) cultures, except HM (-40%) cells. USR increased significantly (p<0.05)
only in day 4 HM-conditioned cells (221+25) compared with day2. Morphology
Hepatocytes maintained in Ml99 and WE, but not HM and Ml640 media
formulations, preserve ultrastructural, and gross morphological features of healthy
cells up to culture day 4. The HBAI utility for multiple comparisons, reinforced by
morphological observations, ranked the media on day 2 as: M199>WE>M1640>HM,
Ml99 retaining primacy up to day 6. The RCCS modality retains stable, liver-
xxx
specific metabolic functions of PPHs, morphological features characteristic of 3D
hepatocyte cultures, and integrin a.5 expression over a 12 day culture period.
Conclusions
High yield PPHs isolations, with high viability and purity, cultured under separate
SFCD formulations, allow maintenance of viable hepatocyte cultures following high
plating efficiencies, compatible with retention of functional activity, for up to 6 days.
Moreover, the type of medium formulation appears to modulate, to varying degrees,
both cell culture morphology and functional activity in vitro. USR, ASR, tP450, and
GE functions for day 2 test media cultures, were up to 300%, 90%, 20%, and 50%,
respectively, of in vivo values for human liver. Medium 199 is the most suitable
synthetic media for culturing PPHs in BALS, which require rapid attachment of cells
with an in vivo-like morphology, whilst maintaining a diverse repertoire of hepatic
support functions. Furthermore, compared with 2D static cultures, the RCCS
modality promotes culture longevity, and cellular functionality (on a per viable cell
basis), while the presence of bile canalicular-like structures, and integrin
a5expression, suggest the viable cell population maintained a differentiated, 3D-
hepatospheroid cytoarchitecture with evidence of polarity. Further study is required
to enhance the viable cell population, phenotype, polarity and thus functional activity




This thesis deals with the characterisation and optimization of primary porcine
hepatocyte (PPH) culture systems for use in bioartificial liver devices (BAL) to treat
acute liver failure (ALF). PPHs are considered the most suitable cell source for BAL
devices. Although it is unclear which specific hepatic support functions are required
in a BAL device, the consensus view is that these cells should have a repertoire of
synthetic, detoxification and metabolic functions.
Despite this assertion, there are no systematic studies which seek to
characterize optimal, defined culture conditions for PPHs, in terms of biochemical
functionality and morphology. To achieve this a novel high yield, high viabilty ex
vivo retrograde collagenase perfusion and isolation technique was first developed.
Subsequently, the modulatory effects of different medium formulations on
hepatocyte biochemical functionality and morphology was assessed in a fully-
defined culture system. In order to define an index of global functional capacity, a
scoring system (hepatocyte biological acitivity index; HBAI) was devised as an
integrated measure of overall functional capability. Finally, the formation of 3-
dimensional hepatosheroids in a simulated microgravity culture system is
investigated as a novel environment for enhancing hepatocyte function, morphology
and lifespan, applicable for BAL devices.
Structure
The first part of the thesis (Introduction, Chapter 1) outlines the normal
anatomy, microstructure and selected functional aspects of liver metabolism, which
enable normal physiological homeostasis to be maintained. The therapeutic potential
of primary porcine hepatocytes (PPHs) is introduced in the context of their
application to the treatment of acute fiver failure, as the biological component of
bioartificial fiver systems. Finally, potential strategies used to retain in vivo-like
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morphological and functional characteristics of isolated hepatic cells in vitro are
presented.
In the second part of the thesis (experimental work, Chapters 2-5), each
chapter is divided into: Introduction, Aim, Materials and Methods, Results, and
Discussion. The 'Introductory' sections extend the discourse of chapter 1 by giving a
more detailed account of each experimental chapter topic. For example, Chapter 5
defines the physical conditions which promote 3D cell configurations in the
simulated microgravity environment. The 'Discussion' sections at the end of each
experimental chapter give an overall critical discussion of results, offer new insights
introduced by the experimental work regarding PPH culture for BAL systems, as
well as future studies emerging from this work.
Chapter 2 deals with the development of a novel high yield, high viabilty ex vivo
retrograde collagenase perfusion and isolation technique. Chapter 3 is a study of the
viability, attachment efficiency, as well as gross and ultrastructural morphology of
PPHs cultured under different, serum-free chemically defined culture conditions. In
Chapter 4, the work of Chapter 3 is extended, by measuring biochemical
functionality of PPHs under these defined conditions. In chapter 4 also, the concept
of the 'hepatocyte biological activity index' is defined and explained. Finally,
Chapter 5 deals with the morphology and function of PPHs grown in a simulated
microgravity environment.
Chapter 6 (Concluding remarks) reviews the findings of this thesis and suggests
future work, which may help improve both the biological component and design
criteria, of BAL systems.





The liver is strategically situated between the splanchnic and systemic circulations to
perform its primary global function - the regulation of the supply of substances to the
systemic circulation and from the intestine. Liver cells are the most versatile cells in
the body. Hepatocyte heterogeneity within the liver acinus, morphological variability
and an abundance and variety of subcellular organelles, reflect the functional diversity
of this remarkable organ. Modulation of the supply of substrates to distant organs is
accomplished by several processes or functional capabilities of liver cells. These cells,
operating within a highly structured organization, perform both endocrine and
exocrine functions, uptake and removal of substances from sinusoidal blood, as well
as synthetic, detoxification and metabolic duties including storage of metabolites.
Derangement of hepatic function, such as in paracetamol-induced acute liver
failure, cause disruption of normal hepatic architecture and function due to massive
cellular necrosis. Patients with this dramatic clinical syndrome have high morbidity
and mortality with liver transplantation being the only effective treatment, albeit
severely limited by a shortage of donor organs, and cost. Alternative treatment
strategies include hepatocyte-based bioartficial liver systems which may allow time for
temporary support of the failing liver until a donor organ becomes available or even to
regeneration of the native liver and full recovery. The consensus view is that the
biological component used in these devices should maintain synthetic, detoxifying,
metabolic and excretory functions. However, systematic studies concerning
optimisation of in vitro culture conditions following high yield extraction of
hepatocytes is lacking.
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This chapter outlines the normal anatomy, microstructure and selected
functional aspects of liver metabolism, which enable normal physiological homeostasis
to be maintained. The therapeutic potential of primary porcine hepatocytes (PPHs) is
introduced in the context of their application to the treatment of acute liver failure, as
the biological component of bioartificial liver systems. Finally, potential strategies
used to retain in vivo-like phenotypic and functional characteristics of isolated hepatic
cells in vitro are presented.
1.2 Gross anatomical features of human and pig liver
The human liver, weighing approximately 1500g («2 % of body weight) in adults, is
the largest solid organ in the body and is surrounded by Glisson's capsule; it is
situated in the right upper quadrant of the abdomen largely protected by the rib cage
(Ham, 1953). In pigs, the liver comprises up to 5 % of body weight, perhaps
reflecting the high intrinsic metabolic capacity of this species. Although many aspects
of microanatomy are similar, there are major differences in gross anatomy between
human and pig liver. For example, in humans the liver is traditionally divided into two
uneven lobes by the falciform ligament, the right lobe being about six times larger than
the left. In contrast, the pig's liver has deep fissures which clearly divide into distinct
left lateral and left medial and right lateral and right medial lobes (Sack, 1982);
centrally are the short quadrate and a caudate process with the gall bladder lying
between the quadrate and right medial lobes (Figure 1.1). Like human liver, the
concave visceral surface of pig liver contains the porta hepatis into which the hepatic
artery and portal vein enter with hepatic veins running in the opposite direction,
collecting blood from the sinusoids to the main hepatic veins, which drain into the
inferior vena cava. Through the portal vein, the liver receives 75 % of its blood supply
from the splanchnic circulation and 25 % through the hepatic artery. Blood flows into
the sinusoids from these vessels (Moseley, 2000).
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Figure 1.1 Schematic drawing of visceral surface of pig liver Modified
from Sack, (1982) 1. Left lateral lobe; 2. Left medial lobe; 3. Right lateral
lobe; 4. Right medial lobe; 5. Quadrate lobe; 6. Caudate process; 7. Porta; 8.
Gall bladder; 10. Caudal vena cava; 11. Hepatic artery; 12. Portal vein and
lymphatic nodes; 13. Bile duct; 14. Oesophageal notch; 15. Median plane.
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1.3 Microstructural organization of the liver
Hepatocytes occupy 78 % of the total liver volume in humans and pigs (Sack, 1982).
The cells are arranged in irregularly shaped plates, 1-2 cells thick along the hepatic
sinusoids (Figure 1.2), which appear as 'cords' in two-dimensions under the
microscope. The plates are branching and anastomosing laminae, arranged radially
around small venules to form anatomical units called hepatic lobules (Rhodin, 1974).
In pigs, the Kiernan's or classic lobule is about 0.7 x 2 mm in size, number about one
million per liver and, unlike human lobules, have sharply deliminated boundaries of
thin interlobular septa of connective tissue, which is hexagonal in outline (Junqueira,
1977). Each peripheral angle of the hexagonal lobule is occupied by portal spaces
containing branches of the hepatic arteries, portal veins and bile ducts. The
centrilobular hepatic veins are found at the centre of the liver lobule (Figure 1.3).
The functional unit of the liver is the simple liver acinus, defined as a unit of
liver parenchyma irrigated by a single blood supply from hepatic arterial and portal
venous branches in a small terminal portal space (Rappaport, 1976). In other words,
the hepatic acinus comprises the region irrigated by one distributing vein (diamond
shape in Figure 1.3). In addition to the terminal branches of the portal vein, an arterial
branch and bile ductile are in the centre of this mass of hepatic parenchyma, which is
situated in adjacent areas of two different classical hepatic lobules (Figure 1.3). Blood
perfuses hepatic cells unidirectionally, becoming progressively poorer in oxygen and
nutrients from acinar zone 1 to zone 3. Interestingly, this zonal arrangment may
explain why potentially hepatotoxic drugs such as paracetamol, induce centrilobular
or zone 3 necrosis, since it is predominantly zone 3 hepatocytes that participate in
drug metabolism and disposition (Moseley, 2000).
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Figure 1.2 Three-dimensional diagram of the classic hepatic lobule
[Rhodin et al 1974], 1. Interlobular portal veins; 2. Interlobular hepatic
arteries; 3. Hepatic sinusoids; 4. Plates of hepatic cells; 5. Central venule; 6.
Sublobular hepatic vein; 7. Bile canalicui; 8. Bile ductules; 9. Bile ducts; 10.
Perilobular surfaces of adjoining hepatic lobules. Hepatic arteries, veins and
bile ducts occupy the portal spaces. Direction of blood flow is indicated by
black arrows, bile fluid by white arrows.
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Figure 1.3 Schematic illustration of the territories of the liver lobules
and hepatic acini [Modified from Junqueira, (1977)]
The classical lobule has a central vein (CV) and is outlined by the (solid)
lines that bind the portal spaces (PS). The hepatic acinus comprises the
region irrigated by one distributing vein (dotted triangles forming a diamond
shape). Blood becomes progressively poorer in oxygen and nutrients from
zone 1 (periportal) to zone 3 (perivenous).
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In addition to hepatocytes and bile duct epithelial cells, four types of
nonparenchymal cells populate the liver which are organized into liver acini (Figure
1.4): Sinusoidal endothelial cells (SECs), Kupffer cells (hepatic macrophages), hepatic
stellate cells (Vitamin A-storing cells) and Pit cells (natural killer cells). In adult liver,
hepatocyte constitute 78 % of the tissue volume, nonparenchymal cells account for 6
% and the extracellular space about 16 % (Fan, 2000). Fenestrated SECs line the
hepatic sinusoids, which separate adjacent plates of hepatocytes. Unlike other
endothelia, SECs lack an underlying basement membrane allowing the direct, selective
exchange of substances, such as secretion of proteins or uptake of protein-bound bile
acids or drugs, between the plasma and hepatocytes via the perisinusoidal Space of
Disse (Moseley, 2000). Hepatocytes typically form one-cell thick plates, which are
joined by junctional complexes demarcating the canalicular space from the sinusoidal
domain. Kupfifer cells and pit cells lie within the sinusoidal lumen whereas endothelial
cells separate this lumen from the Space of Disse, wherein lie stellate cells (lipocytes)
(Figure 1.4).
Within the thickness of the hepatic plates the bile canaliculi form an
anastomosing polygonal network, constantly separated by a half-cell thick layer of
cytoplasm from the hepatic sinusoids. The canaliculi secrete bile into periportal
cholangioles or canals of Hering, which connect canaliculi to the smallest interlobular
bile ducts (Figure 1.2), composed of cuboidal epithelial cells. These ducts convey bile
to the extrahepatic bile duct, the gallbladder and the duodenum where bile facilitates
fat digestion and absorption. These differences in the structure and function of the
sinusoidal and canalicular membrane define the hepatocyte as a highly polarized
epithelial cell (Rhodin, 1974; Moseley, 2000).
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Figure 1.4 Schematic illustration of the microanatomy of the liver cell
plate [Modified from Moseley, (2000)].
The relationship between hepatocytes, the four types of nonparenchymal
cells and sinusoids in a part of the liver acinus is shown (not to scale).
Hepatocytes typically form one-cell thick plates, which are joined by
junctional complexes demarcating the canalicular space from the sinusoidal
domain. Blood (solid arrows) passes through the sinusoidal lumen allowing
exchange of solutes (broken arrows) with hepatocytes via fenestrae and the
Space of Disse. Kupffer cells and pit cells lie within the sinusoidal lumen
whereas endothelial cells separate this lumen from the Space of Disse,
wherein lie stellate cells (lipocytes).
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1.4 Microanatomy and ultrastructure of hepatocytes
Hepatocytes are polyhedral cells with a diameter of 20-30 pm. The nucleus is large,
often binucleate with one or two prominent nucleoli. Nuclei vary in size due to
polyploidy, increases in DNA content being associated with both age and pathology.
In histological sections stained with haematoxylin and eosin, the cytoplasm of
hepatocytes is eosinophilic due in part to the presence of smooth endoplasmic
reticulum but mainly because of the presence of large numbers (1000-2000) of
mitochondria (Junqueira, 1977), giving the cytoplasm a granular appearance under
light microscopy (Burkitt et al., 1993).
The large surface area of basolateral microvilli projecting into the
perisinusoidal Space of Disse allows direct contact with sinusoidal blood so enabling
the high absorbtive and secretory activity of hepatocytes. As well as exhibiting a
distinct polarity, hepatocytes have uptake mechanisms for the bidirectional exchange
of solutes including amino acids, hexose sugars, and organic anions such as bile acids
fatty acids and bilirubin; receptor mediated endocytotic processes; Na+,K+-ATPase;
and export processes for albumin, lipoproteins and clotting factors (Finlayson, 1997;
Moseley, 2000)
Electron microscopy, subcellular fractionation and biochemical techniques
have revealed great ultrastructural and functional diversity of hepatocytes.
Mitochondria are respiratory organelles which are particularly numerous in
hepatocytes and assume a spherical or ovoid shape. The primary function of
mitochondria is the conservation of energy, from the oxidation of substrates by
oxygen, in the form of ATP. Their inner membranes and cristae are involved with
oxidative phosphorylation and fatty acid oxidation whereas the matrix is a
concentrated protein solution of enzymes of the tricarboxylic acid and urea cycles
(Berry et al., 1991; Desmet, 1994).
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The endoplasmic reticulum (ER) and Golgi complexes are involved in the
synthesis, processing, packaging and sorting of cellular proteins prior to exocytosis.
The ER is a collection of continuous membranous tubules, vesicles and flattened sacs
that extends throughout the cytoplasm. Only granular ER, which is more developed in
acinar zone 1 (periportal hepatocytes), has cisternae with attached polyribosomes,
which are sites of protein synthesis. Smooth ER, on the other hand, has no ribosomes
and functions in lipid biosynthesis, calcium regulation and detoxification through
biotransformation. The Golgi complex is usually closely associated with the granular
ER from which it receives newly synthesized proteins for subsequent processing and
export to different destinations within the cell and to the cell surface. Peroxisomes are
spherical structures smaller than mitochondria which provide important metabolic
links between both anabolic and catabolic biochemical reactions of carbohydrates,
lipids, fats, proteins and nucleic acids. Lysosomes are membrane-bound vesicles
containing more than fifty hydrolytic enzymes involved in the digestion and catabolism
of various endogenous and exogenous substances (Berry et al., 1991; Burkitt et al.,
1993; Hargreaves, 1968; Junqueira, 1977).
1.5 Extracellular matrix, cell-matrix and cell-cell interactions
Normal liver lacks a true basement membrane and the stromal compartment is greatly
reduced. As a result, the density, distribution and organization of hepatic extracellular
matrix (ECM) is unique. Immunohistochemistry and electron microscopy analysis,
reveal that some ECM proteins in the acini reside in the Space of Disse, including:
collagen types I, III, IV, V and VI; fibronectin and laminin; and various proteoglycans
and glycosaminoglycans. The main producers of ECM are hepatic stellate cells and
hepatocytes and to a lesser extent SECs. (Fan, 2000; Maher, 1998; Portmann, 2000).
ECM in normal liver is considered important in the structural organization of
liver parenchyma and in the regulation and modulation of hepatocyte function in the
acinus. The ECM provides intercellular cohesiveness and communication, gene
expression and function as well as induction of cell polarity and maintenance of
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differentiated cell phenotype. These events appear to be regulated by specific cell-
matrix and cell-cell interactions that are modulated by ECM geometry and binding to
cell surface adhesion molecules called integrins (Berthiaume et al., 1996; Fan, 2000).
The first identified ligands of integrins were matrix proteins and the first identified
matrix-specific receptor of the integrin family was fibronectin integrin ctsPi, which is
particularly abundant in liver. Integrin receptors bind to ECM proteins and mediate
attachment of ECM to intracellular cytoskeletal elements eliciting a signal
transduction cascade influencing the physiological activity of the cell including, in
addition to the above, cell motility and proliferation (Berman and Kozlova, 2000).
The microstructural organization and anatomy of liver described above,
suggests a significant role for heterotypic cell-cell interactions, in concert with various
growth factors including epidermal growth factor (EGF) and cytokines, in
coordinated liver function. In both developing and adult liver, such cell-cell
interactions between parenchymal and nonparenchymal neighbours appear to
modulate cell growth, migration and differentiation (Bhatia et al., 1999; Maher,
1998).
1.6 Hepatic biochemical function
As outlined above, the multiplicity of function of hepatic cells is related to their great
morphological and ultrastructural diversity. The liver is well recognized as being
central to the metabolism of lipids, proteins and carbohydrates as well as xenobiotic
substances (Gumucio, 1992). The interplay between some of these metabolic
pathways is outlined in Figure 1.5. In this section we concentrate on selected
functional aspects of liver. In particular, albumin, ammonia, galactose, and
cytochrome P450 metabolism are examples of important specific metabolic functions
of liver.
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Figure 1.5 Central metabolic pathways of proteins, carbohydrates and
lipids in the liver (Modified from Moseley, 2000).




Albumin production is unique to the adult liver and is the predominant product of
hepatic protein synthesis with an average synthesis of 8-14 grams daily. The normal
serum albumin levels are 35-50 g/L accounting for about 50 % of the serum proteins.
Its main functions are to maintain the colloid oncotic pressure of blood, as a blood
buffer and as a carrier vehicle for the transport of many substances including
xenobiotics, bile acids, bilirubin, fatty acids and hormones (Percy-Robb and Finlayson,
1997; Finlayson, 1997; Doweiko and Nompleggi, 1991a; Doweiko and Nompleggi,
1991b).
Polyribosomes bound to the (granular) endoplasmic reticulum synthesise and
secrete albumin into the sinusoidal blood via the Golgi complex (Rothschild et ai,
1973). Release of albumin from the hepatocyte appears to be sensitive to the
concentration of both potassium and tryptophan. Albumin synthesis is regulated by
changes in nutritional status, osmotic pressure and systemic inflammation. In addition,
the hormonal milieu of the hepatocyte is important; corticosteroids, growth hormones
and insulin alter albumin production and their effects may be additive (Doweiko and
Nompleggi, 1991a; Doweiko and Nompleggi, 1991b).
Albumin is also important as a diagnostic and prognostic determinant as well
as a useful therapeutic agent. In culture, hepatocytes readily produce albumin under a
variety of conditions and is considered a marker of protein synthetic function and
differentiation in vitro. Of course, the liver produces other important proteins such as
vitamin K-dependent coagulation-factor pro-enzymes (factors II, VII, IX and X)
involved in normal blood coagulation; ai-antitrypsin; a2-macroglobulin;
ceruloplasmin; and iron transport proteins, to name but a few (Percy-Robb and
Finlayson, 1997; Desmet, 1994; Finlayson, 1997; Moseley, 2000).
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1.6.2 Ammonia metabolism
Excess nitrogen resulting from proteolysis and amino acid degradation is converted to
non-toxic urea in hepatocytes by the Krebs-Henseleit ornithine cycle. The entry of
ammonia into the systemic circulation must be prevented because at plasma levels >50
pM, it is highly toxic to the central nervous system (Meijer et al., 1990). Carbamoyl
phosphate synthetase catalyses the products of amino acid catabolism, NH/ and
HC03", to form carbamoyl phosphate (Figure 1.6). A further four enzymatic steps
result in the formation of urea. The urea cycle occurs partially in the mitochondrion
and partially in the cytosol with ornithine and citrulline being transported across the
mitochondrial membrane by specific transport systems (Voet, 1995). Carbamoyl
phosphate synthetase controls flux through the cycle and is the key regulatory enzyme
in urea synthesis from ammonia. The concept of metabolic zonation of the liver acinus
accepts that hepatic nitrogen metabolism including ureogenesis and all five enzymes of
this cycle, confirmed by histochemical observations, occur in the periportal zone of
the acinus. Urea thus formed is secreted into the blood and sequestered by the kidneys
for excretion in the urine (Moseley, 2000). Glutamine synthetase, on the other hand, is
located in the last few perivenous hepatocytes surrounding the terminal hepatic venule
and converts ammonia to glutamine - essentially serving as a 'scavenger' for stray
ammonium ions (Meijer et al., 1990). Glutamine is subsequently released into the
terminal hepatic venule and the systemic circulation. Ammonium chloride (1-10 mM)
added to hepatocyte cultures is readily converted to urea and is a convenient
biochemical method of determining the detoxifying capability of cells in vitro
(Flendrig et al., 1997a; Koebe and Schildberg, 1996; Naik et al., 1996; te Velde et al.,
1995).
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Figure 1.6 Highly simplified drawing of ammonia metabolism in
periportal hepatocytes (Modified from Voet, 1995). Ammonia is removed
from the circulation by periportal hepatocytes and converted to urea by the
Krebs-Henseleit Ornithine Cycle (Urea Cycle), which occurs partially in the
mitochondrion and partially in the cytosol with ornithine and citrulline being
transported across the mitochondrial membrane by specific transport
systems (shaded circles). The five enzymes of the urea cycle are 1)
carbamoyl phosphate synthetase, 2) ornithine transcarbamoylase, 3)
argininosuccinate synthetase, 4) argininosuccinase, and 5) arginase.
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1.6.3 Galactose metabolism
Following a meal rich in carbohydrate, glucose is preferentially taken up by
perivenous hepatocytes from the portal blood, where it undergoes glycolysis and / or
may be converted to and stored as glycogen. In the postabsorptive or fasting state,
periportal hepatocytes facilitate the supply of glucose that can be oxidized in
peripheral tissues, to provide energy by glycogenolysis of stored glycogen and by
gluconeogenesis from substrates such as lactate, pyruvate or alanine. However,
glucose is not the only ingested carbohydrate that can be metabolised by the liver.
Galactose occurs in milk in the form of lactose. Since galactose and glucose are
epimers that differ in their configuration about Carbon-4, an epimerization reaction
must occur before galactose can enter the glycolytic pathway. This metabolic
conversion in human liver follows the Leloir pathway (Leloir, 1951) outlined in Figure
1.7.
Depending on the metabolic state of the liver, glucose-1-phosphate formed in
the transferase reaction can be converted to glucose-6-phosphate and enter the
glycolytic pathway for oxidation and provision of energy. Also, UDP-glucose arising
in the epimerase reaction may be directed toward glycogenesis (Seifter and Englard,
1994).
Galactose loading is useful clinically as an index of functional liver cell mass
(Winkler et al., 1993), in fact, galactose elimination may be a useful prognostic
indicator in patients with fulminant hepatic failure (Baker, 1992). Galactose
elimination is also a convenient measure of hepatocyte carbohydrate metabolism in
culture (Flendrig et a/., 1997a; Sajiki et al., 2000).
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Figure 1.7 The metabolism of galactose - the Leloir pathway. Four
enzymes participate in the conversion of galactose to the glycolytic
intermediate glucose-6-phosphate: 1) galactokinase, 2) galactose-l-
phosphate uridylyl transferase, 3) UDP-galactose-5-epimerase, and 4)
phosphoglucomutase (Modified from Voet, 1995).
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1.6.4 Cytochrome P450 metabolism
Cytochrome P450, present within smooth ER membranes, is the major component of
the liver mixed function oxidase system and plays a central role in the detoxification
and metabolism of many exogenous and endogenous compounds (Monshouwer et al.,
1998). Hepatic biotransformation is performed by these mixed function oxidases
which involve phase I oxidation or reduction reactions of the parent compound.
Conjugation by sulfation or glucuronidation by phase II reactions, render the
compound highly water soluble for urinary elimination (Neuberger and Finlayson,
1997). Not all xenobiotics however undergo sequential phase I and II reactions
(Moseley, 2000). Certain drugs such as paracetamol may produce toxic intermediates
under certain conditions.
In cell culture systems, the functional activity of the many P450 isoenzymes is
typically measured by their ability to detoxifiy compounds such as lidocaine,
diazepam, 7-ethoxycoumarin or paracetamol; the metabolites are usually detected by
high performance liquid chromatography (Flendrig et al., 1997a; Jauregui et al., 1997;
Gregory et al., 2000; Liu et al., 1999). Alternatively, total cytochrome P450 content
(tP450) of cultured hepatocytes can be measured in whole cell or microsomal samples
as a indicator of retained liver function, interpreted as the biotransformation potential
of the culture system (Mitaka, 1998; Nelson et al., 2000; Watts et al., 1995). Rather
than measure the functional activity of a particular component of the cytochrome
P450 system, whilst it remains unclear which isoenzyme is centrally involved in ALF
or may be down-regulated in hepatocytes, we consider tP450 to be useful 'global'
marker of the liver cytochrome P450 monooxygenase system.
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1.7 Pathophysiology of paracetamol-induced acute liver failure
Paracetamol, in therapeutic doses, is detoxified by a combination of phase I and phase
II reactions involving glucuronidation, sulfation and renal excretion. Following an
overdose, these pathways become saturated and a greater proportion of paracetamol
is metabolised through the cytochrome P450 system, leading to production of the
toxic metabolite, N-acetyl parabenzoquinoneimine (NAPQI). Glutathione (GSH)
detoxifies NAPQI and thus protects hepatic cellular constituents from its direct toxic
effect. However, once GSH levels are depleted by large amounts of NAPQI, as
occurs in significant overdose, centrilobular hepatic necrosis results which may lead to
the dramatic clinical condition of acute liver failure (ALF) (Newsome et al., 2000;
Neuberger and Finlayson, 1997).
1.7.1 The need for bioartificial liver systems
Paracetamol-induced severe hepatocellular dysfunction and necrosis is the commonest
cause of ALF in Britain and the United States. This syndrome is defined by the
appearance of hepatic encephalopathy (HE) in patients with acute liver injury (Blei,
2000; Plevris et al., 1998). The annual incidence in Scotland is 0.4 per 100 000 of the
population with paracetamol overdose accounting for 73 % of all ALF cases [Dr A
Bathgate, personal communication]. Mortality is high (70-90%) due to multi-organ
failure and cerebral oedema, which often leads to brain stem herniation and death. In
the 8 years since the opening of the Scottish Liver Transplant Unit (SLTU), over 300
cases of FHF have been referred for management. Approximately 50% required ITU
support, of whom, 20% were transplanted. Currently, orthotopic liver transplantation
(OLT) is the most effective therapeutic option, but is limited by a shortage of donor
organs. A significant proportion of patients die on the emergency list as they rapidly
deteriorate before a donor liver becomes available. For these patients temporary
bioartificial liver (BAL) support may be beneficial by prolonging survival until a liver
graft becomes available or, since ALF is potentially reversible, by promoting the
regenerative capacity of the diseased, native liver and full recovery. Development of a
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large animal model of paracetamol-induced ALF, ongoing in our laboratory, will
allow characterisation of underlying pathophysiological mechanisms and evaluation of
bioartificial liver support systems (Newsome et al., 2000).
1.7.2 Pathogenesis of hepatic encephalopathy in ALF
HE and renal failure are major complications of ALF. Although the pathogenesis of
the HE component is unknown it is generally accepted that accumulation of a variety
of toxic substances from the portal system as well as from the necrotic liver itself play
a significant role. Endotoxins, ammonia, aromatic amino acids, fatty acids,
mercaptans, bile acids, cytokines, transforming growth factor-1 and gamma-amino
butyric acid (GABA) have all been implicated in such deleterious systemic and local
effects. (Maddrey, 2000; Plevris et al., 1998; Jauregui and Gann, 1991a; Cao et al.,
1998) Even though none of these substances have been identified as being
pathognomonic for ALF, both hyperammonemia and increased GABA levels, are
considered to be intimately connected with the development of HE. In ALF plasma
ammonia concentrations are frequently elevated (with depletion of brain glutamate)
and can rapidly reach toxic levels (Record, 1991; Clemmesen et al., 1999). Ammonia
is neurotoxic to brain astrocytes, the site of brain ammonium detoxification, and
contributes to brain oedema whereas GABA, a major inhibitory neurotransitter, may
induce neural inhibition through endogenous benzodiazepine accumulation and
GABAa receptor activation (Ampola, 1994; Jauregui and Gann, 1991b; Jones and
Schafer, 1986; Albrecht and Jones, 1999) In this context, failure of the detoxification
capacity of the liver is accepted as playing an important role in this disorder. This has
directed study of PPH function to ammonia detoxification and phase I drug
metabolising enzymes and phase II conjugating enzymes.
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1.8 Liver support systems
Poor prognosis heralded by hepatic coma has led investigators to develop liver
support systems that might control the accumulation of potentially toxic substances
ordinarily metabolised or excreted by the liver. Strategies for liver support have
utilized both non-biological and biological systems.
1.8.1 Historical perspectives
Many of the aforementioned toxins are small (<5 kDa) and middle (5-15 kDa)
molecular weight compounds which, it was hypothesized, could essentially be
physically removed from the circulation by detoxification, usually involving sorption
therapy (Cao et al., 1998). Techniques employed since the 1950's have included:
blood exchange, plasma exchange (plasmapheresis), haemodialysis, haemofiltration,
total body blood washout, charcoal or resin haemoperfiision, and haemadsorption
using non-biological adsorbents (Demetriou, 1998). Despite anecdotal reports of
beneficial clinical effects, none of these systems has been consistently proven in
controlled trials to treat ALF. Problematic in the use of sorption therapy is that, since
many toxins are bound to plasma proteins such as albumin, it is difficult to remove
these substances from a patient's circulation without causing other problems. For
instance, haemadsporption uses sorbents which can efficiently remove protein-bound
toxins directly from the circulation; unfortunately, sorbents are equally efficient at
removing important components such as platelets, leukocytes, clotting factors, and
other humoral regulatory factors. Some of these techniques may however be useful as
adjuncts of more complex detoxification devices, such as hepatocyte-based systems.
In the late 1960's and early 1970's, whole blood, ex vivo liver perfusions were
used to treat patients with liver failure using a variety of species including baboon ,
porcine, dog, calf and human cadaveric livers (Abouna et al., 1970; Eiseman et al.,
1965). In most cases transient improvements in HE were noted although many
problems related to the use of xenografts were encountered including rapid rejection,
bleeding, haemolysis and cessation of function (Demetriou, 1998). For these reasons,
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notwithstanding the cumbersome and costly nature of the procedure, this technique
has been largely precluded as a treatment therapy for ALF. Recently, however
(Horslen et al., 2000) successfully 'bridged' 9 of 14 patients with severe ALF by
extracorporeal liver perfusion using human and pig livers. Intracranial pressure and
cerebral perfusion pressure were stabilized whereas both ammonia and bilirubin levels
were reduced.
1.8.2 Bioartificial extracorporeal liver support systems
Primarily because of the limited success of non-biological liver support systems and ex
vivo liver perfusions, the continuing disparity between the supply and demand of
cadaveric human livers for transplantation, and the high levels of morbidity and
mortality associated with ALF - despite advances in modern clinical management -
has led to development of hepatocyte-based bioartificial liver (BAL) support devices.
The development of a BAL device represents a formidable challenge. Unlike
the heart, lung or kidney, which essentially perform one primary task, the liver
performs thousands of functions. As stated above, the highly complex structure-
function relationships of the liver allow it to perform its synthetic and degradative
functions which impact upon almost every aspect of body metabolism and
physiological regulatory processes. Moreover, the aetiology of ALF is still not well
defined and therefore it is not clear what is essential to keep ALF patients alive in the
BAL setting. Despite these obvious shortcomings, the consensus view is that a
clinically successful BAL device should maintain a range of metabolic, excretory and
synthetic functions to support a patient with ALF. Using exogenous hepatocytes in
this context, may provide the opportunity to achieve more than just removal of toxins,
specifically, by optimising metabolic and excretory hepatic support functions (Cao et
al., 1998; Demetriou, 1998; Hoofnagle et al., 1995; Maddrey, 2000).
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The key features of a BAL system are: a) the biological component; b) a
bioreactor which can accommodate these cells and c) an efficient circuit between the
patient and the BAL in order to provide optimal exchange of nutrients, oxygen and
permit detoxification of the patient's plasma.
1.8.2.1 Biological component
Mammalian hepatocytes, in particular porcine-derived, are the most popular cellular
component of BAL devices. In theory, human hepatocytes are the cells of choice,
however the problem of relative scarcity is compounded by competing demands of
whole organ liver transplantation and hepatocyte transplantation. As with whole organ
transplantation, immune rejection is also a problem although hyper-acute rejection,
which often applies in xeno-transplantation, is generally not relevant. Finally, sourcing
of human hepatocytes from resected liver tissue from partial
hepatectomy/hepatocellular carcinoma operations has raised concern about
transmission of malignancy or infection into the patient. As a consequence of these
problems human hepatocytes have not been widely used in BAL devices and attention
has turned to immortalised human hepatocyte lines or xenogeneic hepatocytes
(Tsiaoussis et al., 2001).
Immortalised human hepatocyte cell lines can provide an unlimited resource
for BAL systems (Ellis et al., 1996; Sussman et al., 1992), but concerns exist about
their relatively poor metabolic function (Stange et al., 1995). Enosawa et al., (1996)
demonstrated that primary rat hepatocytes outperformed 31 types of hepatocyte cell
lines, including HepG2 and HuH 6 human hepatoblastoma derived lines, in terms of
ammonia removal and 7-ethoxycoumarin deethylation activities. Nyberg et al., (1994)
showed that ureagenesis and biotransformation performance of primary rat
hepatocytes, seeded into their gel-entrapment BAL device, were superior to HepG2
cells in this environment. Transmission of immortalised cells or tumourigenic
substances into the patients' circulation is also a potential risk factor (Zeidl-Engelhart
and Rabes, 1992). This concern is particularly relevant in that patients with liver
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failure are immuno-compromised for long periods of their lifetime, either acutely or
post-transplantation thus decreasing their ability to remove such malignant cells from
the circulation. This does however still remain a theoretical concern, as there is no
evidence of transmission so far (Paradis et al., 1999). However, transmigration of
HepG2 cells into the extracapillary compartment (analogous to the patient's
compartment during clinical application) was observed in a prototype BAL device
(Nyberg et al., 1994; Nyberg et al., 1994). The extracorporeal liver assist device
(ELAD) developed by Sussman and coworkers (Ellis et al., 1996; Sussman et al.,
1992), utilises the C3A cell line, a clonal derivative of the human hepatoblastoma
HepG2 cell line which exhibit strong contact inhibition of growth. C3A cells are
reported to have a more differentiated hepatic phenotype than HepG2 and other cell
lines (Sussman et al., 1992). Metabolic studies of the C3A line have shown levels of
synthetic function such as albumin and alpha-fetoprotein production and also
nitrogen-metabolizing activity, similar to that of perfused rat livers (Ellis et al., 1997).
However, when compared with primary porcine hepatocytes, the C3A cell line has
lower levels of cytochrome P450IA1 activity, ammonia removal and amino acid
metabolism (Wang et al., 1998).
The ready availability, high viability and yield of primary porcine hepatocytes
(PPHs) -which support the requirements of a BAL device - coupled with anatomical,
physiological, and a range of metabolic function similar to that of human hepatocytes,
confer PPHs with significant advantages over other xenogeneic mammalian cell
sources. Large cell numbers are required for BAL systems since it is estimated from
recent animal studies that at least 20 % of host liver mass is required for effective
support, corresponding to approximately 2x 1010 hepatocytes. High yield isolation of
PPHs usually involves anterograde collagenase perfusion of the portal and / or hepatic
artery (Sheil et al., 1998; Sharda et al., 1996; Rozga et al., 1993b; Naruse et al.,
1996b; Naik et al., 1996; Morsiani et al., 1998; Gerlach et al., 1996a; Flendrig et al.,
1997a), such techniques are cumbersome, time-consuming, expensive, and require
expert licensed personnel with appropriate surgical expertise and facilities. To
circumvent this, we developed a retrograde ex vivo whole liver collagenase perfusion
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technique that gives the required yield and viability for large-scale BAL devices and
can be performed in any standard cell biology research facility (Nelson et al., 2000).
PPHs exhibit a wide range of differentiated functions under a variety of in vitro
culture conditions including performance testing in protoype and scaled-up BAL
devices. Functional activity has been evaluated in terms of urea and albumin synthesis;
numerous biotransformatory functions; carbohydrate and bile metabolism; as well as
proliferative activity (De Bartolo et al., 2000; Demetriou, 1998; Desille et al., 1999;
Flendrig et al., 1997a; Gregory et al., 2000; Jauregui et al., 1997; Nelson et al., 2000;
Rozga et al., 1993b; Waring et al., 1995; Bader et al., 2000) These attributes of
PPHs support their candidacy as the premier cell source for BAL systems.
1.8.2.2 The bioreactor
The majority of current bioreactor designs utilize hollow-fibre technology based upon
original proposals by Wolf and Munkelt, (1975). Synthetic semi-permeable (hollow-
fibre capillary) membranes act both as a cell support and as a channel for the transport
of perfusates in the bioreactor. The design is based on the counter-current blood flow
principle used in conventional renal haemodialysis systems where the patient's blood
is perfused through the hollow-fibre lumen with functional hepatocytes on the extra-
luminal side and enclosed in a plastic shell housing. Bi-directional solute transport and
oxygen delivery is achieved by fluid convection (Starling flow) driven across the
membrane by a trans-fibre pressure drop, which is proportional to the axial flow rate
(Demetriou, 1998; Cao et al., 1998).
The complexity and diversity of liver function are reflected in the range of
innovative bioreactor designs under development. Novel bioreactor models include
configurations based upon: various hollow-fibre systems; microcarrier systems; flat
membrane bioreactors (see Figure 1.8); spirally-wound ('Swiss-roll') nonwoven
polyester sheets; spouted-bed and packed-bed bioreactors; and intra-luminal gel-
entrapment devices (Nyberg et al., 1993; Gerlach etal., 1994a; Flendrig et al., 1997a;
Demetriou, 1998; De Bartolo et al., 2000). The two major BAL systems under
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evaluation in clinical trials are briefly described as well as some of the prototype BAL
configurations currently under assessment - all of which incorporate PPHs as the
biological component.
Demetriou & Rozga (Chen et al., 1996; Chen et al., 1997; Kong et al., 1996)
developed a novel, hybrid extracorporeal liver support device using plasma separation
and high-performance sequential plasma perfusion through a column loaded with
activated cellulose-coated charcoal particles and through a hollow-fibre bioreactor
with viable, collagen matrix/microcarrier-anchored, cryopreserved PPHs. This device
has been used to treat some 3 8 patients with ALF of varying aetiologies; all but one
survived and were successfully transplanted; with one patient recovering fully without
transplantation. Significant decreases in intracranial pressure, plasma ammonia levels
and bilirubin were described with an increased cerebral perfusion pressure,
neurological improvement and reduction in cerebral oedema. No adverse reactions to
PPHs after intermittent (6 hours) multiple treatments were observed. However there
was no significant reduction in prothrombin time.
The ELAD used by Sussman's group (Ellis et al., 1996) utilized high density
C3A cell cultures (described above), attached directly to the extraluminal domain of
uncoated hollow-fibre membranes. No charcoal sorbent column was used. Continuous
(«72 hours) perfusion of heparinized whole blood did not result in significant
improvement in survival of 24 patients with ALF compared with controls. However,
galactose elimination was improved and there was a 4-fold increase in human growth
hormone after 6 hours of haemoperfusion. Whether the ELAD can effectively remove
inhibitors of regeneration remains unclear.
Gerlach and coworkers (Gerlach et al., 1995; Gerlach et al., 1994a) developed
a bioreactor system whereby separate bundles of hollow-fibres, were arranged in a 3-
dimensional network enclosed in a plastic casing. Four capillary systems were
apposed in different directions in the bioreator space for: plasma inflow; oxygenation
as well as CO2 removal; and coculture with SECs. This system recreated in v/vo-like
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liver microarchitecture to some extent, by attachment of PPH aggregates to the extra-
luminal compartment capillaries coated with Matrigel™. Albumin synthesis, galactose
elimination and P450 function was maintained for up to seven weeks. This system has
not been tested in clinical trials.
Another innovative system developed by (Flendrig et al., 1997a), comprises
spirally-wound nonwoven polyester sheets in a 'Swiss-roll' formation which allows a
high density 3-dimensional framework for PPH immobilization and aggregation.
Functional activity (galactose elimination; urea and albumin synthesis; lidocaine and
amino acid metabolism) was well maintained over the four-day test period.
Significantly, no ECM material was required and the bioreactor was autoclavable;
resulting in a safer, cheaper and more convenient device. Moreover, this device
prolonged survival and plasma ammonia and total bilirubin levels, in pigs with
complete liver ischaemia, using 14 x 109 PPHs, with no adverse effects (Flendrig et
al., 1999).
Finally, Bader's group in Germany (De Bartolo et al., 2000; Bader et al.,
1995a; Bader et al., 1995b) attempted to reconstruct hepatic-specific tissue
microarchitecture in their modular flat membrane bioreactor (Figure 1.8). Liver cells
are organized as 'acinar-like' plates within a collagen gel sandwich, on either side of
the sandwich are gas permeable hollow fibre membranes, supplying culture medium
(or plasma, in clinical test mode) or C02 / 02. After 18 days in culture cells retained
polarity and differentiated function including albumin and urea synthesis as well as
biotransformation activity. Clinical trials of this device are eagerly awaited.
Unlike Demetriou's BAL device described above which uses an external
oxygenator, this device and that of both Gerlach and Flendrig, provide integral
oxygenation - considered an essential parameter for modern BAL systems
encompassing 3D cellular configurations (De Bartolo et al., 2000; Balis et al., 1999).
1-27
Reservoir
Figure 1.8 Schematic illustration of a flat membrane bioreactor (Modified
from De Bartolo et a!., 2000)
The bioreactor is a modular stackable plate arrangement that can
accommodate 1010 cells (50 plates in parallel). Cells and serum-free medium
are oxygenated by diffusion of humidified air (C02 / 02) across a 35pm non-
porous gas permeable membrane and perfused via a multi-channel
persistaltic pump, at a flow rate of 9 ml/hour. Following seeding and
attachment of cells onto a single layer of Type I collagen, a second layer of
matrix is placed on top, creating a 'collagen gel sandwich' configuration.
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A novel prototype bioreactor has been developed the University of Strathclyde
(US) Bioengineering Unit (SUBU) and Dept of Chemical and Process Engineering,
our collaborators in the development of a PPH-based BAL device (Smith et al., 1996;
Smith et al., 1997a; Smith et al., 1997b). The SUBU bioreactor (Figure 1.9) has a
modular, stacked-plate configuration incorporating hollow-fibres for integral
oxygenation which allows improved control of cell surface p02 and optimal mass
transfer capability. Hepatocytes are arranged as both small aggregates and monolayers
attached to the extracapillary space allowing optimal exchange of nutrients, oxygen
and removal of toxins. The scaled-up bioreactor will utilise at least 1010 freshly
isolated hepatocytes representing >10% of total functional liver mass, which is the
required theoretical mass to treat a 30kg pig model of paracetamol-induced ALF,
being developed in our laboratory (Newsome et al., 2000).
This represents a configuration of twenty (30cm x 60cm) stacked-plates with a
cell density of 0.18xl06 cm"2. Further scale-up to accommodate >1010 cells is
underway. Functional assessment of the bioreactor, in terms of urea synthesis,
galactose elimination and albumin production show promising results.
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Figure 1.9 Prototype bioreactor developed at the University of
Strathclyde Bioengineering Unit (Dr J Gaylor, personal communication)
Panel A shows a schematic illustration of the general bioreactor geometry.
Panel B In pre-clinical mode, each module is comprised of 2 plates (P1, P2),
which are sealed together by a gaskit (g). Cells attach directly to the plastic
surface (P1) as monolayers and small aggregates. Medium (or plasma in
clinical mode) is perfused through the inlet port (in) and flows over the
attached cells via a channel reservoir (ch) and exits at the outlet port (out).
Hollow-fibres for integral oxygenation are incorporated into plate P2, which
allow improved control of cell surface p02 and optimal mass transfer
capability. A configuration of sixty (30cm x 60cm) stacked-plates (0.5 cm
thick) with a cell density of 0.18x106 cm"2 would allow attachment of
approximately 1010 cells. Panel C The plate stacks are clamped and held in
place by the bioreactor housing.
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1.9 Background and Aims of Research Project
Modulation of function and morphology of primary hepatocyte cultures
The need for species-specific characterization of cellular function for optimal BAL
device implementations is crucial. Numerous hormonal, medium and substrate
conditions have been described in the literature for restoring and maintaining well
differentiated functional and morphological properties of cultured hepatocytes using
the rat as model (LeCluyse et al., 1996). In the field of BAL development, such data
gleaned from studies using rat hepatocytes has inevitably been translated or
extrapolated to porcine hepatocytes. However, not only do distinct species differences
exist in terms of attachment efficiency, functional, morphological and proliferative
properties, but very few comprehensive comparisons of culture conditions have been
reported with physiologically relevant endpoints pertaining to the use of PPHs for
BAL support therapy.
As described above, many types of bioreactors with variable cell culture
configurations, medium composition / supplements, and ECM are used. Similarly, the
endpoints used, to analyse function, for example, are equally variable due in part to
the lack of understanding of the precise requirements for an effective BAL device. As
proposed by Skett and Bayliss, (1996), standardization of both isolation and culture
conditions will allow for more reproducible and relevant evaluation of in vitro data.
This will allow direct comparisons between laboratories of the performance efficacy
of different BAL systems.
The major interdependent factors which enhance the liver-specific function
and phenotype in primary hepatocyte cultures are recognized as: a) the medium
composition (soluble components), b) the ECM, and c) cell-cell contacts (Gerlach et
al., 1995; Bhatia et al., 1999; Berthiaume et al., 1996; Ben-Ze'ev et al., 1988;
LeCluyse et al., 1996). This implies that both cell shape and the microenvironment
may have an important influence on liver cell function both in culture and in vivo.
1-32
Evidence that cell shape, cell-cell and cell-matrix interactions were important in
preservation of liver-specific phenotype and maintenance of function came from
studies of densely packed confluent monolayers of hepatocytes cultured on collagen
gels or Matrigel™ and hepatocytes cultured as spheroids (Berthiaume et al., 1996;
Bhatia et al., 1999; Koide et al., 1989; Koide et al., 1990; Landry et al., 1985; Sakai
et al., 1996; Yuasa et al., 1993). Furthermore, gross morphological observations of in
vitro hepatocyte cultures and ultrastructural analysis, give important clues as to cell
'fitness' and differentiative state, respectively.
In BAL devices, the significance of cell aggregation in improving in vitro
performance of PPHs has been emphasized (Bader et al., 1995b; De Bartolo et al.,
2000; Demetriou, 1998; Flendrig et al., 1997a; Gerlach et al., 1994a; Jauregui et al.,
1997). To achieve this, all of the aforementioned BAL devices, except for Flendrig et
al (1997a), utilize some form of ECM substrata; while all of the above systems use
medium formulations such as William's medium E, Medium 199 or RPMI 1640
medium, supplemented with foetal bovine serum. The latter has been routinely
employed with medium formulations culturing rat hepatocytes as prerequisite for
improving attachment, survival and morphology. However, detrimental effects of
serum on hepatocyte differentiation have been observed including cytostatic and
cytotoxic effects, leading to cellular dedifferentitation, which may preclude its use in
pre-operational, clinical BAL systems (Berry et al., 1997; LeCluyse et al., 1996).
Moreover, studies from our laboratory, and others, have shown that PPHs do
not require serum supplementation or ECM substrates for high viability culture and
function ( Gregory et al., 2000; Nelson et al., 2000; te Velde et al., 1995). The
reasons for this are unknown. Perhaps the small clusters (5-20 cells) of PPHs, typical
of isolates following collagenase digestion, retain sufficient endogenous ECM
components 'trapped' within the aggregates. Alternatively, this three dimensional
organization may retain expression of cell adhesion molecules, including integrins, for
more efficient attachment and establishment in culture, compared with other
mammalian hepatocytes.
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The commercially available (basic) media formulations mentioned above
contain a complex mixture of amino acids, vitamins, trace elements and cofactors.
Despite the large number of media used for rat hepatocyte culture (LeCluyse et al.,
1996), very few studies have compared the effects of medium formulation on the
maintenance (or potential modulatory influence) on liver-specific function and
morphology for in vitro rat models (Jauregui et al., 1986; LeCluyse et al., 1999;
Michalopoulos et al., 1999; Turner and Pitot, 1989; Williams et al., 1977). The
influence of medium formulation may be significant. For instance, LeCluyse et al.
(1999) showed that medium formulation and culture dish material had significantly
greater effects on the induction of cytochrome P4502B by phenobarbital than either
collagen or Matrigel™ sandwich cultures of rat hepatocytes. As mentioned, distinct
species differences are known to exist. For example, cell proliferation studies have
shown porcine hepatocytes to have a much greater proliferative potential than rat
hepatocytes cultured on collagen in hormonally-defined medium (Joly et al., 1997;
Wegner et al., 1992). In addition, pig hepatocytes reproduced cytochrome P450-
dependent oxidative metabolism of human hepatocytes to a greater extent than either
rat, rabbit or dog primary cells, or the HepG2 hepatoma cell line (Donato et al.,
1999). Finally, oxygen uptake rates, an important parameter in BAL design, were
significantly higher for PPHs than rat hepatocyte monolayer cultures (Balis et al.,
1999). These studies highlight the need for species-specific characterisation ofhepatic
cellular function to optimise performance for BAL systems.
However, there is no information available on the influence of medium
composition on liver-specific function and morphology using porcine hepatocytes. It
seems reasonable to assume that serum-free medium, containing soluble supplemental
factors - including the use of hormones such as insulin and dexamethasone, growth
hormones as well as growth factors (eg EGF or HGF) - may improve cell survival,
morphology and function of PPHs in vitro. However, very little is known about
whether PPHs can be maintained under such chemically-defined culture conditions on
simple uncoated surfaces, such as tissue culture plastic or hollow-fibre membranes,
without either serum or ECM substrata. Importantly, BAL configurations which
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utilize Engelbreth Holm Sarcoma Natrix (EHS) or Matrigel as substrata, may risk
leaking potentially tumourigenic or murine proteins, respectively, into the patients
circulation, raising questions of potential immunogenicity and bioreactor safety.
Unlike PPHs, rat and human hepatocytes, have an absolute requirement for
exogenous matrix proteins for cell attachment (Christiansen et al., 1988; Odenthal et
al., 1992). We propose that identifying in vitro culture conditions, which could
maximize differentiated hepatic function of PPHs, under serum-free fully defined
conditions on simple, unmodified surfaces, such as tissue culture plastic, may improve
efficacy, safety, and reduce costs of BAL devices. Furthermore, improving the hepatic
culture environment would contribute to being able to provide the required cell mass
for more ergonomic BAL designs.
This thesis will address some of these issues by attempting to delineate the
optimal test medium for retention of liver-specific function and phenotype, and assess
whether different medium formulations modulate these parameters in vitro.
Furthermore, we introduce the concept of a 'hepatocyte biological activity index'
(HBAI), to simplify analysis of the multiple (functional) comparisons requisite of such
a study. The HBAI normalises each hepatic functional parameter with respect to an
equally weighted scoring system. Additionally, the impact of media formulation on
culture morphology and phenotype is taken into account.
Finally, the feasibility of using a novel simulated microgravity (rotary cell
culture system) modality is investigated, in order to improve the hepatic culture
environment by growing PPHs as 3-dimensional 'hepatospheroids' which may more
closely resemble in v/vo-like tissue architecture and enhance cell-cell cell matrix
interactions. Recently, human liver cells grown in microgravity were shown to exhibit
liver tissue-specific morphological and functional characteristics over a 60-day culture
period (Khaoustov et al., 1999; Yoffe et al., 1999). Characterisation of the optimal
culture conditions for PPHs will help further clarify their therapeutic potential for use
as the biological component of BAL systems.
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Inasmuch as media supplementation, biomatrices and cell-cell contacts have
been shown to maintain, enhance or prolong hepatocyte differentiated performance in
vitro, alternative strategies are available which may elicit these effects, including: a)
Preferential cell isolation b) Coculture, c) Chemical modulators, and d) The use of
spheroid cultures. Future developments that may be implemented to enhance the
hepatic culture environment are discussed within the framework of relevant
experimental chapters.
Aims of research project
■ To develop a rapid, low-cost, high viability, high yield and reproducible ex
vivo method for obtaining functional primary hepatocytes from whole livers of
weanling piglets for use in BAL systems.
■ To assess the modulatory effects on hepatocyte morphology of different
serum-free chemically-defined media formulations on cultured porcine
hepatocytes in terms of:
1) Gross cellular morphology under phase contrast light microscopy
2) Cell ultrastructure under transmission electron microscopy
3) Biochemical parameters related to cellular attachment and viability
■ To assess differential effects of separate, serum-free chemically-defined
medium formulations on differentiated hepatic support functions of cultured
porcine hepatocytes for future BAL devices.
■ Using biochemical, histological, ultrastructural and immunocytochemistry
studies, we sought to identify whether spheroid aggregate formation in the
unique environment of simulated microgravity, maintained stable, liver-specific
metabolic capacity and characteristic hepatic morphology for an extended
period. The expression of integrin a5, as a marker of hepatic differentiation




An Improved Ex Vivo Method Of Primary Porcine Hepatocyte
Isolation For Use In Bioartificial Liver Systems
2.1 Introduction
Primary porcine hepatocytes (PPHs) are used for in vitro studies of hepatocyte
function including studies on hepatotoxicology, transfection / gene transfer,
hepatocyte transplantation and bioartificial liver (BAL) systems for treatment of acute
liver failure (ALF) (Demetriou, 1998; Guillouzo et al., 1997).
Immortilized human hepatocyte cell lines' such as Hep G2, can theoretically
provide an unlimited resource for use in BAL systems (Sussman et al., 1992).
However, problems associated with possible transfer of tumourigenic proteins to the
patient via the BAL, and the rather limited functional range of these dedifferentiated
cells, have severely limited usage of cell lines in BAL devices (Jauregui et al., 1997;
Jauregui and Gann, 1991; Nyberg et al., 1994; Plevris et al., 1998). Hepatocyte
viability from standard rat liver perfusions is similar to that obtained from pigs
(Nyberg et al., 1993b), but yields of 108 hepatocytes are not sufficient to be
incorporated into a scaled-up clinical device for use in humans. Since primary human
hepatocytes are not readily available (Plevris et al., 1998) and large yields of
functional hepatocytes are required for a clinically effective BAL, PPHs are the cells
of choice for BAL devices. They are differentiated hepatocytes with similar
biochemical and metabolic functions to human hepatocytes and can be obtained with
good viability and yield (Clement et al., 1998; Gerlach et al., 1994c; Gerlach et al.,
1996a; Jauregui et al., 1997; Jauregui and Gann, 1991). A concern in the use of PPHs
for clinical BAL application, however, remains the possible transfer of pig
endogenous retroviruses to humans (Martin et al., 1998).
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Conventional in vivo isolation of PPHs involves anterograde perfusion of the
portal vein, sometimes in combination with perfusion of the hepatic artery. However,
although producing excellent cell viability and yield, this technique requires large
perfusion volumes with the associated high collagenase costs with increased perfusion
times (Flendrig et al., 1997a; Fremond et al., 1996; Gerlach et al., 1994c; Hu et al.,
1997; Sheil et al., 1998; Sielaff et al., 1995b). Moreover, in vivo techniques involve
anaesthetic maintenance regimes and extensive surgical facilities requiring expert
licensed personnel. These requirements may preclude many laboratories from
obtaining and utilizing the considerable research potential of porcine hepatocytes.
Ex vivo isolation of PPHs from livers of abattoir origin can attain acceptable
viabilities (Donini et al., 1997; Koebe and Schildberg, 1996) but with several
disadvantages including insufficient yield for BAL devices, availability and locality
constraints of the abattoir source, relatively high collagenase costs and potential
infection problems with abattoir-derived organisms.
Since an effective high yield and high viability method ofobtaining functionally
active PPHs is prerequisite for efficient BAL devices, different perfusion methods and
conditions were tested to establish a reproducible isolation technique suitable for
subsequent morphological and functional evaluation under different culture
conditions.
2.2 Aim
The aim of this study was to develop a rapid, low-cost, high viability, high yield and
reproducible ex vivo method for obtaining functional primary hepatocytes from whole
livers of weanling piglets for use in BAL systems.
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2.3 Materials and methods
2.3.1 Animals
2.3.1.1 Method I: Liver wedge isolations
Livers (1.5 kg) were retrieved from 60 kg pigs obtained from Forth Meat Supplies
Abattoir (Galashiels, Scotland, UK). Prior to liver retrieval, animals were killed
instantly with a captive bolt gun to the cranium before immersion in a 65°C water
bath. The whole liver was then removed from the carcass before the liver wedge was
dissected out for subsequent perfusion.
2.3.1.2 Methods II and III: Whole liver isolations
The animals were treated in accordance with UK Home Office Guidelines (Scientific
Procedures Act, 1986). Following euthanasia, all procedures were performed post
mortem. Piglets (Large white; <15 kg) were obtained from the Roslin Institute
(Roslin, Scotland) on the day of isolation and maintained on standard feed and water
ad libitum up to the time of sacrifice. Animals were anaesthetized with 30 mg/kg
body weight (bwt) of pentobarbitone sodium via the auricular vein and then killed
with an i.v. bolus dose of 150 mg/kg bwt. The abdominal cavity and lower chest were
opened with a midline incision exposing the viscera and the suprahepatic inferior vena
cava (IVC) clamped just below the heart, cannulated with a Foley catheter and
secured with a ligature. The infrahepatic IVC was also clamped (Figure 2.1).
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Figure 2.1 Diagram showing the Foley catheter / perfusion assembly
Diagram shows the Foley catheter assembly in the supra-hepatic inferior
vena cava (IVC) and positioning of tie clamps for retrograde perfusion of
whole piglet liver (not to scale). Perfusate enters the liver through the supra-
hepatic IVC, while clamping the infra-hepatic IVC shunts the perfusate to exit
via the porta hepatis; (ha) hepatic artery, (hv) hepatic vein, (pv) portal vein.
Broken lines with arrow heads depict the direction of retrograde perfusion.
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2.3.2 Reagents
Type IV collagenase (from Clostridium histolyticum), ethylene glycol-bis[p-
aminoethyl ether]-N,N,N'N'-tetraacetic acid (EGTA), N-2-Hydroxyethylpiperazine-
N'-2-ethanesulfonic acid (HEPES), albumin (Fraction V), long epidermal growth
factor (L-EGF), Triton X-100, and Williams E (WE) medium were obtained from
Sigma Chemical Co. (St Louis, Mo, USA). Penicillin-Streptomycin, Gentamycin,
Fungizone (Amphotericin B), L-Glutamine, phosphate-buffered saline (PBS, pH 7.4)
and Hanks' Balanced Salt Solution (HBSS; Ca and Mg free, pH 7.4) were cell culture
grade supplied by Gibco (Paisley, UK). Analar grade chemicals for the perfusion
solutions and P450 buffer were obtained from Life Technologies (BDH Merck).
University of Wisconsin (UWS) preservation solution (Viaspan™) was obtained from
DuPont Chemical Co (USA). Other reagents were: Dexamethasone (David Bull Labs,
England), Aprotinin (Trasylol™, Bayer) and porcine insulin (Pork Velosulin™, Novo
Nordisk, Denmark).
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2.3.3 Perfusion and washing buffers
2.3.3.1 Methods I and II [Drs J Gerlach, M Smith; personal
communication];
Perfusion Stock Solutions: 1) For 1L [lOx] Hanks Buffer Stock Solution: 80g NaCl,
4g KC1, 2g MgS04.7H20, 0.6g Na2HP04.2H20, and 0.6g KH2P04 were dissolved in
distilled water (dH20), made up to 1L and stored at 4°C (for <3 months). 2) For 2L
[2x] Krebs-Henseleit Buffer Stock Solution (KHBS): Solution A: in the following
order, 785ml dH20 200ml 16.09% NaCl (32.18g NaCl / 200ml), 150ml 1.1% KC1
(1.605g / 150ml ), 25ml 0.22M KH2P04 (0.748g / 25ml), 50ml 2.74% MgS04.7H20
(1.37g / 50ml) and 100ml 0.12M CaCl2.6H20 (2.628g / 100ml) were added to a 2L
brown bottle and equilibrate with 95%02/5%C02 gas for 10 minutes; Solution B:
9.71g NaHCCb was dissolved in 1L dH20 and gassed as above. Add solution A
(1310ml) to 690ml solution B for 2L KHBS. Store at 4°C. NB Solution must be clear
upon mixing (if a precipitate was evident the solution was discard). Liver Perfusion
Solutions: Hanks I: Add 2.1g NaHCCh, 3.0g HEPES, 6.66g Bovine Serum Albumin
(BSA), 228mg EGTA, and 100ml [xl 0] Hanks Stock Solution to 600ml dH20, mix
well, make up to 1L and pH to 7.4 with 5N NaOH then sterile-filter. Store at 4°C.
Hanks II: Add 2.1g NaHCCb 3.0g HEPES, 294mg CaCl2,2H20 and 100ml [xlO]
Hanks Stock solution to 600ml dH20, mix well, make up to 1L and pH to 7.4 with
5N NaOH and sterile-filter. Store at 4°C. Krebs Albumin Buffer (KAB): For 1L KAB;
add 3.0g HEPES, lOg BSA and 500ml [x2] Krebs Stock Solution to 300ml dH20
(adding BSA last), mix well, make up to 1L and pH to 7.4 with 5N NaCl then sterile-
filter solution. Store at 4°C. Cell Washing Solutions: (Krebs HEPES Buffer (KHB)):
For 1L KHB; add 3.0g Hepes and 500ml [x2] Krebs Stock Solution to 300ml dH20,




Stock solution: 2 litres of a stock Perfusion Buffer (PB) containing 154 mmol/L NaCl,
5.6 mmol/L KC1, 5 mmol/L glucose, 25 mmol/L NaHC03 and 20 mmol/L HEPES
was made up with distilled H20, adjusted to pH 7.4 and sterile filtered. PB1 consisted
of 500ml stock PB supplemented with EGTA (at 1 mmol/L), 20 mg dexamethasone
and 1.4 mg aprotinin; PB2 contained 500ml stock PB with EGTA (at 1 mmol/L)
alone; PB3 consisted of 100ml PB stock only; PB4 was 500ml stock PB containing
5mmol/L CaCl2, and either 0.03, 0.04, or 0.05 % (w/v) Type IV collagenase; PB5
was 200ml Williams E medium only.
2 litres of washing buffer (WB) containing 120 mmol/L NaCl, 6.2 mmol/L KC1, 0.9
mmol/L CaCf, 10 mmol/L HEPES and 0.2% (w/v) albumin, was made up with
distilled H20, adjusted to pH 7.4 and sterile filtered. All equipment was sterilized by
autoclaving (Koebe and Schildberg, 1996).
2.3.4 Perfusion methods
2.3.4.0 General description
Four perfusion methods were tested to permit isolation of primary porcine
hepatocytes (PPHs) with high viability and yield for use in BAL systems. Method I:
Liver wedge isolation from 60kg abattoir-sourced pigs; Method Ila: Whole liver
isolation from piglets (<15kg). Both these preliminary methods utilized perfusion
solutions previously used for in vivo isolation techniques (Drs J Gerlach, M Smith;
personal communication). Method lib: This procedure was identical with Method Ila
except that heparin was added to the initial saline flush solution. The above mentioned
methods utilized 0.05% (w/v) Type IV collagenase. Method III: Modified whole liver
retrograde isolation technique (Adapted from Koebe & Schildberg, 1996): Different
concentrations (0.03-0.05% (w/v)) of collagenase were tested and the optimal
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(0.03%) was adopted as the final (most favorable) method for isolating PPHs (Nelson
et al., 2000) and used for all subsequent experiments presented in this thesis. The
advantages and disadvantages of each method will be discussed in Section 2.6.
2.3.4.1 Method I: Liver wedge isolation from abattoir-soureed pigs
On site (in the abattoir), a 400-500g central wedge portion of liver was removed so
that medium-sized hepatic veins were clearly visible (thin-walled vessels with a brown
appearance). These veins were flushed with 1 litre of UWS using a sterile 50 ml
syringe. The liver was stored on ice in UWS in a sterile sealed container for transport
back to the lab.
Perfusion solutions Hanks I, Hanks II, Krebs Albumin Buffer (KAB), and Krebs
Hepes wash Buffer (KHB) were prewarmed to 37°C in a water bath and equilibrated
with 95% 02 / 5% C02. Inside a Class II hood, the liver wedge was kept in UWS on
ice and 4 to 8 hepatic veins cannulated using Venflon™ catheters sutured into place.
The liver was then placed into a sterile bowl kept at 37°C and connected to a 4-
cannulae perfusion rig. Perfusion was performed either open loop or closed loop using
a Watson-Marlow peristaltic pump to transport perfusate to (or from) the liver via
sterilized 5mm bore silicon tubing connected (via luer caps) to the Foley catheter and
the adapted perfusion bottle lid. The pump was run briefly with perfusate to expunge
any air bubbles. The liver was then perfused with: (1) 1 litre Hanks I buffer at 50
ml/min (open loop); (2) Closed loop (recirculating flow) of 500 ml Hanks II buffer
with 0.05% (w/v) type IV collagenase at 100 mlmin"1, until there was clear evidence of
regional tissue disruption (liver wedge shows pallor and becomes flaccid). The
collagenase-digested portions of the liver wedge were, using sterile gloves, gently
sloughed off into 500ml KAB solution. The crude cell suspension was sterile-filtered
sequentially through 1000, 360, 190, and 70 pm mesh filters. Parenchymal cells were
allowed to sediment in KAB and the non-parenchymal cell fraction (supernatant)
aspirated. The hepatocytes were then washed with KHB, using 3 centrifuge-wash
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cycles at 50g (room temperature) for 5 minutes. Finally, cells were resuspended in
100ml KHB.
2.3.4.2 Method II: Whole liver isolation
Method lla: The liver was perfused retrogradely in situ with 500ml ice-cold 0.9%
sterile iv saline solution (Baxter) via the Foley catheter which was coupled to a
Vygon™ connector and 50ml syringe both with luer locks (Figure 2.1). The whole
liver was excised and exsanguinated with a further 500ml 0.9% saline confirmed by a
clear perfusate emerging from the portahepatis (leaving the Foley assembly and
intrahepatic 1VC clamp in place), the whole organ was then rinsed with 250ml
University of Wisconsin Solution (UWS), placed in a polythene bag with 750ml UWS
on ice, and transported to the laboratory.
For this isolation method of ex vivo retrograde perfusion, Hanks I, Hanks II and KAB
were pre-warmed in a water bath at 37°C and directly oxygenated with 95%02 /
5%C02 gas. The liver was transferred from UWS storage to a warmed container.
Perfusion was open loop or closed loop at a flow rate of 75 ml min" . Organ
Perfusion: An initial open loop perfusion with 1.5 L of Hanks I solution was
performed followed by a closed loop recirculating perfusion of 1.5 L Hanks II
perfusate containing 0.05% w/v collagenase Type IV for 45-60 minutes. Following
the completion of each perfusion step the perfusate was discarded. A final closed loop
perfusion with 750ml KAB was effected. Following this step, the perfusate was
discarded and 750ml (37°C) KAB added (at this stage, the liver appears flaccid,
shows pallor and easily ruptures upon testing with a blunt instrument). Whole Liver
Dissociation: The liver was then gently disrupted manually into KAB using sterile
gloves, removing non-perfused tissue and the intact gall bladder. The hepatocyte
suspension was cooled on ice and the cell suspension filtered using 300, 200 and 100
pm stainless steel filters into a 2 litre sterile Duran bottle. Next, 300ml oxygenated
(4°C) KHB was added and the parenchymal cells allowed to sediment for 15-30
minutes, and supernatant aspirated. This step was repeated with KHB, followed by 2
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centrifuge wash cycles in KHB at 4°C. Finally, the washed cell suspension was
resuspended in then oxygenated Williams E media, and cell viability and yield assessed
on a haemocytometer under phase contrast microscopy, incorporating the trypan blue
exclusion test.
Method lib: In one series (n=3; animals 11.2±0.9 kg bwt), following euthanasia,
25000 U heparin was added to the 0.9% saline flush solution. Otherwise, the protocol
was identical with Method 11 a.
2.3.4.3 Method III: Modified whole liver retrograde isolation technique
The liver was retrogradely perfused in situ with 250ml PBS at 4°C, via the Foley
catheter which was coupled to a Vygon™ connector and 50ml syringe both with luer
locks (Figure 2.1). The whole liver was excised and exsanguinated with a further 250
ml of PBS, confirmed by a clear perfusate emerging from the portahepatis (leaving the
Foley assembly and intrahepatic IVC clamp in place), the whole organ was then rinsed
with PBS, placed in a polythene bag with 200 ml PBS on ice, and transported to the
laboratory.
Prewarmed perfusion buffers (PB1-4) were saturated with 95% 02 / 5% C02 and the
liver transferred to a stainless-steel bowl and placed in a 37°C water bath with the
buffers (Figure 2.2). Perfusion was either open loop (non-recirculated; PB 1-3, PB5)
or closed loop (recirculated; PB4). The liver was sequentially perfused via the Foley
catheter connected to a peristaltic pump (Watson-Marlow, USA) set at 50 ml/min via
silastic tubing thus: PB1 («8 mins), PB2 (~8 mins), PB3 («2 mins), PB4 («16mins)
and PB5 (at 4°C for «3mins). Perfusate was removed following steps PB1, PB2 and
PB3.
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Figure 2.2 Photographs showing the general perfusion set-up for ex
vivo retrograde perfusion and the effects of collagenase digestion on
whole piglet liver
These photographs show the general set-up of a successful Method III
isolation procedure. Panel A Perfusion buffers (PB1-4) were connected to a
coupling lid which allowed either open- or closed-loop retrograde perfusion
of the liver via silastic tubing and a peristaltic pump. Panel B This ventral
view of the liver shows closed-loop perfusion whereby the collagenase
solution is pumped retrogradely (green arrow) into the superior IVC (not
visible) via the Foley catheter / Vygon connector assembly. Clamping of the
intrahepatic inferior vena cava (Inf. IVC) shunts perfusate through the porta
hepatis (ph). After 10 minutes collagenase perfusion, the liver is very pale in
colour and there are signs of tissue blanching (black asterisks). Panel C This
dorsal view of the liver shows that, after 16 minutes collagenase perfusion,
the liver capsule has ruptured (white asterisks) and cells released into the
perfusate. See Section 2.3.4.
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2.3.5 Method III: Hepatocyte Isolation
Following perfusion the whole liver was dissected aseptically with sharp scissors into
«1 cm3 pieces and the disrupted tissue placed in an orbital shaker at moderate speed
for 5 minutes at 37°C in the presence of PB4 and PB5. The resulting cell suspension
was transferred to a laminar flow hood and sequentially filtered through a stainless-
steel collander and meshes of grid size 200, 150 and 100 pm respectively into
collection bottles placed on ice. Collagenase activity was neutralised by adding 500 ml
WB at 4°C (containing 0.2% albumin) to the filtered suspension to achieve a final
volume of 1200ml. The predominantly parenchymal cell fraction was allowed to
sediment on ice and the non-parenchymal fraction aspirated. The hepatocytes were
then washed with WB, using 3 centrifuge-wash cycles at 25 g (4°C) for 5 minutes.
Finally the hepatocyte pellets were resuspended in Williams E medium at 4°C. Cell
number and viability were initially determined by the trypan blue exclusion test using a
Neubauer brightfield haemocytometer (BDH, Merck). Aliquots of fresh cell
suspension were analysed for total protein content, total cytochrome P450 content,
LDFI activity and for urea synthesis rate following ammonium chloride challenge.
2.3.6 Method III: Hepatocyte cultures
Cells were seeded at a density of 8x106 viable cells per 90mm culture dish (Dow
Corning, USA) in 8ml WE medium at 37°C. The culture medium consisted of serum-
free, hormonally-defined Williams E media (WE+) supplemented with 50 ng/ml L-
EGF; lOpg/ml porcine insulin; 1 pmol/L dexamethasone; 2 mmol/L L-Glutamine; 50
mg/ml Gentamycin; 50 mg/ml Penicillin-Streptomycin and 2.5 pg/ml Fungizone. The
culture dishes were shaken gently to aid dispersal of cells for attachment and placed in
a humidified incubator under a 95% air: 5% C02 atmosphere. For the initial cell
attachment phase, the incubator was gassed with 30% 02 / 5% C02 for 2 hours
(Sharda et al., 1996). Next day (day 1), the culture dishes were aspirated and fresh
WE+ medium added.
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2.3.7 Method III: Biochemical assays
On the day of isolation (day 0) and on day 2, total protein (TP) and total cytochrome
P450 content, lactate dehydrogenase (LDH) activity and urea synthesis rate (USR) of
the cells were measured. This was performed in 5 separate isolations, unless stated
otherwise.
2.3.7.1 Treatment of fresh cell suspension for total protein and LDH
measurements
On day 0, 10ml (5x107) fresh cell suspension in WE medium was centrifuged at 25g
(4°C) for 5 minutes and 1ml samples of the supernatant taken (F1 fraction) and stored
at -70°C until analysis of extracellular LDH activity (Marsh et al., 1991; Poullain et
al., 1992). The cell pellet was resuspended in 10ml 0.25% Triton X-100 in HBSS and
frozen to -70°C, thawed, centrifuged at 200g (4°C) for 5 minutes and 1ml samples of
supernatant (F2 fraction) taken as above for analysis of cytosolic LDH and total
protein (TP). TP was analysed using the Bradford assay (Bradford, 1976) modified
for a COBAS FARA centrifugal analyser (Roche Diagnostics); results are expressed
as mg protein / 106 cells. LDH activity was determined in the F1 and F2 fractions by
following the rate at which NADH is converted to NAD+ at >0340 nm in the presence of
pyruvate as enzyme substrate (Sigma Diagnostics LDH kit DG1340-K) adapted for
use on the COBAS FARA. The percentage of total extracellular LDH released into
the medium is calculated as follows: %LDH = F1 / (F1 + F2) x 100 whereas the
percentage of total cellular (cytosolic) LDH = 100 - F1 / (F1 + F2) x 100.
2.3.7.2 Treatment of day 2 monolayer cell cultures for total protein and LDH
measurements
On day 2, 1 ml samples of medium (F1 fraction) were taken from duplicate dishes and
stored at -70°C until analysis for extracellular LDH. The medium was then aspirated
completely, the cell monolayer washed twice with HBSS (4°C) and 5ml 0.25%
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Triton-X 100 in HBSS added. Dishes were freeze-thawed and cells scraped from the
dish using a pastette. Residual cells were rinsed from the dish with 5ml HBSS, added
to the lysed cell homogenate and centrifuged at 200g (4°C) for 5 mins, and 2x1 ml
samples of supernatant (F2 fraction) stored at -70°C until analysis for TP and LDH
activity (as above).
2.3.7.3 Treatment of fresh cell suspension and day 2 monolayer cultures for
total cellular cytochrome P450 levels
On day 0, 2x107 freshly isolated cells in WE medium were centrifuged at 25g (4°C)
for 5 mins and the supernatant aspirated. 2ml of ice-cold P450 buffer (Watts et al.,
1995) (0.1M sodium phosphate buffer pH 7.6, 0.02% Nonidet P-40, 20% glycerol,
ImM EGTA and ImM Dithiothreitol) was added to the cell pellet and the crude
suspension homogenised using 7 strokes of a teflon-glass Dounce homogeniser and
stored at -70°C until analysis. Day 2 monolayer cultures were washed twice with
HBSS (4°C), 2ml P450 buffer added and the cells scraped from the culture dish; the
crude homogenate was collected and treated as above. Following assay of the TP
content as above, both fresh and cultured cells were diluted with P450 buffer to 4mg
protein / ml and 1 ml of sample placed into each of two 1 cm quartz glass sample and
reference cuvettes with blackened sides. 1 mg sodium hydrosulphite was added to
both cuvettes; 2 minutes later the sample cuvette was bubbled at 2 bubbles / second
for 20 seconds with 99% pure CO gas. The P450 content was assessed by carbon
monoxide-difference spectroscopy of the sodium hydrosulphite-reduced samples
(Omura and Sato, 1964) using a Kontron dual beam spectrophotometer scanning
between 7.4oo-7,soo nm. The difference in absorbance between A450 and A490 nm was
recorded, using an extinction coefficent, £ = 91 mM cm"1, and path length of 1cm, to
calculate the P450 concentration (c) according to Beer's law, thus:
Absorbance = £1C
[P450] = Absorbance / £1 (pmol)
Results are expressed as pmol/mg protein (corrected for total cellular protein
content). A representative P450 spectrum is shown in Figure 2.3.
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Figure 2.3 Representative Carbon Monoxide-difference Spectra of


















Freshly isolated cells were solubilized in 'P450 buffer', homogenized and the
protein content determined. Following addition of 1 mg sodium hydrosulphite
to both sample and reference cuvettes, a baseline (curve A) was recorded
using a Kontron dual beam spectrophotometer scanning between X40o-^5oo
nm. Two minutes later the sample cuvette were bubbled at 2 bubbles /
second for 20 seconds with 99% pure CO gas, the P450 spectrum recorded
(curve B) and the P450 content assessed by carbon monoxide-difference
spectroscopy of the sodium hydrosulphite-reduced samples (Omura and
Sato, 1964) as detailed in Section 2.3.7.3. Cultured hepatocytes in each test
media were scraped from the culture dishes and treated as above.
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2.3.8 Urea synthesis
2.3.8.1 Calculation of urea concentration
The absorbances for the chromogenic reaction were measured for each time point at
A,525 nm in a Pye Unicam spectrophotometer and the [urea], Ci (at to) and C2 (at t2)
calculated in mmol/L, using the equation derived from the slope of the urea standard
curve (Figure 2.4), x, of the form:
y = ax + b Equation 1
Rearranging, x = y-b / a Equation 2
Where, x is defined as [urea], Ci or C2 in mmol/L
2.3.8.2 Calculation of urea synthesis rate (USR) in primary porcine
hepatocytes cultures
USR = [C2V2] - [C,Vi] / NT
where, V2 = Vi - Vs
2.3.8.3 Definition of parameters:
Vi volume of medium in the dish prior to sampling at t0
t0 that time at which the assay is just beginning
V2 that volume of medium in the dish prior to sampling at t2
t2 that time at which the assay is just finishing (in hours)
Vs that sample volume removed from the dish between to and t2
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Ci that concentration of solute quantified on the to sample (from equation
2 above)
C2 that concentration of solute quantified on the t2 sample (from equation
2 above)
T that time which has elapsed between to and t2
N the value of total protein in the culture dish (mg/dish)
Units: nmol urea synthesized / hour / mg total protein
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Figure 2.4 Representative Urea Standard Curve
Representative standard curve for the determination of urea concentration in
the test media. Standard solutions of urea standard (0 - 2.5 mM) were
assayed in duplicate according to the manufacturer's instructions, and the
absorbances for the chromogenic reaction measured for each concentration.
The data was fitted to a linear regression curve (y = 0.32x + 0.003) using
FigP (version 2.5) software programme. The concentrations in 'unknown'




Previous studies of urea synthesis rates following NH4C1 challenge of primary
hepatocytes have used NH4CI concentrations of between 2 (Dr P Gregory, pers.
comm.) and 10 mmol/L (Watt et al., 1995). In our study, urea production was
assessed in day 2 cultured porcine hepatocytes in HBSS reference medium:
(a) Using different concentrations of NH4C1 (1-10 mmol/L) to find the saturating
[NH4CI], and
(b) As a function of time to test for constant urea synthesis.
(a) Cells cultures were incubated in duplicate with 1, 2, 4, 8 or 10 mmol/L of NH4C1
in HBSS for 2 hours. Urea production rate (UPR) is expressed as mM/hour/mg TP
(Figure 2.5A).
(b) Cells were incubated as in a), except with 2mmol/L NH4C1 only for 2 hours;
samples were taken at 0, 30, 60, 90, and 120 minutes and the urea concentration
measured as described above. Urea production is expressed as mM/mg TP (Figure
2.5B).
The data was fitted to a linear regression curve of the form y=0.003x-0.0274, where
UPR=0.003t-0.0274, corresponding to a USR = 153 nmofh/mg TP with a
correlation coefficient, R2=0.955. Although the saturating concentration of NH4CI
was «1 OmM we chose to perform the experiments at 2mM because (i) it ensured a
stable urea synthesis over the 2 hours and (ii) it is more likely to reflect the
supraphysiological concentration encountered in a BAL device. The linearity of urea
synthesis was confirmed in later experiments under different culture conditions (see
Chapter 4, page 4-17, Figure 4.2).
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2.3.8.5 Protocol
Fresh Cells (Day 0): Freshly isolated hepatocytes were inoculated at a density of
8x107 in 55ml WE+ medium containing 2 mmoFL NH4C1 (Flendrig et al., 1997a), into
a rotary cell culture vessel (high aspect ratio vessel; Cellon-Sarl, Luxembourg) and
rotated at 10 revolutions per minute for 2 hours in a humidified incubator at 37°C
under an atmosphere of 95% air / 5% CCF.
Day 2: Duplicate cell culture dishes were washed 2x with HBSS (37°C) and
incubated in 8ml WE+ with 2 mmol/L NFLCl for 2 hours at 37°C as above. Cells were
subsequently collected and analysed for total protein content using the Bradford
assay.
The urea synthesis rate (USR) was determined for each day in 0.5 ml samples taken at
t=0 and t=2 hours using a modified colourimetric urea nitrogen kit (Sigma kit 535-B)
and corrected for total protein content for each culture modality.
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Figure 2.5 (opposite page) Urea production of cultured porcine
hepatocytes was measured as a function of (a) [NH4CI], and (b) time.
(a) Cells cultures were incubated in duplicate with 1, 2, 4, 8 or 10 mmol/L of
NH4CI in HBSS for 2 hours. Urea production rate (UPR) is expressed as
mM/hour/mg TP; (b) Cells were incubated as in (a), except with 2mmol/L
NH4CI only for 2 hours; samples were taken at 0, 30, 60, 90, and 120
minutes and the urea concentration measured as described above. Urea
production is expressed as mM/mg TP. The data was fitted to a linear
regression curve of the form y=0.003x-0.0274, where UPR=0.003t-0.0274,
corresponding to a USR = 153 nmol/h/mg TP with a correlation coefficient,
R2=0.955.
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Figure 2.5 Urea production response to ammonium chloride challenge
of primary porcine hepatocytes cultured in HBSS reference medium
A) Urea production rate as a function of [NH4CI]
♦
♦
2 4 6 8 10
[NH4CI] (mM)
B) Urea production as a function of time
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2.3.9 Morphology and isolate purity
Morphology was assessed using a Zeiss inverted microscope (Zeiss, Germany) under
phase-contrast on both day 0 and day 2 of culture. Photomicrographs recorded
hepatocytes in suspension and monolayer culture. The purity of the freshly isolated
cell suspension was assessed by histological staining and manual cell counting, and
confirmed by an independent expert observer (Dr C Bellamy, Dept. of Pathology,
University of Edinburgh). Following cytospin (200 g; 2x103 cells), cells were stained
with hematoxylin and eosin (H&E) and counted using the above microscope (using
x20 objective lens) fitted with an eye piece graticule. Three random fields per slide
were scored (n=4 separate isolations) for the presence of parenchymal cells
(hepatocytes: large distinct round nuclei, eosinophilic-positive cytoplasm; high
cytoplasmic to nuclear ratio; visible nucleoli; diameter 20-30 pm) and non-
parenchymal cells (irregular nuclei; diameter <10 pm). Periodic Acid Schiff (PAS)
stain was used to verify glycogen replete hepatocytes.
2.3.10 Statistics
Results are expressed as mean ± standard error. Student's t-test was used to compare




Table 2.1 summarizes the results of the 4 methods tested for large-scale isolation of

























































Table 2.1 Comparison of the different isolation methods used in this study to
isolate primary porcine hepatocytes from livers of weanling piglets. Table
compares isolation time, cell viability, yield and body weight. In this series,
the collagenase concentration was maintained at 0.05% (w/v). Liver wedges'
or whole livers were processed as described in Materials and Methods
(Sections 2.3.1 to 2.3.5). Results are expressed as mean ± standard error.
The number n, of hepatocyte isolations performed is shown in parentheses.
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2.4.1 Method I: Liver wedge isolation from abattoir-sourced pigs
Warm ischaemic time was 10-20 minutes before the liver was removed from the
carcass, cold ischaemic time was 2 hours. Perfusion time was «90 minutes. Total
isolation time (from animal sacrifice to final cell wash) was «4 hours (n=8). Cell
viability was 70±14% (trypan blue exclusion test) with a yield of 140±120 x 106 cells
from 62±5 kg pigs using 0.05% (w/v) collagenase (n=8; Table 2.1). Hepatocytes from
4/8 isolations were successfully plated and grown in monolayer culture, only if
viability >70%. Microbiological tests of cell cultures showed sensitivity to gentamicin.
The latter was subsequently added to test cultures derived from this method.
2.4.2 Method II: Whole liver isolation
2.4.2.1 Total isolation time (from animal sacrifice to final cell wash) was reduced to
<3 hours (n=13), compared with Method I.
2.4.2.2 Method lla Cell viability was 66±16% (trypan blue exclusion test) with a
yield of 36±33 x 109 cells from 13±2 kg pigs using 0.05% (w/v) collagenase (n=13;
Table 2.1). Hepatocytes from 6/11 isolations were successfully plated and grown in
monolayer culture only if viability >70%. Less infection was evident with these
cultures (supplemented with pen-strep / gentamicin) compared with Method I
cultures.
2.4.2.3 Method lib
Cell viability was 45±13% (trypan blue exclusion test) with a yield of 4.6+2.6 xlO9
cells from 13.4±2 kg pigs using 0.05% (w/v) collagenase (n=3; Table 2.1). No cells
plated from isolations containing heparin in the saline flush solution.
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2.4.3 Method III: Modified whole liver retrograde isolation technique
Table 2.2 summarizes the results obtained using Method III and shows the influence
of collagenase concentration on cell viability and yield.
Table 2.2 Influence of collagenase concentration on hepatocyte viability
and yield using Method III
Cell Isolation Body Weight [Collagenase] % Viability Yield
Group (kg) % (w/v) (Trypan (x109))
blue)
1 (n=5) 12.8+1.3 0.05 82+9 4.3+0.22
2 (n=5) 14.1+0.6 0.04 76+6 7.0+0.20
3 (n=20) 12+1 0.03 85+6 24+0.5
Table 2.2 Hepatocyte isolation from whole livers of weanling piglets using
Method III (Section 2.3) showing the influence of collagenase concentration
on cell viability and yield. Results are expressed as mean ± standard error.
The number n, of hepatocyte isolations performed is shown in parentheses.
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Times from animal sacrifice to initial PBS flush and PBS flush to cold storage using
0.03% (w/v) collagenase, were 12±4 (n=20) and 16±6 (n=20) minutes, respectively.
Transport time to the lab was 12±3 minutes, while hepatocyte isolation time (PB1 to
final cell wash) was 65±6 minutes (n=20). Total isolation time (from animal sacrifice
to final cell wash) was 105±5 minutes (n=20). Similar times were noted for isolations
using the higher collagenase concentrations.
The common Large White strain of pig (<15kg; costing 15 pounds sterling each) was
used in the hepatocyte isolation experiments. Reducing the collagenase concentration
from 0.05 to 0.03% (w/v) produced a 5-fold increase in cell yield, p<0.05 (Table 2.2)
whilst maintaining high viabilities, and significantly reduced the cost of the isolation
(130 pounds sterling per g).
Cell viability was 85+6% (trypan blue exclusion test) with a yield of 2.4±0.5 x 10l°
cells from 12±1 kg piglets using 0.03% (w/v) collagenase (n=20; Table 2.2).
Hepatocytes from all isolations were successfully plated and grown in monolayer
culture. Microbiological sensitivity tests of cell cultures showed no evidence of
infection.
2.4.2 Method III: Biochemical and morphological analysis
Biochemical measurements of both the isolate and cultured PPHs are summarized in
Table 2.3. In freshly isolated hepatocytes (day 0), total protein content (TP) was
1.2±0.1 mg/106 cells (n=5) and 1.2+0.3 mg/106 cells (n=5) for day 2 monolayer
cultures, corresponding to approximately 9x106 hepatocytes/dish; percentage of total
LDH released into the medium was 13+4% for day 0 and 8+4% at day 2; conversely,
intracellular LDH activities were 87+4% and 92+4% of total, respectively; the urea
synthesis rate was 196+36 nmol/hour/mg protein at day 0 (n=4) and 292+62
nmol/hour/mg protein (n=9) at day 2. Total P450 content was 99+11 pmol/mg TP for
fresh cells (n=5) and maintained at 89+35 pmol/mg TP (n=3) in day 2 cultures.
2-28
Table 2.3 Biochemical parameters of freshly isolated porcine
hepatocytes (Method III) and subsequent day 2 monolayer cultures




% LDH in medium (F1) 13±4 8±4
% LDH retained in cells 87±4 92+4
(F2)
Total Protein 1.2±0.10 1.17±0.27
(mg /106 cells)
Urea Synthesis Rate 196±36 292±62
(nmol hr"1/ mg protein) (n=9)
Total P450 99+11 89+35
(pmol / mg protein)
Table 2.3 Biochemical parameters of freshly isolated hepatocytes (day 0)
and for day 2 hepatocyte monolayer cultures: Cells were isolated using
Method III (0.03% collagenase). Cell viability was assessed as a function of
percentage total lactate dehydrogenase (LDH) released into the medium
(F1) and retained as cytosolic LDH (F2); total protein (TP) approximates to
cell number and urea synthesis rate (USR) to detoxification capacity. Total
P450 content indicates cellular biotransformation potential. Results are
means (± standard error) from at least five separate hepatocyte isolations
measured in duplicate for each parameter.
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2.4.2 Method III: Biochemical and morphological analysis (continued)
Phase contrast microscopy (Figure 2.6A) showed that the cell suspension was
composed of single cells and small aggregates of between 5-20 cells showing bright
cytoplasm, sharply defined borders, commonly with round or polygonal shape and
little physical damage (blebbing). In monolayer culture, hepatocytes showed a
flattened morphology with typical trabecular arrangement, sharp retractile borders and
dark cytoplasm with a pronounced nucleus often with 2 or more nucleoli (Figure
2.6B). Hepatocyte purity for freshly isolated cells was 97±3 % (n=4) (Figure 2.6, C-
E). PAS staining revealed a high hepatocyte glycogen content (Figure 2.6F).
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Figure 2.6 Morphology of primary porcine hepatocytes
Panel A Freshly isolated porcine hepatocyte suspension following the final
washing step: under phase contrast microscopy, hepatocytes show bright
cytoplasm, sharply defined borders with round or polygonal shape and little
physical damage (blebbing). Panel B Hepatocytes in confluent monolayer
culture show flattened morphology with typical trabecular arrangement,
sharp retractile borders and dark cytoplasm with pronounced nucleus and
often with 2 or more nucleoli. Panels C-F Histological staining of fresh cell
isolate to estimate purity of preparation: Following cytospin and standard
staining with H&E, at least 200 cells were counted in each of 3 random fields
per slide (n=4 separate isolations) for the presence of parenchymal and non-
parenchymal cells (NPCs). The purity of the isolate was >95%, which was
confirmed by an independent expert observer (Dr C Bellamy, Dept of
Pathology, University of Edinburgh). Hepatocytes (diameter 20-30 pm)
typically displayed large distinct round nuclei, eosinophilic-positive
cytoplasm; high cytoplasmic:nuclear ratio and visible nucleoli. Panel C
Under low power (x100, scale bar 100pm) several hundred hepatocytes are
shown (open arrows) with very few 'contaminating' NPCs evident (irregular
nuclei, diameter <10 pm: Closed arrows in C, and D (x200, bar 50pm)).
Large distinct round nuclei (closed arrows) and eosinophilic-positive
cytoplasm (open arrows) are clearly shown in E (x400, bar 25pm). Periodic
Acid Schiff (PAS) stain was used to verify glycogen replete hepatocytes in F
(x400, bar 25pm); PAS positive hepatocytes (magenta colour, open arrows)
with nuclei counterstained with haemotoxylin (closed arrows). Cell samples
were processed as described in Materials and Methods (Sections 2.3.5-6
and 2.3.9).
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Panel A: Freshly isolated hepatic cells
Panel B: Day 2 cultured porcine hepatocytes
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2.6 Discussion
Hepatocyte based BAL systems for treatment of FHF require large numbers of
hepatocytes capable of synthetic, metabolic and detoxifying functions. Inadequate
yield from rat livers and other small mammals prohibits direct scale-up to clinical BAL
application, whereas human-derived liver cell lines have a dedifferentiated metabolic
profile and may introduce tumourigenic proteins into the patient. Moreover, because
primary human hepatocytes are scarce, PPHs are currently used in scaled-up BAL
systems. These cells are considered to be biocompatible with normal human
hepatocytes and can be obtained in sufficiently high yield and viability (Demetriou,
1998; Donato et al., 1999; Jauregui et al., 1995; Jauregui and Gann, 1991; Naruse et
al., 1996a).
The most common perfusion method for isolating porcine hepatocytes is in vivo
anterograde collagenase perfusion via the portal vein which can provide sufficient
yield for BAL systems, with viabilities over 85% reported (Clement et al., 1998;
Demetriou, 1998; Flendrig et al., 1997a; Fremond et al., 1996; Gerlach et al., 1994c;
Sheil et al., 1998). However, shortcomings of the in vivo technique are its relative
complexity, expense, time-consuming nature and above all animal welfare
considerations. To conduct an in vivo anterograde perfusion under general
anaesthesia in the UK would require a licence from the Home Office under the
Animals (Scientific Procedures) Act 1986. The Act states: "The Secretary of State
shall not grant a project license unless he is satisfied:
(a) That the purpose of the programme to be specified in the licence cannot be
achieved satisfactorily by any other reasonably practicable method not entailing the
use ofprotected animals; and
(b) That the regulated procedures to be used are those which use the minimum
number of animals, involve animals with the lowest degree of neurophysiological
sensitivity, cause the least pain, suffering, distress or lasting harm, and are most likely
to produce satisfactory results".
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(Animal (Scientific Procedures) Act, Chapter 14, section 5(5);
http://www.homeoffice.gov.Uk/animact/aspag6.htm#Personal)
The in-vivo technique could not satisfy the above requirements if the ex-vivo
technique could produce comparable results using a protocol which is judged to cause
less pain, suffering or lasting harm. In fact the pigs used in this study did not require
licensing under the Act because they were killed humanely, using an approved method
under the Act (Animal (Scientific Procedures) Act 1986, Schedule 1;
http://www.homeoffice.gov.uk/animact/aspag9.htm) prior to any procedures being
conducted. Because animal welfare is the overriding consideration a comparison of in
vivo versus ex vivo techniques regarding their relative complexity and cost is less
relevant. However the in vivo technique would require the assistance of several
personnel skilled and appropriately licensed in veterinary anaesthesia and surgery. The
method is technically more challenging due to the requirement of obtaining
intravenous access to the portal vein while maintaining stable anaesthesia and
circulation. The cost of conducting this procedure is estimated to be ten times that of
the ex-vivo. In this regard, the major advantages of developing ex vivo methods are:
improved animal welfare, increased reproducibility of the procedure, easier
accessibility for perfusion (via the suprahepatic IVC), no animal licensing
requirements, and a major reduction in costs.
Previous ex vivo methods attempting large-scale isolation of PPHs have attained
comparable viabilities but with low yields, probably due to the use of liver wedges as
the tissue source (Donini et al., 1997; Koebe and Schildberg, 1996; te Velde et al.,
1995).
To circumvent these problems we aimed to develop a simple, reproducible and cost-
effective ex vivo method of isolating high quality PPHs from whole piglet livers
suitable for BAL usage. A comparison of the different methodologies used in this
study to achieve this objective is shown in Table 2.1.
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In preliminary experiments using liver wedge portions (Method I) from 60kg abattoir-
sourced pigs both yield and viability were compromised compared with similar
techniques. For example, Koebe & Schildberg (1996) achieved significantly higher
viabilities (84±5%) and yield (2.2±0.5 xlO9) than our method. Whole liver retrograde
perfusion (Method II) improved yield by up to two orders of magnitude, with similar
viabilities as reported with Method I (Table 2.1), with the exception of Method lib
(Section 2.3.4.2). Here, when heparin was used in the initial saline flush solution,
viability decreased markedly compared with all the other methods tested.
Interestingly, in the absence of heparin under the same conditions (Method Ila) yield
was greater by up to an order of magnitude (along with improved viability), in
comparison with Method lib. Reports of a direct, dose-related hepatotoxic effect of
heparin in rat hepatocyte cultures (resulting in cell damage and death) may explain this
phenomenon (Sanders et al., 1984), although other investigators have demonstrated
an hepatotrophic function in vivo (Matsumoto & Nakamura, BBRC 1996). Several
studies administered iv heparin as a prelude to in vivo isolation (Seilaf et al., 1995;
Wang et al., 2000) with excellent yields and viabilities reported (see also Table 2.5
below). Perhaps the apparently negative effect of heparin on whole pig liver (Method
lib) occurs predominantly under ex vivo conditions, or that too high a dosage was
used in our study.
Adaptation of Method Ila allowed more consistent reproducibility in both viability and
yield (Table 2.1) resulting in Method III. The methodological modifications
undertaken to achieve the stated aims of this study are outlined in Table 2.2, where
the collagenase concentration was set at 0.05 % (w/v). Further refinement of Method
III was made by titrating the [collagenase] to its optimum of 0.03% for this technique
(see Table 2.2), which gave more consistent high viabilities as well as sufficient yield
for most BAL devices.
Whilst acknowledging that it is virtually impossible to identify exactly which were the
primary factors in the much improved isolation technique, it is possible to consider
some of the major changes and the criteria by which modifications were made.
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Table 2.4 outlines methodological modifications undertaken in this study to improve
the ex vivo isolation ofprimary porcine hepatocytes.
Table 2.4 Comparison of methodological modifications undertaken in this
study to improve the ex vivo isolation of primary porcine hepatocytes
Parameter Method I Method lla Method lib Method III Comment
Mean Body 62 13 11 13 *Abattoir-
Wt (kg) (Adult*) (Weanling) (Weanling) (Weanling) sourced
Perfusion Hepatic veins Supra Supra Supra All
Route hepatic IVC hepatic IVC hepatic IVC Retrograde
Flush / UWS only Saline / UWS Saline/hep/ PBS only All 4°C
Storage UWS
Solutions
Perfusion Hanks/Krebs Hanks/Krebs Hanks/Krebs PB1-5 Hanks / PB1-
Buffers 0.05% Wash steps KHB wash KHB wash PB5 at 4°C 4 at 37°C;
(w/v) at RT at 4°C at 4°C PB1 contains
[collagenase] aprotinin,
dex/glucose;
Perfusion Up to 1L Up to 1.5L Up to 1.5L All 0.5L
Volumes (L)
Flow Rates 50 (Hanks) 50 (Hanks) 50 (Hanks) 50 constant
(ml/min) 100 (Krebs) 100 (Krebs) 100 (Krebs)
Total 4 3 3 <2
Isolation
Time (hrs)
Blood Clots Some Some Some Rare
% Viability 53-90 34-90 31-62 76-94
(range)
Mean Cell 0.14 36 4.6 4.3
Yield (x109) (24) (at 0.03%
collagenase)
In general Methods I and II gave inconsistent yields and viabilities from pig livers.
Since liver wedges were obtained from 60kg adult pigs, weanling piglets were
subsequently used since Gerlach et al. (1996a) had established that viability and yield
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declined with increasing pig weight (6-40 kg). This may reflect an increase in fibrous
tissue content in the more mature pig liver compared with the livers of weanling
piglets. However, ex vivo perfusion of liver wedges from 35-115 kg abattoir-sourced
pigs gave high viability but inadequate yield for BAL use (Donini et al., 1997; Koebe
& Schildberg, 1996). Initial experiments using saline and UWS as flush and storage
solutions surprisingly did not improve the quality of the isolate whereas heparin
appeared hepatotoxic using Method II. The cost of UWS (200 pounds / L) was also
prohibitive for multiple isolations required for subsequent experimental work.
Method II used large volumes of complex perfusion buffers designed for, and perhaps
more suited to, use with in vivo procedures (Dr J Gerlach, personal communication)
which could more efficiently handle increased perfusion times and flow rates (up to
300ml/min) since the liver could be more extensively perfused in situ (with the
animals heart beating) down to the microcirculatory or sinusoidal level - not
achievable with the ex vivo scenario. Another problem encountered for preliminary ex
vivo isolations was incomplete perfusion due to blood clots. On the other hand,
attempts to cannulate the portal vein and/or hepatic artery for anterograde perfusion
of whole fiver, following Method II, proved unsuccessful (data not shown) and
resulted in many more blood clots, and increased pre-perfusion time (ie prior to
initiation ofPB1).
Koebe & Schildberg (1996) as mentioned, attained high viabilities using an ex vivo
technique of isolation from abattoir-sourced fiver wedges. Although yield was
insufficient for scaled-up BAL devices, it was surmised that using whole piglet fiver
(with an intact Glisson's capsule) may well increase the yield whilst maintaining high
viability. Empirically, we observed that any damage or lesions to the whole piglet fiver
during the isolation / perfusion steps, decreased yield, viability and quality of the
isolate. Ex vivo isolations using fiver wedges have one or two open cut surfaces where
perfusate can extrude and which results in decreased efficiency of the perfusion and
subsequent yield. It was reasoned that lower perfusion volumes and an accessible
perfusion route (retrograde, via the suprahepatic IVC) would decrease the overall
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isolation time and improve outcome. Moreover, the use of aprotinin (as a fibrinolytic
to prevent blood clots) in the initial perfusion step (PB1) may improve efficacy of the
technique by increasing perfusate flow down to the microcirculatory level, whereas
the addition of dexamethasone and glucose at this stage would stabilize cell integrity
by stimulating protein synthesis and the redox potential, respectively, of isolated cells.
Finally, a constant reduced flow rate of 50ml/min, coupled with the initial flush with
ice-cold PBS, and the aforementioned modifications, ensured that the liver showed
early signs of uniform perfusion (very pale colour and flaccidity) even after the first
perfusion step (PB1). Perfusion with cooled Williams E (after the collagenase
recirculation step) prior to disruption and mechanical handling of the digested liver
acts as a cytoprotectant (Gerlach et al., 1994c), whilst the relatively high amino acid
content contributes to preservation of nitrogen balance (Berry et al., 1991c) Finally,
all purification and washing steps were stringently undertaken at 4°C, and at low
centrifugation (x25g) which improved overall isolate quality, reproducibility and
consistency. Indeed, Kreamer et al., (1986) suggests that NPC contamination is less
with methods employing both cooled washing steps with low speed centrifugation (<
x50g) as well as shorter exposures to collagenase, as for Method III («16 minutes).
Under these conditions, further refinement of Method III involved determination of
the optimal [collagenase]. This factor appeared important since demonstrable
improvements in cell yield (5-fold) whilst maintaining high viability (Table 2.2) were
evident. Determination of the optimal [collagenase] may be critical in the isolation
process for the reasons of batch-to-batch variation, unknown composition and
variable enzymatic activity of Type IV collagenase (which also contains other
proteolytic enzymes such as pronase and dispase). Collagenase is also known to alter
plasma membrane components, decrease transcription of liver-specific genes and
protein synthesis, as well as causing many other phenotypic changes even under
optimal conditions (LeCluyse et al., 1996). Consequently, excess collagenase may
further damage cells, so reducing viable cell yield and isolate quality (Alpini et al.,
1994).
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Comparative yields and viabilities of differing methods of PPH isolation
reported in the literature are outlined in Table 2.5. With a mean cell viability of 85%
and a viable cell yield of 2.4 xlO10, our data compare favourably with in vivo
techniques (Clement et al., 1998; Demetriou, 1998; Fremond et al., 1996; Gerlach et
al., 1994c; Jauregui et al., 1997; Sheil et al., 1998; Sielaff et al., 1995b), while
outperforming yields obtained using comparable ex vivo isolation methods by an order
of magnitude (Donini et al., 1997; Koebe and Schildberg, 1996). Considering that a
12 kg piglet's liver weighs «500g and the wet weight of undigested liver was ~15()g,
then the yield approximates to 60x106 viable cells/g wet weight of liver, or, 60% ofall
hepatic parenchymal cells were harvested as viable hepatocytes, assuming the liver
contains «108 cells/g. This is 3 times more efficient than the in vivo method of
Morsiani et al., (1998) although viability was slightly higher at 93±3 %. Moreover, the
isolated hepatocytes successfully form high viability confluent monolayer cultures, as
demonstrated by high intracellular LDH activity (Marsh et al., 1991; Poullain et al.,
1992) and total protein content (Baserga, 1995; Sharda et al., 1996). The cultured
cells maintain cytosolic total protein levels comparable to fresh hepatocytes and are
capable of detoxification of ammonia through conversion to urea.
The functional liver mass required for a clinically effective BAL is at least 1010
hepatocytes (Allen et al., 2001, Demetriou, 1998; Fremond et al., 1996; Jauregui et
al., 1997; Sielaff et al., 1995b, Strain & Neuberger, 2002), which could be
accommodated using our ex vivo method or conventional in vivo techniques
(Demetriou, 1998; Flendrig et al., 1997a; Fremond et al., 1996; Gerlach et al., 1994c;
Jauregui et al., 1997; Jauregui and Gann, 1991; Joly et al., 1997; Sharda et al., 1996;
Sheil et al., 1998; Sielaff et al., 1995b).
Most of these in vivo isolation procedures have adapted the two-step collagenase
perfusion techniques originally described in rat isolations by Seglen (1976). Following
anaesthesia, intubation and mechanical ventilation, the pig liver is perfused (via the
portal vein) in situ with perfusion buffer containing EGTA. The liver is then excised
and perfused ex vivo with a recirculating collagenase buffer and disrupted.
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Table 2.5 Comparative data of various techniques employed to isolate
primary porcine hepatocytes (See text for details)
Perfusion Route Body [Collagenase] % Viability Mean Cell Reference




Retro/ex vivo 12±1 0.03 85+6 24 Nelson 2000
RetroHn vivo/hep 12 0.08 79+6 24 Naik 1996
ex v/'vo/LW 35-115 0.05 84+5 0.22 Koebe 1996
pv/hep 8+3 [1mg/ml] 90 8 Gregory 2000
fv/LW* 22+3 [60U/ml] 88+4 <1 teVelde 1995
pv 8+2 0.1 90 20 Lazar1995
pv/hep 8+3 0.1 92+2 26 Wang 2000
pv 12+2 0.05 85 30 Naruse 1996a
pv 9+1 0.05 95 <20 Kawazoe 1999
pv/hep 8+2 0.1 95 21 Seilaff 1995
pv 8.5+1 0.1 71+7 12 Waring 1995
pv 20 0.05 90 25 Morsiani 2001
pv 12 0.1 90+4 24 Iwata 1999
pv/hep 9+1 0.05 92+2 15 Kong 1996
Pv 22+2 0.06 >95 75 Joly 1997
Table 2.5 Table compares mean values of body weight, collagenase
concentration, cell viability and yield (+SEM, if data reported in literature) of
different hepatocyte isolation methodologies from pig livers. All methods
cited are whole liver in vivo (anterograde perfusion) procedures, except
where indicated: Retro., refers to retrograde perfusion via the inferior vena
cava. Pv, portal vein; hep, iv heparin administration (prior to perfusion); fv,
femoral vein; LW, (*subsequent) liver wedge isolation.
2-40
Table 2.5 shows that most of these in vivo procedures result in both viabilities
and yields comparable with our ex vivo technique (Method III; see Table 2.2).
Improvements in outcome however have been achieved. Using this methodology, Joly
et al (1997) obtained yields of 5-lOxlO10 and viabilities >95% from 20kg pigs.
Gerlach et al., (1994c) reported very similar results with 5kg piglets by means of a
sophisticated 5-step in vivo method (with 0.08% collagenase) combined arterial and
portal vein perfusion. Nonetheless, this technique gave lower viability (70%) and yield
in 12 kg piglets compared with our ex vivo method, using only 0.03% enzyme (Table
2.2). Thus although producing improved outcome under certain conditions, the final
method reported here (Nelson et al., 2000) enabled large scale isolation of high
viability PPHs appropriate for most BAL devices under development, and this method
was commensurate with both the majority of in vivo methods reported in the literature
(Table 2.5) and the requirements of the Animals (Scientific Procedures) Act 1986.
In practical terms, development of an improved ex vivo isolation method has
achieved savings in both the cost and time of large-scale isolation of PPHs. This has
been realized by: a) substituting UWS for PBS as the initial flush / storage solution; b)
obviating the need for expensive anaesthetic procedures and licensed personnel; c)
reducing collagenase concentrations and perfusate volumes, and d) using an
inexpensive strain ofpig. In terms of logistics, we have found it is more satisfactory to
utilize pigs killed on the day of isolation as demand dictates, with comparable
viabilities and inherently higher viable cell yield than other ex vivo methods. This
permits more flexibility in cell usage without the greater risks of introducing infection,
as is the case for abattoir methods, while eliminating the logistical constraints of the
latter. In addition, we have successfully applied our technique to isolation of human
hepatocytes from unused donor livers (data not shown).
Cell purity assessment requires morphological, biochemical, histochemical, or
immunohistochemical techniques (Alpini et al., 1994). Hepatocytes are readily
identified on the basis of morphological characteristics (ie size and appearance)
whereas cell-specific assays are preferable in the identification of NPCs. Using
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Method III, histological staining and morphological analysis indicated that at least
95% of the isolated cells were hepatocytes (Figure 2.6). Hepatocytes, 20-30 pm in
diameter, typically displayed large distinct round nuclei, eosinophilic-positive
cytoplasm, high cytoplasmic:nuclear ratio, and visible nucleoli, whereas non-
parenchymal cells with diameter of <10 pm appeared irregular in shape. Periodic Acid
Schiff (PAS) stain was also used to verily glycogen replete hepatocytes. Biochemical
measurements of LDH activity (and trypan blue exclusion) showed the high viability
of the isolate, suggesting preservation of hepatocyte membrane integrity. Further,
indirect evidence of the high parenchymal cell content of the fresh cell isolate is
observed under SEM (see Chapter 5, Figure 5.9), where large hepatocytes with intact
membranes and characteristic abundant microvilli (Arterburn et al., 1995) are evident.
Whilst freshly isolated cells showed ultrastructural characteristics typical of
hepatocytes (Figure 3.3, page 3-17). In our experience, and others (Donini et al.,
1997; Koebe and Schildberg, 1996;), Percoll™ density gradient purification enhances
viability by «10% (up to 98%; Kreamer et al., 1986) but reduces yield by 40-50%. In
preliminary experiments, day 2 (WE+) cell cultures seeded from Percoll-purified cells
(obtained using Method III; Nelson et al., 2000) were morphologically and
functionally (urea and albumin synthesis) very similar (data not shown) to non-Percoll
treated cells (see Table 2.3) from the same isolate, which is considered to be
consistent with high initial purity (Gregory et al., 2000). However, Percoll may render
cells unsuitable for BAL use due to membrane damage and reduction of the inherent
nonparenchymal cell population present, which may have implications if heterotypic
cell interactions are important for optimal BAL function.
Fresh cell suspensions showed a tendency of the hepatocytes to aggregate into
small clusters of 5-20 cells (Figure 2.6A). This might be advantageous for cells
expediently seeded into a bioartificial liver device. Indeed, there is evidence that
isolated hepatocytes arranged into multicellular formations, establish cell-cell and cell-
matrix contacts which result in improved differentiation and liver-specific function,
when compared with single cell culture monolayers (Bhatia et al., 1999; Koide et al.,
1989; Kong et al., 1996; Naruse et al., 1996b; Watts et al., 1995). It is thought that
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formation of cell aggregates may provide an in v/'vo-like liver microarchitecture
promoting maintenance of viability and differentiated functions (Ben-Ze'ev et al.,
1988; Flendrig et al., 1997a; Jauregui et al., 1997; Lazar et al., 1995a; Yuasa et al.,
1993).
Total protein (TP) content of freshly isolated cells was 1.2 mg per 106 cells,
consistent with recent reports (Gregory et al., 2000; Sharda et al., 1996). While TP
content is only a rough guide to cell number, the day 2 TP content of monolayer
cultures could be approximately equated to 9x106 cells per dish. This level of cell
count accorded with morphological observations (Figure 2.6B), which confirmed cell
confluence. LDH is a reliable indicator of hepatocyte viabilty, attachment and
membrane integrity (Jauregui et al., 1981; Marsh et al., 1991; Poullain et al., 1992).
Thus high cytosolic LDH activity, increasing from 87% (of total LDH) for freshly
isolated cells to 92% in day 2 monolayer hepatocyte cultures, confirms both the high
viability of the cell isolation (initially assessed by trypan blue exclusion) and
establishes that the cells have recovered from the trauma of isolation and consolidated
their structural integrity. Hepatocyte-specific synthesis of urea from ammonium
chloride in both freshly isolated cells and day 2 cell cultures, was obtained at levels
comparable to those reported in previously (Flendrig et al., 1997a). Ammonia (NH3)
is a putative neurotoxin in the development of hepatic encephalopathy and brain
oedema in FHF, so that NH3 detoxification is considered an essential prerequisite for
an effective BAL device in clinical treatment (Gerlach et al., 1994a; Gerlach et al.,
1996b; Jauregui et al., 1997; Sharda et al., 1996; Strain, 1994). In addition, we have
shown that these cells retain P450 function and thus have metabolic biotransformation
potential (Table 2.3). Although cellular P450 content is known to decline with culture
age in most species, it can be enhanced by modulating culture conditions (Watts et al.,
1995) or by administration of phenobarbital prior to cell isolation. Recently, pig
hepatocytes have been shown to outperform both rodent and dog hepatocytes in
maintenance of phase 1 and phase 2 activities, whilst high metabolic similarities were
found between pig and human hepatocytes (Donato et al., 1999). These attributes of
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pig hepatocytes support their usage as the most appropriate species forming the
biological component of BAL devices.
For hepatocyte cultures, we use serum-free, hormonally-deftned medium
containing long-EGF and insulin. Porcine hepatocytes cultured this way show much
greater growth potential than rat hepatocytes cultured under the same conditions
(Wegner et al., 1992). Indeed density-dependent inhibition of cell growth was less
pronounced with the porcine hepatocytes even after reaching confluency (Hughes and
Williams, 1996; Yuasa et al., 1993). Morphologically, we have observed overgrowth
of pig hepatocytes even after reaching confluence on day 1/day 2 and up to day 6 (not
shown). This may be important in terms of maintaining differentiated, multicellular
formations in BAL devices as discussed above.
The possible transfer of pig endogenous retroviruses (PERV) to humans via
PPHs used in BAL systems at the clinical level may be problematic (Dixit V., 1994;
Omura and Sato, 1964). However, recent studies have shown no evidence of pig
DNA or PERV infection in patients with short-term extracorporeal connection to pig
kidneys or from porcine islet-cell xenografts (Donato et al., 1999; Watts et al., 1995).
In conclusion, our method provides a high viability, high yield and rapid
isolation technique, which is easy to perform in a standard research laboratory.
Outcome is similar to most in vivo protocols reported, although improvements in
yield and viabilities are attainable with the latter. Nevertheless, the method obviates
the need for relatively complex, in vivo surgical techniques and facilities, which are
time-consuming and require highly trained, licensed personnel. Cells can be deployed
in a variety of in vitro liver model systems in under two hours, whilst maintaining
viability and hepatocyte functionality. In this study, yield, viability and function of




Light and Transmission Electron Microscopy Reveal
Modulatory Effects of Serum-Free Chemically-Defined Media
Formulations on Gross Morphology and Ultrastructure of
Primary Porcine Hepatocytes
3.1 Introduction
Hepatocyte shape and structure are considered to be intimately related to functional
activity (Gerlach et al., 1995; Ben-Ze'ev et al., 1988; Mitaka, 1998; Folkman and
Moscona, 1978; Goulet et al., 1988). The idealized cellular component of bioartificial
liver (BAL) systems should maintain a well-differentiated in v/'vo-like phenotype and
undergo controlled rounds of proliferation in vitro (Jauregui and Gann, 1991; Riordan
et al., 1998). That this has not yet been achieved is primarily due to the well
documented deterioration of both liver-specific metabolic activities and hepatocyte
morphology which occurs within days of culture (Clayton and Darnell, 1983; Gerlach
et al., 1995; LeCluyse et al., 1996; Moshage and Yap, 1992; Reid and Jefferson,
1984).
Various strategies have been adopted to address this problem, such as the use
of complex biomatrices, microcarriers or synthetic membranes to improve attachment
and function of cells (Demetriou, 1998; Gerlach et al., 1994a). Recently however,
primary porcine hepatocytes cultured on tissue culture plastic were shown to perform
equally well compared with cells grown on a variety of exogenous attachment
substrates (te Velde et al., 1995; Gregory et al., 2000). In Chapter 2, it was shown
that under defined, serum-free conditions, primary porcine hepatocytes (PPHs) retain
characteristic gross morphological and functional features of hepatic monolayer
cultures in vitro (Nelson et al., 2000). Furthermore, culture morphology was
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indistinguishable from that reported in previous studies in which PPHs were similarly
grown in William's E medium in the presence of serum on tissue culture plastic alone
or with various biomatrices including: Type I and IV collagen, laminin, fibronectin,
Engelbreth-Holm-Swarm Natrix (EHS) and Matrigel™ (Gregory et al., 2000; te
Viva
Velde et al., 1995). The latter have been shown to be a suitable substrata with which
to maintain differentiated function and improve cellular polarity, in rat hepatocytes
(Berry et al., 1991a; Michalopoulos et al., 1999). In contrast, porcine hepatocytes
appear unique in their ability to maintain these desired attributes without the aid of
exogenous substrates or serum (te Velde et al., 1995; Gregory et al., 2000; Nelson et
al., 2000; te Velde et al., 1995). Formation of 3-dimensional tissue-like cultures of
PPHs, cultured on a Matrigel-coated, polypropylene hollow fibre bioreactor design,
was reported to retain ultrastructural features of liver parenchyma in vivo (Gerlach et
al., 1994a; Gerlach et al., 1995).
A major concern of this type of BAL configuration is the leakage of potentially
tumourigenic or murine proteins from EHS or Matrigel, respectively, into the patients
circulation, raising questions of potential immunogenicity and bioreactor safety. Non-
autologous serum, on the other hand, introduces unknown factors and contains
selective inhibitors, bacterial endotoxins and lipids which may contribute to the
observed cytostatic and cytotoxic effects, which are inhibitory to the expression of
differentiated, liver-specific functions and selective for the growth of non-parenchymal
cells (Enat et al., 1984; Berry et al., 1991a). Moreover batch variation of sera,
particularly in comparative studies, present difficulties of adequate characterization of
the culture system.
For these reasons, we have used serum-free chemically-defined media formulations to
study their influence on the gross cellular and ultrastructural morphology of primary
porcine hepatocytes cultured on unmodified tissue culture plastic. William's E
Medium (Flendrig et al., 1997a; Bader et al., 1996; De Bartolo et al., 2000; Flendrig
et al., 1998a), Medium 199 (Gerlach et al., 1989; Gerlach et al., 1990) and Medium
1640 (Kong et al., 1996) are commonly used in current BAL systems; whereas
3-2
Hepatocyte Medium is a new formulation which apparently maintains in vitro
differentiated function in other mammalian species (Sigma-Aldrich Technical Services,
personal communication).
The marked functional diversity of the hepatocyte, including protein synthesis, bile
secretion, storage of metabolites and detoxification, is reflected in the great variety of
cytoplasmic organelles visible under transmission electron microscopy. The presence
of an intact cytoplasmic membrane, plentiful mitochondria, endoplasmic reticulum,
glycogen storage granules and bile canaliculi structures are considered to be the 'gold
standard' when assessing morphological markers of differentiation (Peshwa et al.,
1996; Portmann, 2000; Fan and Steer, 2000; Shatford et al., 1992; Mitaka, 1998;
Junqueira, 1977; Gerlach et al., 1995; Berry et al., 1991b; Hargreaves, 1968). The
morphological characteristics of hepatocyte cultures were studied in parallel with
biochemical parameters of plating efficiency, viability and total cellular protein
content.
3.2 Aims
The aims of this study were to assess the modulatory effects on hepatocyte
morphology of different serum-free chemically-defined media formulations on
cultured hepatocytes in terms of:
1. Gross cellular morphology under phase contrast light microscopy
2. Cell ultrastructure under transmission electron microscopy
3. Biochemical parameters related to cellular attachment and viability
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3.3 Materials and methods
3.3.1 Reagents
All reagents used were as detailed in Chapter 2 with the following additions: Culture
media (Williams E (WE), Hepatocyte medium (HM), Medium 199 (Ml 99), RPMI
1640 (Ml640)), and Hanks' Balanced Salt Solution (HBSS, pH 7.4) were obtained
from Sigma Chemical Co. (Sigma, Poole, UK). LDH and urea kits were obtained
from Sigma Diagnostics. Reagents for TEM were obtained from BDH Merck (UK).
3.3.2 Hepatocyte isolation
Hepatocytes were isolated from weanling piglets (<15kg) using our ex vivo
collagenase perfusion method described in Chapter 2 (Nelson et al., 2000).
3.3.3 Hepatocyte cultures
Cells were seeded at a density of 107 viable cells per 100mm tissue culture plastic
(TCP) dish (Dow Corning, USA) in 8ml of each of the four test media (WE, HM,
M199, M1640) at 37°C. Each culture medium consisted of serum-free, chemically-
defined medium (either WE, HM, Ml99, Ml640) supplemented with 50 ng/ml Long-
Epidermal Growth Factor (L-EGF); lOpg/ml porcine insulin; 1 pmoFL
dexamethasone; 2 mmol/L L-Glutamine; 50 mg/ml Gentomycin; 50 mg/ml Penicillin-
Streptomycin and 2.5 pg/ml Fungizone. The culture dishes were shaken gently to aid
dispersal of cells for attachment and placed in a humidified incubator under a 95% air:
5% C02 atmosphere. For the initial cell attachment phase, the incubator was gassed
with 30% 02 / 5% C02 for 2 hours. Next day (day 1), the culture media were
aspirated and fresh medium added which was subsequently changed on days 2 and 4.
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3.3.4 Biochemical and metabolic assessment
3.3.4.1 General description
For each test medium hepatocytes were cultured on duplicate TCP dishes and
evaluated at the time points indicated. On the day of isolation (day 0) and on culture
days 2, 4 and 6 the total cellular protein content (TP) and lactate dehydrogenase
(LDH) activity of the cell lysates was measured. In addition, samples of culture media
and cellular lysate were analysed for LDH activity. Samples were stored at -70°C until
analysis. This was performed on 10 separate isolations. Plating efficiency was assessed
by measuring TP of day 1 cultures (defined below), whereas the degree of confluency
(% confluency) was measured quantitatively, using computer aided image analysis, for
each time point.
3.3.4.2 LDH and total protein measurements
Intra- and extracellular LDH activity and total protein (TP) content were determined
in fresh cell suspensions and for hepatocytes cultured in each medium on days 2, 4
and 6 in duplicate culture dishes, as described in detail previously (Nelson et al.,
2000); see Chapter 2, Sections 2.3.7.1 and 2.3.7.2). Plating efficiency, measured on
day 1 cultures for each test media, was defined as the TP content as the percentage of
the TP content measured, compared to the number of fresh cells seeded into each dish
(Watts etal., 1995).
3.3.5 Morphology
3.3.5.1 Light microscopy: phase contrast microscopy
An objective assessment was made of the gross morphology of the cells cultured on
TCP dishes in the different media by: (a) Two independent, blinded observers, and (b)
computer-aided image analysis of percentage confluency (see below). Healthy cells
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were defined as having (under phase contrast light microscopy): A confluent
monolayer of densely packed cells; compact polygonal shape delimited by sharply-
defined refractile borders; large bright nuclei; evidence of bile canaliculi (lucent,
refractile rim surrounding each hepatocyte), according to Arterburn et al., 1995; Berry
et al., 1991a; and Moghe et al., 1995. A inverted microscope (Zeiss, Germany) was
used to assess culture morphology under phase contrast light microscopy.
Photographs recorded hepatocytes in culture using Kodak™ 400 film and a Canon
EOS camera. To examine gross morphology, TCP cultured cells were examined under
phase-contrast on days 1, 2, 4 and 6 of culture for each test medium and were
photographed.
3.3.5.2 Computer-aided image analysis of cultured porcine hepatocytes
Semi-automated computer-aided image analysis was used to quantitatively measure
the percentage confluency of each test culture. This was achieved by measurement of
the surface area covered by hepatocytes. Images were acquired, processed, and
analysed using Image-Pro Plus™ software.
To obtain a representative estimate of culture dish surface area covered by attached
cells the following analysis was undertaken. Primary porcine hepatocytes were
cultured as described above (Section 3.3.3) for up to 6 days. On days 1, 2, 4, and 6
culture dishes were washed 2x in HBSS, fixed in formal saline, and stained with H&E
using standard histological techniques. Images were acquired using a Coolsnap™
CCD camera (RS Photometries) attached to a BE12 BE1S microscope (Olympus™) via
a 0.63x C-mount adapter. Acquisition and analysis were performed using Image-Pro
Plus™ (version 4.5, MediaCybernetics™). Five randomly selected fields were acquired
per culture dish, one for each test medium, and the percentage area containing no cells
assessed using Image-Pro Plus. This was performed in duplicate for 3 separate
isolations. Images were acquired at 1392 x 1040 pixels and saved as TIFF files.
Microsoft Excel was then used to collate data and statistical analysis was performed
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with the SPSS 9.0 statistical software package using ANOVA and Post Hoc tests as
described below (Section 3.3.7).
3.3.6 Transmission electron microscopy
On days 2 and 6, cells cultured in each test medium, obtained from the same isolation
as used for the phase-contrast study, were washed in HBSS buffer to remove dead or
loosely attached cells and trypsinized with [0.5x] normal trypsin-EDTA (Sigma, St
Louis, Mo, USA). Following low-speed centrifugation (20 g; 5 minutes) and washing
steps in HBSS / 5 % FBS to neutralize trypsin activity, the cell pellet was resuspended
and fixed with 3% glutaraldhyde in 0.1 M sodium cacodylate buffer solution (Sabatini
et al., 1963) at pH 7.3 for two and a half hours at room temperature. Fresh liver
tissue and freshly isolated cells were similarly treated as controls. After several
washings with cacodylate buffer solution the samples were post-fixed with 1%
osmium tetroxide in 0.1 M cacodylate buffer solution (Palade, 1952) at pH 7.3 for
one hour at room temperature. Following dehydration in a graded series of acetone
solutions (50, 70, 90, and 100 % (3 times)), the tissue was infiltrated and embedded in
araldite mixture. In order to orientate and select an area for the ultrastructural
observations, 1 pm semi-thin sections were cut with glass knives, stained with 1%
toluidine blue and examined under the light microscope. Ultra-thin sections with silver
gold interference colour (approximately 70-80 nm in thickness) were cut on an
OMU4-Reichert Ultracut ultramicrotome and collected on 200 mesh uncoated copper
grids. The sections were double stained in saturated uranyl acetate in 50% methanol
for 30 minutes followed by lead citrate in water (Hayat, 1970) for 5 minutes. Ten
areas from each of 4 copper grids were selected for investigation and representative
grids examined and photographed in a Philips CM 12 electron microscope at 80kV.
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3.3.7 Statistical analysis
For each parameter, multiple comparisons were made using ANOVA of: 1) between
media evaluations on each day of culture and 2) between day evaluations for each
medium formulation. One-way single factor ANOVA (assuming equal variances) was
subsequently performed followed by Post Hoc multiple comparisons tests of least
significant differences using the SPSS 9.0 statistical software package. The mean
difference was considered significant at the 0.05 level. Statistical tables (Tables 3.1-
3.6) show relevant p-values for multiple comparisons of either or both 1) and 2)
above.
3.4 Results
3.4.1 Morphology, plating efficiency and viability of porcine
hepatocytes
3.4.2 Cell isolation viability and yield
The hepatocytes were isolated using our ex vivo method described in detail in Chapter
2. For these experiments, cell viability was 87±5% (Mean±SEM) with a yield of
2.2±0.8 x 10i0 (Mean±SEM) cells from 12+1 kg piglets (n=T0). Trypan blue viability
of fresh cell suspensions was verified by assessing in vitro cell attachment efficiencies
(see below) after 16 hours (day 1) culture in each medium formulation (Gerlach et ah,
1994c).
3.4.3 Total cellular protein content
Between media evaluations of total cellular protein content were made on each day of
culture (Figure 3.1 and Table 3.1). Plating efficiencies on day 1 for WE, HM, Ml99
and M1640 were 86±9, 75+9, 99±12 and 87±12 %, respectively. Although medium
formulation did not appear to significantly influence establishment of cell culture on
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day 1, the plating efficiencies confirmed the high quality isolate, initially determined
with the trypan blue exclusion test. Total protein content for freshly isolated
hepatocytes was 0.84 mg/106 cells determined from the slope of a linear regression
curve constructed over a range of counted cell samples (0.6-20 x 106 cells) shown in
Figure 3.1.1. Total protein content for the cells cultured for 2 days in WE, HM, Ml99
and RPMI 1640 media were 9.8+0.6, 7.3+1.0, 10.5+1.0 and 7.0+0.9 mg/ culture dish;
corresponding to 11.7+0.7, 8.7+1.2, 12.5+1.2 and 8.3+1.1 xlO6 cells/ dish,
respectively. Total protein content was significantly higher in Ml99 than HM
(p=0.013) and RPMI 1640 (p=0.006), whereas WE medium attained significantly
greater cellular protein levels than HM (p=0.043) and RPMI 1640 (p=0.028). This
suggests that the type of medium influenced cell proliferation by culture day 2 with
Ml99 in particular stimulating growth. Total protein content up to day 6 of culture
averaged «9mg/ culture dish, with the exception of RPMI 1640 grown hepatocytes at
6.1+1.1 mg; although the difference was not found to be statistically significant. All
other media comparisons (Table 3.1) and between day comparisons for each medium
formulation were not significantly different at the 5% level.
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Figure 3.1 Total Protein Content Of Porcine Hepatocytes Cultured In
Four Separate Chemically-Defined Media Formulations
14
day 1 day 2 day 4 day 6
Days
Figure 3.1 Porcine hepatocytes were seeded at 107 viable cells per 100mm
dish in William's E, HM, M199 and M1640 chemically-defined media for up
to 6 days. Cells were scraped from dishes on days 1, 2, 4 and 6 and total
protein content determined using the Bradford assay. Results are expressed
as mg total protein per dish as a measure of biomass (cell number). All
values represent the mean±SEM of seven (day 1) and ten (days 2, 4, 6)
experiments performed in duplicate culture dishes.
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Table 3.1 Showing p-values for Post Hoc (least significant difference;
LSD) Pairwise Multiple Comparisons of Total Protein Following Oneway
ANOVA Single Factor Analysis
Media
p-value
Day 1 Day 2 Day 4 Day 6
WE vs HM 0.511 0.043* 0.786 0.557
WE vs M199 0.411 0.544 0.820 0.476
WE vs
M1640
0.922 0.028* 0.669 0.348
HM vs M199 0.131 0.013* 0.618 0.899
HM vs
M1640
0.433 0.776 0.876 0.131
M199 vs
M1640
0.451 0.006** 0.513 0.103
* Significant at the level p<0.05; "Significant at the level p<0.01**
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Cell Number (x 106)
Figure 3.1.1 Graph Showing Total Protein Content of Freshly Isolated
Primary Porcine Hepatocytes as a Function of Cell Number Counted
Following the cell purification procedure (Chapter 2), isolated hepatocytes
were stained with trypan blue and viable cells counted using a Neubauer
haemocytometer. Aliquots of 0.6, 1.2, 2.5, 5.0, 10, and 20 x 106 cells were
taken in duplicate from 4 separate isolations and total protein content
analysed using the Bradford assay modified for a COBAS FARA centrifugal
analyser (Chapter 2, Section 2.3.7.1). The data was fitted to a linear
regression curve (y = 0.84x + 0.1) using FigP (version 2.5) software
programme. Total protein content was 0.84 mg/106 cells determined from the
slope (x) of the curve. The correlation coefficient, r2 was 0.999 while the
intra-assay coefficient of variance (CV) was 5% and the inter-assay CV was
8%.
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3.4.4 Hepatocyte culture viability as a function of percentage retained
LDH activity
Primary porcine hepatocytes were shown to retain high viability throughout the
culture period. The choice of medium had significant influence on retained LDH
activity in HM medium on day 2. Between-media comparisons of cell viability were
made on each day of culture (Figure 3.2 and Table 3.2). Both WE and Ml99 media
displayed significantly higher viability (p<0.05) compared to HM medium on culture
day 2 (96±1, 96±1, 85±6 %, respectively). Viability in RPMI 1640 was higher
(87+11) than HM medium, although the difference was not significant. By day 4 of
culture, the greatest difference in viability was observed between Ml99 and RPMI
1640 (96+2 v.s' 82+8 %, respectively; p=0.063). Viability remained very stable at
93+2% in all test media except RPMI 1640, which appeared markedly lower at
77+11%, while tending towards statistical significance (M1640 versus: WE, p=0.061;
HM, p=0.052; Ml 99, p=0.057, respectively). All other media comparisons (Table
3.2) and between day comparisons for each medium formulation were not
significantly different at the 5% level.
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Figure 3.2 Cell Viability of Porcine Hepatocytes in Four Separate
Chemically-Defined Media Formulations Expressed as Percentage
Retained Intracellular LDH Activities
120
2 4 6
Day of Cell Culture
Figure 3.2 Porcine hepatocytes were cultured at 107 viable cells per 100mm
dish in William's E, HM, M199 and M1640 chemically-defined media for up
to 6 days. Samples were taken on days 1, 2, 4 and 6. and LDH activity
determined for each medium using a modified LDH assay as described in
Materials and Methods. Results are expressed as a % of total cytosolic LDH,
as an indicator of cell viability. All values represent the means±SEM of eight
experiments in duplicate.
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Table 3.2 Showing p-values for Post Hoc (least significant difference)
Pairwise Multiple Comparisons of LDH Activity Following Oneway
ANOVA Single Factor Analysis
p-value
Media Day 2 Day 4 Day 6
WE vs HM 0.027* 0.948 0.938
WE vs M199 0.919 0.632 0.975
WE vs 0.147 0.159 0.061
M1640
HM vs M199 0.034* 0.587 0.963
HM vs 0.404 0.179 0.052
M1640
M199 vs 0.176 0.063 0.057
M1640
* Significant at the level p<0.05.
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3.5 Hepatocyte morphology
3.5.1 Morphology of fresh hepatic tissue and cultured hepatocytes
3.5.1.1 Transmission electron microscopy of fresh liver tissue and isolated
hepatocytes
Figure 3.3 shows that fresh liver tissue (panels, A-D) and isolated hepatocytes (panel
E) share many common fine structural features. These included one or two nuclei with
nucleoli; well-defined plasma- and nuclear membranes; abundant mitochondria and
rough endoplasmic reticulum (RER) interspersed between the mitochondria; smooth
endoplasmic reticulum (SER); numerous dense glycogen P-particles and rosettes (a-
particles) between SER and in close proximity to mitochondria; peroxisomes and
lysosomes. Bile canalicula-like structures are evident in both fresh liver tissue (B and
D; x28000) and in isolated hepatocytes (E; x3800).
3.5.2 Morphology and image analysis of cultured porcine hepatocytes
3.5.2.1 Morphology of Day 1 cultures under phase contrast light microscopy
and computer-aided image analysis (see Section 3.5.6)
The effects of medium formulation on gross cellular morphology and overall culture
integrity of day 1 cultures are shown in Figure 3.4. Plating efficiencies (Section 3.4.3),
assessed by TP content (Figure 3.1) were not statistically significant between test
media. However, quantitative image analysis (Figure 3.13A; Section 3.5.6, page 3-42)
supported the morphological observations (Figure 3.4) in terms of confirming
differences in the degree of confluency observed between test medium. In particular,
Ml99 appeared superior to both HM and Ml640 in promoting initial cell attachment
(see also Figure 3.13B). Figure 3.4 shows hepatocytes maintained in HM medium
(panels B, F) and to a lesser extent, in Ml640 (panels D, H) display the formation of
discrete colonies of piled up cells (denoted by asterisks in Figure 3.4) as evidenced by
the difficulty in obtaining an even plane of focus throughout the field. Monolayer
formation is more evident in Ml640. In contrast, cells grown in both Ml99 (A, E)
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and WE (panels C, G) media, establish more classical features of monolayer cultures
although with some loosely attached cells still present.
Figure 3.3 (opposite page) Transmission electron microscopy of fresh
liver tissue and isolated hepatocytes
Fresh liver tissue and isolated hepatocytes exhibited common fine structural
features: Round nuclei (N) with nucleoli (Nu) and well-defined plasma- (Pm,
arrows) and nuclear- (Nm) membranes and lysosomes (L, arrow head)
(panel A; x3800); abundant mitochondria (Mt) and granular endoplasmic
reticulum (ger) interspersed between the mitochondria (panels A, B; x10000
and C; x17000); smooth endoplasmic reticulum and Golgi apparatus (Ga,
panel D, x28000); peroxisomes (P) are evident, as well as numerous dense
glycogen (G) p-particles and rosettes (a-particles) between smooth
endoplasmic reticulum and in close proximity to mitochondria (panels B and
C). Bile canalicula-like structures (Be) are formed between adjacent
hepatocytes in both fresh liver tissue (panels B and D;) and in isolated
hepatocytes (panel E; x3800).
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Figure 3.4 Gross Morphology of Primary Porcine Hepatocytes on Day 1
of Culture
Phase contrast photomicrographs showing gross morphology of primary
porcine hepatocyte cultures, 16 hours post-seeding in serum-free chemically-
defined WE, HM, M199 and M1640 media (A-D respectively; x100; scale bar
100pm) and corresponding higher magnification photographs (E-F; x200;
scale bar 50pm). Cells were seeded at a density of 107 viable cells per
100mm tissue culture plastic (TCP) dish in 8ml of each of the four test media
(WE, HM, M199, M1640) at 37°C as described in Section 3.3.3. The
appearance of cultured cells was assessed for day 1 (and subsequent
cultures) using an inverted phase contrast microscope, by 2 independent
blinded observers using the criteria outlined in Section 3.3.5.1. These images
show the influence of test media on the attachment efficiency or degree of
confluency on culture day 1. The corresponding total protein content and
image analysis data is shown in Sections 3.4.3 and 3.5.6, respectively. Cells
grown in both WE (panels A, E) and M199 (panels C, G) media appear as
almost confluent monolayers whereas HM (panels B, F) and M1640 (panels




3.5.3 Morphology and image analysis of day 2 cultures
3.5.3.1 Phase contrast light microscopy and image analysis
Hepatocytes maintained for 2 days in both WE (Figure 3.5, A-B) and Ml99 (Figure
3.7, A-B) show characteristic morphology of healthy cell culture monolayers. This
was confirmed by 2 independent observers. These cultures, under phase contrast
reached an almost confluent monolayer of densely packed cells, which exhibited a
compact polygonal cell shape delimited by sharply-defined refractile borders,
containing bright nuclei. The lucent rim surrounding each hepatocyte represents the
presence of bile canaliculi-like structures. Percentage confluency was also enhanced in
WE and Ml99 cells as confirmed by image analysis (Section 3.5.6; Figure 3.13) and
supported by TP data (Figure 3.1). Contrastingly, discrete cell colonies (denoted by
asterisks in Figures 3.6 and 3.8) were conspicuous in HM- (Figure 3.6, A-B) and
M1640-grown (Figure 3.8, A-B) day 2 cultures, which persisted up to day 4 in HM
maintained cultures (not shown). In both media, monolayers of hepatocytes were
more evident than on day 1, although with areas devoid of cells. In addition,
hepatocyte monolayers cultured in HM and, to a lesser extent in Ml640, were
generally more spread out (see Figure 3.6, A-B) on the TCP surface compared to WE
and Ml99 cultures often showing cellular processes including pseudopodia (Figure
3.6, B). These morphological characteristics were evident up to day 4 of culture (not
shown).
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3.5.3.2 Transmission electron microscopy (TEM)
All day 2 cells had a non-polyhedral, rounded appearance probably as a result of the
trypsinization process. However, only WE (Figure 3.5, C-F) and Ml99 (Figure 3.7,
C-F) cultured hepatocytes showed many of the classical ultrastructural features of
fresh liver tissue. Some WE grown hepatocytes, uniquely, showed bile canaliculi-like
structures (Figure 3.5, panels C, E) (confirmed using fluorescein diacetate
fluorescence microscopy; not shown) and Golgi saccules (with very low density
lipoprotein granules). On the other hand, Ml99 grown hepatocytyes contained a
much greater RER network (which correlated with high total protein content and
albumin synthesis rate on day 2) and glycogen content (which correlated with high
PAS staining; not shown) than all other test media. In contrast, both HM (Figure 3.6,
C-D) and Ml640 (Figure 3.8, C-D) cultures exhibited less mitochondria, lipid
droplets, discrete fluid filled vacuoles and showed asymmetric swelling of the outer
mitochondrial compartment.
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Figure 3.5 Gross and Ultrastructural Morphology of Hepatocytes
Cultured In William's E Medium for 2 Days
Panels A and B: Representative phase contrast photographs showing gross
morphology of primary porcine hepatocyte cultures, 2 days post-seeding in
serum-free chemically-defined WE medium (A, x100; scale bar 100pm) and
corresponding higher magnification photographs (B; x200; scale bar 50pm).
These images show the influence of WE medium on the attachment
efficiency or degree of confluency on culture day 2. The corresponding total
protein content and image analysis data is shown in Sections 3.4.3 and 3.5.6,
respectively. Note the classical confluent monolayer of densely packed cells,
exhibiting a compact polygonal cell shape delimited by sharply-defined
refractile borders containing bright nuclei. Cells were cultured and analysed
as outlined in Figure 3.4.
Panels C-F: Transmission electron micrographs of the cultured hepatocytes
shown in panels A and B. The micrographs in panels C (x 5000), D (x8000)
and E (x8000) demonstrate a uniform distribution of the classical
ultrastructural features of fresh liver tissue including: intact plasma
membrane (Pm) with microvilli (Mv), large round nucleus (N) with nucleoli
(Nu), abundant mitochondria (Mt), lysosomes (L, arrow heads) and granular
endoplasmic reticulum (ger) surrounding mitochondria; panel E shows clearly
electron-dense glycogen granules (G) and the presence of a bile canalicula
(Be) whereas panel F (x75000) shows hepatocyte fine structure including
mitochondrial cristae (Mtc), granular endoplasmic reticulum with attached
ribosomes and part of the nucleus (N). Cells were cultured and processed as
described in Materials and Methods (Section 3.3.6).
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Figure 3.6 Gross and Ultrastructural Morphology of Hepatocytes
Cultured In Hepatocyte Medium for 2 Days
Panels A and B: Representative phase contrast photographs showing gross
morphology of primary porcine hepatocyte cultures, 2 days post-seeding in
serum-free chemically-defined HM medium (A, x100; scale bar 100pm) and
corresponding higher magnification photographs (B; x200; scale bar 50pm).
These images show the influence of HM medium on the attachment
efficiency or degree of confluency on culture day 2. The corresponding total
protein content and image analysis data is shown in Sections 3.4.3 and 3.5.6,
respectively. Discrete cell colonies (black asterisk) are a conspicuous
feature, which persisted up to day 4 (not shown) Monolayers of hepatocytes
were more evident than on day 1, although with areas devoid of cells (white
asterisks). In addition, hepatocyte monolayers cultured in HM were generally
more spread out on the TCP surface (compared to WE and M199 cultures)
often showing cellular processes including pseudopodia (arrow heads, panel
A). Cells were cultured and analysed as outlined in Figure 3.4.
Panels C-D: Transmission electron micrographs of the cultured hepatocytes
shown in panels A and B. Panel C (x 6500) displays a binucleate hepatocyte
although with evidence of degenerative cell abnormalities such as
vacuolation (V), few mitochondria and other organelles, and asymmetric
mitochondrial swelling (aMt). Panel D (x75000) shows that some normal fine
structure is maintained with mitochondrial cristae (Mtc), granular endoplasmic
reticulum (ger) and glycogen storage granules (G) in evidence. Cells were
cultured and processed as described in Materials and Methods.
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Figure 3.7 Gross and Ultrastructural Morphology of Hepatocytes
Cultured In Medium 199 for 2 Days
Panels A and B: Representative phase contrast photographs showing gross
morphology of primary porcine hepatocyte cultures, 2 days post-seeding in
serum-free chemically-defined M199 medium (A, x100; scale bar 100pm) and
corresponding higher magnification photographs (B; x200; scale bar 50pm).
These images show the influence of M199 medium on the attachment
efficiency or degree of confluency on culture day 2. The corresponding total
protein content and image analysis data is shown in Sections 3.4.3 and 3.5.6,
respectively. In common with WE-grown hepatocytes, these cells exhibit a
classical confluent monolayer of densely packed cells and a compact
polygonal cell shape delimited by sharply-defined refractile borders
containing bright nuclei. Cells were cultured and analysed as outlined in
Figure 3.4.
Panels C-F: Transmission electron micrographs of the cultured hepatocytes
shown in panels A and B. Panel C (x 6500) shows a binucleate hepatocyte
with prominent nucleoli (Nu), and classical ultrastructural features of fresh
liver tissue including: many mitochondria, granular endoplasmic reticulum
(ger), glycogen particles (G) and other sub-cellular organelles. Panels D
(x22000), E (x28000) and F (x75000) shows clearly electron-dense glycogen
granules (G) and free ribosomes (R), and many mitochondria surrounded by
granular endoplasmic reticulum. Part nucleus (N) is indicated in D and E.
Cells were cultured and processed as described in Materials and Methods.
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Figure 3.8 Gross and Ultrastructural Morphology of Hepatocytes
Cultured In RPMI 1640 Medium for 2 Days
Panels A and B: Representative phase contrast photographs showing gross
morphology of primary porcine hepatocyte cultures, 2 days post-seeding in
serum-free chemically-defined M1640 medium (A, x100; scale bar 100pm)
and corresponding higher magnification photographs (B; x200; scale bar
50pm). These images show the influence of M1640 medium on the
attachment efficiency or degree of confluency on culture day 2. The
corresponding total protein content and image analysis data is shown in
Sections 3.4.3 and 3.5.6, respectively. Discrete cell colonies are a prominent
feature (black asterisks), which persisted up to day 4 (not shown). In addition,
hepatocyte monolayers cultured in M1640 displayed areas of compact and
'spread out' monolayers and some regions devoid of cells (white asterisk in
panel A). Cells were cultured and analysed as outlined in Figure 3.4.
Panels C-E: Transmission electron micrographs of the cultured hepatocytes
shown in panels A and B. Panels C (x 5000) and D (x6300) display
hepatocytes with normal nuclei (N) and nucleoli (Nu, panel C), although with
clear evidence of degenerative cell abnormalities including extensive
vacuolation (V), lipid droplets (Ld) and asymmetric mitochondrial swelling
(aMt). Panel E (x28000) shows that some normal fine structure is maintained
with normal mitochondria (Mt), granular endoplasmic reticulum (ger) and
glycogen storage granules (G) in evidence. Cells were cultured and





3.5.4 Morphology and image analysis of day 6 cultures
3.5.4.1 Phase contrast light microscopy and image analysis
All cultures maintained in each test medium showed distinct but varying signs of
degeneration by day 6 (Figures 3.9-3.12) including cell detachment, general loss or
'blurring' of delineating cell borders, nuclear fragmentation and the appearance of
necrotic and apoptotic cells. A striking feature of WE medium was the appearance in
culture of discrete foci of small cell aggregates (denoted by F* in Figure 3.9, A-B)
with a radiating cord-like arrangement of hepatocytes reminiscent of the in vivo cell
microenvironment. However, although cell detachment was clearly evident,
hepatocyte morphology was well preserved and similar to day 4 cultures. A distinct
feature of HM cultures was the presence of small rounded structures, possibly lipid
droplets or small vacuoles (Figure 3.IOC). No quantitative differences in %
confluency were observed between media on day 6 (Figure 3.13A)
3.5.4.2 Transmission electron microscopy
By day 6, vacuolation, organellar swelling, ER vesiculation and irregular hepatocyte
shape were more exaggerated and widespread in HM (Figure 3.10, C-D) and M1640
(Figure 3.12, C) cultures compared with WE (Figure 3.9, C) and M199 (Figure 3.11,
C) maintained cells.
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Figure 3.9 Gross and Ultrastructural Morphology of Hepatocytes
Cultured In William's E Medium for 6 days
Panels A and B: Representative phase contrast photographs showing gross
morphology of primary porcine hepatocyte cultures, 6 days post-seeding in
serum-free chemically-defined WE medium (A, x100; scale bar 100pm) and
corresponding higher magnification photographs (B; x200; scale bar 50pm).
These images show the influence of WE medium on the attachment
efficiency or degree of confluency on culture day 6. The corresponding total
protein content and image analysis data is shown in Sections 3.4.3 and 3.5.6,
respectively. Note the appearance in culture of discrete foci (denoted by F*)
of small cell aggregates (Figure 4.3 A and B) with a radiating cord-like
arrangement of hepatocytes, reminiscent of the in vivo cell
microenvironment. However, both cell detachment and poor overall
morphology compared with day 2 cultures was evident. Cells were cultured
and analysed as outlined in Figure 3.4.
Panels C: Transmission electron micrograph of the cultured hepatocytes
shown in panels A and B. The micrograph in panel C (x 5000) shows some
features of degenerating and damaged hepatocytes; including irregular
shape, vacuolation (V) more prevalent in the lower cell (devoid of
mitochondria), and both normal (Mt) abnormally shaped (aMt) mitochondria.
Cells were cultured and processed as described in Materials and Methods.
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Figure 3.10 Gross and Ultrastructural Morphology of Hepatocytes
Cultured In Hepatocyte Medium for 6 Days
Panels A and B: Representative phase contrast photographs showing gross
morphology of primary porcine hepatocyte cultures, 6 days post-seeding in
serum-free chemically-defined HM medium (A, x100; scale bar 100p) and
corresponding higher magnification photographs (B; x200; scale bar 50p).
These images show the influence of HM medium on the attachment
efficiency or degree of confluency on culture day 6. The corresponding total
protein content and image analysis data is shown in Sections 3.4.3 and 3.5.6,
respectively. Discrete cell colonies are less common (panels A and B, black
asterisks) and signs of cell degeneration, including cell detachment (panel A,
white asterisks), general loss of delineating cell borders (panels A and B,
black arrows) and the appearance of lipid droplets and / or vacuoles (panel
B, white arrow). Cells were cultured and analysed as outlined in Figure 3.4.
Panel C: Transmission electron micrograph of the cultured hepatocytes
shown in panels A and B. The micrograph in panel C (x 3800) shows
features of degenerating and damaged hepatocytes including: extensive
vacuolation (V), abnormally shaped mitochondria (aMt) and areas devoid of
organelles. Panel D (x17000) shows loss of integrity of the endoplasmic
reticulum and adjacent to the large vacuole is a mitochondria with
asymmetric swelling (aMt) of the outer compartment. Glycogen particles (G)




Figure 3.11 Gross and Ultrastructural Morphology of Hepatocytes
Cultured In Medium 199 for 6 days
Panels A and B: Representative phase contrast photographs showing gross
morphology of primary porcine hepatocyte cultures, 6 days post-seeding in
serum-free chemically-defined M199 medium (A, x100; scale bar 100pm) and
corresponding higher magnification photographs (B, x200; scale bar 50pm).
These images show the influence of M199 medium on the attachment
efficiency or degree of confluency on culture day 6. The corresponding total
protein content and image analysis data is shown in Sections 3.4.3 and 3.5.6,
respectively. Cell detachment is evident (asterisks) and general signs of cell
degeneration such as loss of delineating cell borders and the appearance of
apoptotic cells, with cell blebbing (arrows), are clearly seen. Cells were
cultured and analysed as outlined in Figure 3.4.
Panels C: Transmission electron micrograph of the cultured hepatocytes
shown in panels A and B. The micrograph in panel C (x 3800) shows some
features of damaged hepatocytes, including vacuolation (V), fewer
cyoplasmic organelles and abnormal nuclear shape (N). Cells were cultured
and processed as described in Materials and Methods.
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Figure 3.12 Gross and Ultrastructural Morphology of Hepatocytes
Cultured In RPM11640 Medium for 6 Days
Panels A and B: Representative phase contrast photographs showing gross
morphology of primary porcine hepatocyte cultures, 6 days post-seeding in
serum-free chemically-defined M1640 medium (A, x100; scale bar 100pm)
and corresponding higher magnification photographs (B; x200; scale bar
50pm). These images show the influence of M1640 medium on the
attachment efficiency or degree of confluency on culture day 6. The
corresponding total protein content and image analysis data is shown in
Sections 3.4.3 and 3.5.6, respectively. The cell colonies evident in earlier
cultures are no longer present. Cell detachment (asterisks) and degeneration
are well under way including general loss of delineating cell borders and the
appearance of apoptotic cells (arrows). Cells were cultured and analysed as
outlined in Figure 3.4.
Panels C: Transmission electron micrographs of the cultured hepatocytes
shown in panels A and B. The micrograph in panel C (x 10000) shows an
irreversibly damaged hepatocyte with extensive vacuolation (V), abnormally
shaped mitochondria (aMt), areas devoid of organelles and an absent
nucleus. Panel D (x3800) shows that some hepatocytes remained intact
although there is an abnormal distribution of organelles and little evidence of
endoplasmic reticular components and glycogen particles. Cells were
cultured and processed as described in Materials and Methods.
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3.5.5 Relative frequencies of cytoplasmic organelles and bile canaliculi
examined under TEM
Table 3.3 shows a comparison of relative frequencies of cytoplasmic organelles and
bile canaliculus structures on days 2 and 6 of culture for each test medium. Ten areas
from each of 4 copper grids per sample for 3 separate isolations were investigated and
the number of organelles (nuclei, mitochondria, GER, glycogen granules, and Golgi
complex) counted. In addition the presence of bile canaliculi in TEM sections was
assessed. Day 2 cultures in WE and Ml99 appeared to have a full complement of
organelles, as observed for fresh liver sections (Figure 3.3) whereas in both HM- and
M1640-grown hepatocytes the number of organelles was depleted. Although the
relative number oforganelles had declined in all media by day 6, the effects were more





































































































































































3.5.6 Computer-aided image analysis of cultured porcine hepatocytes
Semi-automated computer-aided image analysis was performed (in duplicate dishes
for each test medium in 3 separate experiments) to make a more objective assessment
of morphological differences, such as attachment and adhesion efficiency, between the
test media cultures. Between media evaluations on each day of culture were made
(Figure 3.13A). In contrast with the total protein data (Section 3.4.3), statistical
significance was shown for culture days 1, 2, and 4. In particular, plating efficiencies
(PE) on day 1 for WE, HM, Ml99, and, Ml640 maintained cells were 71 ±14, 38±3,
78±5, and 55±10 respectively; PE being greater in WE (p<0.05) and the difference
highly significant (p<0.01) in M199 cells, compared with HM cells. Percentage
confluency was significantly lower (p<0.01), notably in HM cultures in relation to all
other test media on days 2 and 4; although no statistical significance was observed on
day 6. Between day evaluations of each medium revealed (with the exception of HM)
significant increases (p<0.05) in % confluency in all test media cultures by day 4
compared with initial day 1 cultures suggesting either cell proliferation and/or
increased cell spreading had occurred. Mean % confluency values for all test media
declined by day 6, although an unexpected significant increase (p<0.05) was observed
in HM on day 6 compared with day 4. This could be due to the aforementioned, or a
delay in cell spreading with culture age.
Opposite page: Figure 3.13B shows examples of image capture
photomicrographs (x25) of day 2 WE, HM, M199, and M1640 cultures prior
to analysis with the Image-Pro Plus image analysis system. Test culture
dishes were washed 2x in HBSS, fixed in formal saline, and stained with
H&E using standard histological techniques as described in Materials and
Methods (see Section 3.3.5.2). Images were acquired, processed, and
analysed using Image-Pro Plus™ software.
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Figure 3.13 Percentage confluency of porcine hepatocytes cultured in
four separate chemically-defined media formulations assessed by
computer-aided image analysis



















B) Image capture photomicrographs showing degree of confluency of cultured




This study was undertaken to evaluate the effect of culture conditions on hepatocyte
morphology. Despite the acceptance of PPHs as being the best candidates for current
BAL devices, the relative scarcity of morphological (or functional) studies using
cultured porcine hepatocytes is increasingly being highlighted (Allen et al., 2001; Joly
et al., 1997; Gregory et al., 2000; Seilaff et al., 1995b). In contrast, there exists an
extensive literature describing the characteristics of rat cultures in vitro (LeCluyse et
al., 1999). Typical approaches include promotion of homotypic or heterotypic cell-
cell interactions, and manipulation of biomatrices or media composition (Allen et al.,
2001). Given the importance of these factors in promoting optimal ex vivo
maintenance of hepatocytes for BAL systems (Selden et al., 1999; Strain &
Neuberger, 2002), identifying the most favourable medium which preserves PPH
phenotype and morphology is one of the first considerations for improving the
efficacy of pre-clinical BAL devices (Naik et al., 1996; Watts et al., 1995). To this
end, morphological characteristics of cultured porcine hepatocytes, on unmodified
TCP were studied under four separate serum-free chemically-defined medium
formulations. Inasmuch as this culture system eliminates the confounding variables
introduced when using serum and / or biomatrix components, it may also reduce the
aforementioned risks associated with use of these factors in BAL devices (Tsiaoussis
et al., 2001; and Section 3.1).
A major limitation of our culture system, and most other conventional
monolayer cultures (LeCluyse et al., 1999) is that hepatocytes did not survive longer
than one week on TCP, and had presumably undergone a rapid retro-differentiation.
Some investigators have reported, notably in 3D porcine culture configurations,
maintenance of long-term differentiated morphology and function for 18 days
(DeBartolo et al., 2000), and up to 7 weeks (Gerlach et al., 1995). Whilst PPHs
cultured in WE with 1% new born calf serum, maintained albumin and urea synthetic
capacity similar to our cultures on TCP dishes, with or without collagen, for up to 19
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days. This is clearly not achievable using our culture system on TCP, although the risk
of genetic transformation or infection is reduced with short-term cultures.
The rationale for examining hepatocyte morphology and functional activity (Chapter
4) over a 6-day culture period in this study follows from the fact that most porcine-
based BAL devices are designed to be operational within 2-4 days of seeding the
bioreactor. (Flendrig et al., 1997a; Gerlach et al., 1994a; Kong et al., 1996; Sheil et
al., 1996; Sheil et al., 1998; Uchino et al., 1991; Wang et al., 1998). The majority of
BAL systems utilise either or both a biomatrix component and serum-supplemented
medium for cell support and nutrition. Porcine hepatocytes are inoculated, either
extra- or intra-luminally, via synthetic hollow fibres of the bioreactor, onto a variety
of substrata. The latter include: monolayer cultures on collagen type I (De Bartolo et
al., 2000), microcarriers (Kong et al., 1996), gel-entrapment or alginate beads
(Falasca et al., 2001; Nyberg et al., 1993; Sielaff et al., 1995a; Sielaff et al., 1995b),
Engelbreth-Holm Sarcoma (EHS) gel Natrix and Matrigel (Gerlach et al., 1995).
However, the influence of unknown variables, such as the purity and composition of
the attachment substrates or heterologous serum, on cellular parameters of growth,
function and morphology were not addressed.
These considerations prompted us to evaluate the effects of serum-free
chemically-defined media on PPH morphology (and related biochemical parameters).
Highly purified recombinant growth factor (L-EGF), insulin and dexamethasone were
selected as agents to promote maintenance of PPH cultures. These supplements were
chosen since they are considered to have the most marked effects on the morphology,
function and survival of hepatocytes on simple substrata (Berry et al., 1991b). Insulin
enhances initial cell attachment, important for cells seeded onto TCP. Long-EGF, a
synthetic analogue of endogenous EGF, with up to ten-times the mitogenic potency
[Sigma Technical Service, personal communication], stimulates DNA synthesis, cell
growth, amino acid transport and protein synthesis (Michalopoulos GK, 1990), as
well as preservation of tissue-specific functions and hepatocyte morphology (Berry et
al., 1991b) acting in a synergistic fashion with insulin. The positive effects of EGF on
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liver metabolism parallel those of insulin (Russell and Carver, 1998). Both hormones
contribute to the preservation of hepatocyte morphology, survival and tissue-specific
functions such as albumin synthesis. This is also true of dexamethasone, which in
addition to supressing fibroblast growth, is also resistant to degradation compared to
naturally occurring glucocorticoids (Berry et al., 1991a). In addition dexamethasone
also promotes retention of a relatively compact, polygonal cell shape and favours the
formation of more bile-canalicular-like structures, at least for cultured rat hepatocytes
(Berry et al., 1991b; LeCluyse et al., 1996).
It has been suggested however, that the beneficial effects educed by
modification of defined media by addition of, for example, dexamethasone or low
concentrations of DMSO, may be inapplicable for BAL designs because of systemic
exposure of patients to these non-physiological media components (Allen et al.,
2001). Moreover, hepatocyte culture media are not approved for medical use. This
may not be problematic considering that pre-clinical BAL systems will be flushed
prior to connection to the patient's circulation. A complex hemofiltration solution
(bicarbonate buffered, glucose, essential minerals) has been identified as suitable for
this purpose (Flendrig et al., 1998).
We have shown for the first time that, in the presence of different serum-lfee
chemically-defined media formulations, exogenous attachment substrates or serum are
superfluous for the culture of PPHs. High plating efficiencies (PE) and viability on
tissue culture plastic can be maintained in the absence of serum or sophisticated
substrate for attachment. PPHs have been shown to readily attached to TCP or to
uncoated nonwoven polyester matrix material in Chamuleau's BAL device (Flendrig
et al., 1997a; Flendrig et al., 1997b; te Velde et al., 1995). To our knowledge,
previous studies, including the latter, of PPH cultures in the context of BAL systems,
have used serum-supplemented media. The use of non-autologous (bovine) serum
may be inappropriate for BAL usage since it is heterogeneous in composition,
promotes rapid cellular dedifferentiation and selective growth of non-parenchymal
cells and may contain endotoxins (Berry et al., 1991a) and potentially, zoonotic
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entities (Enat et al., 1984). Cell attachment or plating efficiencies based on TP
measurements are defined as 'the TP content as a percentage of the initial value of the
number of cells seeded into each culture dish' (Watt et al., 1995; Gerlach et al.,
1994c), and are frequently used to assess both the quality of the initial isolate and
subsequent cultures. PE on day 1 of culture (Figure 3.1), as measured by total cellular
protein content, were significantly greater than both rat and sheep hepatocytes
cultured in WE and Ml99, containing 5% serum (Watts et al., 1995). However,
computer aided image analysis showed quantitatively (Figure 3.13), that percentage
confluency (analogous to plating or attachment efficiencies) to be significantly lower
than day 1 TP based measurements, although the pattern of between media
comparisons was similar. Moreover, this trend continued for HM-maintained cultures
up to day 4. These data suggest that biochemical measurements of TP content may
not alone be a reliable indicator of assessing PE or maintenance of cell culture
confluency in the different media formulations. This may be due to the labile nature of
cellular protein synthesis, reflecting variable TP content of cultured cells under certain
conditions. On the other hand, the high TP content, translating into relatively high PE
(compared with the image analysis data) could be a consequence of increased biomass
residing in the discrete cell colonies observed in HM cultures (Figure 3.6), although
this discrepancy was not observed for Ml640 cultures, which showed similar gross
morphology to the latter under light microscopy (see Figure 3.8) but with significantly
higher % confluency.
Interestingly, te Velde et al., (1995) demonstrated, by analysis of both DNA
and TP content, identical day 1 PE of 76% for PPHs cultured in 10%FCS/WE
medium on different biomatrices (including Matrigel, fibronectin, and collagen),
compared with cells cultured on TCP. Morsiani et al., (1997) reported a 70%
attachment efficiency of PPH onto microcarrier beads. These data correspond to a PE
of «*75% in HM cultures (Figure 3.1) on TCP, but are substantially lower than the
other test media, suggesting neither serum, nor biomatrix, had influenced cell
attachment in the other test media. Release of xenogenous proteins from Matrigel or
EHS Natrix may anyway preclude their use in the BAL setting, despite some
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demonstrable, enhancing effects on retention of in vitro liver-specific functions and
culture longevity (Bhatia et al., 1999; De Bartolo et al., 2000). It is possible that the
hormonal supplements (L-EGF, insulin and dexamathasone) in our defined culture
system promote cell attachment through up-regulation of cell adhesion molecules or
membrane stabilisation. Indeed, culturing hepatocytes as monolayers on tissue culture
surfaces does allow recovery from the 'trauma' of isolation. During this respite
period, cells can repair membranes, partially restore polarity and cell-cell interactions
(Berry et al., 1991c). Not surprisingly perhaps, environmental cues which enhance
cellular repair mechanisms may be provided by a greater range of amino acids in
complex media such as WE or Ml99 (see APPENDIX I). Originally developed to
optimise the serum-free growth of hepatoma cells, Ml640 is a relatively simple
medium compared with WE or Ml99 and may explain its inability to maintain normal
ultrastructure even at day 2, whereas HM is a proprietary formulation, based on
Leibovitz L-15 formulation. The latter contains very high amino acid concentrations
but does not contain important components such as proline, as well as aspartate,
cystine and glutamate. Thus with wide variations in the amount and range of amino
acids and other media componenets, it is not possible to delineate which factors are
responsible for the observed differences in morphology between the test media with
the present study design.
Image analysis (Figure 3.13) on the other hand imply that both WE and Ml99
maintained cultures are more efficient in terms of promoting the degree of confluency
compared with E1M and to a lesser extent, Ml640 cells up to day 4. In fact, although
somewhat subjective, light microscopic observations suggest that hepatocyte
morphology was improved by day 2 of culture, as compared to day 1, particularly in
both WE and M199 media (Figures 3.5 and 3.7; panels A-B, respectively). The near
normal ultrastructure (Figures 3.5 and 3.7; panels C-F, respectively), high viability
and total protein content (Figures 3.1 -3.2) of these cells on day 2, as well as the image
analysis data (Figure 3.13) lends support to the gross morphological observations and
PE data.
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Intracellular LDH activity has been shown to be proportional to the number of
viable hepatocytes (Poullain et al., 1992) whereas total protein content is a
approximate correlate of cellular biomass with cell number (Gregory et al., 2000;
Sharda et al., 1996). In our study, viability remained high (range 80-90%) throughout
the culture period (Figure 3.2). Again, day 2 cultures demonstrated significantly
higher viabilities in WE and Ml99 than HM medium (Figures 3.1-3.2). Furthermore,
our data may suggest an increase in cell numbers in cultures supported by Ml99 and
WE, perhaps reflecting the greater concentration of amino acids, particularly proline,
in both media, which stimulate cell growth (Houck and Michalopoulos, 1985;
Michalopoulos GK, 1990; Mitaka, 1998; Berry et al., 1991a). However, the
correlation between TP content and cell number in PPHs cultures is questionable as
mentioned, despite evidence of linearity for freshly isolated cells (Figure 3.1.1). Image
analysis data (Figure 3.13) on the other hand, demonstrated, with the exception of
HM, increases in % confluency in all test media cultures by day 2, and significant
increases by day 4 compared with initial day 1 cultures. This suggests either cell
proliferation and/or increased cell spreading had occurred, which correlates with the
morphological observations for day 1 (Figure 3.4) versus day 2 cultures (Figures 3.5-
3.8), where the gross morphology of day 2 cells appeared identical to day 4 cultures
(not shown). In retrospect, it would have been useful to measure cell proliferation in
the different test media, at different time points. Experiments confirming proliferation
of the cultured cells, under these different culture conditions, could be made by
quantifying DNA and labelling with tritiated thymidine, followed by scintillation
counting. Indeed, hepatocytes suitable for BAL systems should ideally have both a
well-differentiated in v/vo-like phenotype and undergo controlled rounds of
proliferation in vitro (Jauregui and Gann, 1991; Riordan et al., 1998). Although
functional activity is measured in Chapter 4, this combined data would give
information on which culture condition provided the best balance between
proliferation and the differentiated function of cells for BAL devices. As expected, the
correlation between viability and functional activity is strong. In agreement with Wang
et al., (1998) we found that if hepatocyte viability fell below 60% functional activity
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including albumin production, urea synthesis and P450 activity was severely
attenuated (data not shown).
To overcome problems associated with subjective observations and bias in
assessing gross cell culture morphology under light microscopy, and to increase
accuracy, semi-automated computer-aided image analysis was used to quantitatively
measure percentage confluency of each test culture, using the Image-Pro Plus™
software programme routinely used in the Department of Pathology (Dr C Bellamy,
University of Edinburgh). A representative estimate of culture dish surface area
covered by attached cells was made and quantified. In addition two independent,
blinded investigators assessed the quality of cell culture morphology by the criteria
outlined in Section 3.3.5.1. This purely subjective analysis ranked the quality of
cultures on day 2 as: M199>WE>M1640>HM, whilst gross morphology of day 6
cultures had substantially deteriorated in all test media, with equal ranking. The image
analysis method adopted here, proved simpler and more convenient, although is less
informative, than nuclear counting and cellular DNA analysis. Measurement of the
latter proving unreliable as measured by fluorimetry (data not shown), whereas the
form of the PPH cultures, particularly in HM and M1640 (Figures 3,6 and 3.8), with
piled up cells and overgrowth in other cultures made counting nuclei undependable.
This form of image analysis is somewhat limited, since it only gives information on the
extent of monolayer formation. Nonetheless, the healthy appearance in day 2 WE and
Ml99 cultures of the monolayers thus formed (displaying a relatively compact,
polygonal cell shape) complements the image analysis data as do the ultrastructural
studies of the intracellular characteristics of PPHs under the different culture
conditions.
Hepatocytes grown in WE (Figure 3.5) and Ml99 (Figure 3.7) media
formulations, maintain and share most of the ultrastructural features of both fresh liver
tissue and isolated hepatocytes (Figure 3.3), at least up to day 2 (Table 3.3). These
observations, and such factors as consistent large round nuclei, are indicative of
differentiated hepatocytes (Michalopoulos et al., 2001). In addition hepatocytes
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exhibit stereotypical gross morphology - distinct nuclei and nucleoli with well-
demarcated reffactile cell borders up to day 4 of culture (not shown). The bright,
lucent rim surrounding each hepatocyte represents the presence of opposing
membranes of bile canaliculi (Bader et al., 1996; LeCluyse et al., 1996), particularly
in WE and Ml99 cultures, although bile canalicular-like structures were established
only in TEM sections of WE-maintained cultures (Figure 3.5 and Table 3.3).
However, these observations do not establish whether they are functional or not. Bile
synthesis was confirmed in WE cultures day 2 cultures however, by detection of
fluorescein diacetate metabolism using fluorescence microscopy (not shown). These
findings suggest at least partial preservation of cellular polarity under defined
conditions, despite the absence of serum or a biomatrix component. Such
phenomenon has been demonstrated for rat hepatocytes cultured on collagen coated
Permanox dishes in Chee's medium containing DMSO, dexamethasone and insulin
(Arterburn et al., 1995). The authors concluded that these supplements, in concert
with components of the culture medium, effectively 'bypassed' the need for
biomatrices or serum.
Distinctive attributes of these media include their ability to preserve bile
canaliculi-like structures whilst enhancing both the glycogen and RER protein
synthetic machinery; the latter correlating with a significantly higher total protein
content on day 2, than both HM and Ml640 media, and a higher recorded albumin
synthesis (Figure 4.9, page 4-29), although this could not be measured in HM. Taken
together, these observations suggest that preservation of such morphological markers
of differentiation and evidence of cellular polarity, reflects a potential for expression
of normal in vitro functional diversity - desirable attributes required for the biological
component of BAL systems.
In sharp contrast to the near normal phenotype expressed in hepatocytes
grown in WE and Ml99 media, atypical gross morphology was evident in both HM
and Ml640 maintained cells up to day 4, most notably: the formation of discrete
colonies (presumably of aggregated cells), the rather limited hepatocyte monolayer
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formation and excessive cell spreading, and loss of delineating cell borders. Consistent
with these findings, even at day 2, HM and Ml640 hepatocyte cultures exhibited
ultrastructural features of unhealthy cells including vacuolation and / or lipid
deposition as well as fewer mitochondria. The relative frequencies of most
cytoplasmic organelles (Table 3.3), was diminished in these media. Taken together,
these findings reinforce the notion that different medium formulations can have
differential effects on hepatocyte morphology, ultrastructure and possibly function.
Moreover, the observed cell detachment, apoptosis, and probable necrosis of day 6
cells (Figures 3.9-3.12), may suggest release necro-inflammatory chemicals, such as
certain cytokines, which are undesirable in the BAL setting. However, differentiated
function, such as albumin synthesis, appeared unaffected by the deranged
morphology.
Our findings make it clear that different serum-free chemically-defined
media formulations allow maintenance of high viability hepatocyte cultures following
high plating efficiencies, compatible with retention of functional activity, for up to 6
days. Furthermore, the type of medium formulation appears to modulate, to varying
degrees, cell culture morphology, plating efficiency and viability in vitro. In particular,
ultrastructural observations showed near normal morphology of subcellular organelles
in both day 2 WE and Ml99 cultures, suggesting these hepatocytes retain an in vivo-
like differentiated morphology. The preservation of intact and abundant subcellular
organelles in these media such as mitochondria, with well preserved cristae and
double membranes (Figures 3.5 and 3.7) reflects the potential of these organs to
produce ATP; RER correlates with the maintained ability to synthesize proteins,
including albumin (Chapter 4). These findings may be of use when considering the
most favourable complex medium with which to support pre-clinical BAL devices.
Despite the high viabilities evident in all test media on day 6, the morphological
observations strongly favour these media over and above the other media used (see
Figures 3.9-3.12). Future studies should address fundamental questions arising from
this work: Which components of the test media account for the observed
morphological variation? In the absence of exogenous attachment substrates, do cells
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synthesize and secrete endogenous ECM? Do hepatocytes retain functional bile
canaliculae, domain-specific proteins and polarity? Do cells proliferate under each test
medium? What are the mechanisms responsible for the de-differentiation process?
How do the cells respond in toxic FHF plasma, and can cytoprotective strategies be
developed in this context? In the next chapter, the influence of these different culture




In Vitro Characterisation of Primary Porcine
Hepatocyte Function
4.1 Introduction
Availability of primary human hepatocytes for cell-based approaches to treat acute
liver failure (ALF) is severely restricted due to a shortage of donor organs. A
corollary to this for experimental hepatocyte transplantation and bioartificial liver
(BAL) therapies, is the possibility of using a variety of mammalian cells from pig,
rabbit or rat species. However small mammals are impractical sources of cells to treat
ALF due to insufficient yields. Indeed, the theoretical functional liver cell mass
required for support is 20% of the whole liver, equivalent to approximately 20 billion
hepatocytes (Nelson et al., 2000; Newsome et al., 2000; Plevris et al., 1998).
As previously mentioned, primary porcine hepatocytes (PPHs) are the most
appropriate biological component for BAL systems for treatment of ALF in terms of
sufficient yield, viability and biocompatibility. PPHs exhibit differentiated function in
culture and have a higher intrinsic metabolic activity compared to other mammalian
hepatocytes (Behnia et al., 2000; Desille et al., 1999; Donato et al., 1999; Naik et al.,
1996). As demonstrated in Chapter 3, unlike other mammalian species, PPHs appear
unique in that they do not require a substratum of exogenous ECM for initial
attachment and survival, in agreement with recent reports (Gregory et al., 2000;
Pahernik et al., 2001; te Velde et al., 1995). We also have shown, that serum-free
cultures of PPHs attach, survive and show ultrastructural features of differentiated
hepatocytes, at least for short-term cultures, applicable to many current BAL devices.
Hepatocyte morphology appeared to be influenced by the culture medium
formulation, since ultrastructural examination of day 2 WE- and M199-maintained
porcine hepatocyte cultures maintained features typical of metabolically active,
differentiated liver cells, in contrast to both HM and RPMI 1640 cultures.
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The influence of medium formulation on cultured cell functional activity can
be significant. For instance, LeCluyse et al. (1999) showed that medium formulation
and culture dish material had significantly greater effects on the induction of
cytochrome P4502B by phenobarbital than either collagen or Matrigel™ sandwich
cultures of rat hepatocytes. Watts et al., (1995) found that Modified Earle's medium
retained hepatic differentiated function, including total p450 (tP450) content and urea
synthesis capacity, significantly better than either Ml99, Chee's media, or WE in rats.
While studies from our laboratory have shown HM to be superior to WE in
supporting tP450 biotransformation potential of cultured porcine hepatocytes (Keatch
et al., 2002).
Ideally, the primary requirement of a BAL system is the preservation of in
v/vo-like metabolic functions. Replacement of impaired fiver functions on a temporary
basis may sustain life by preventing and/or decreasing the progress of hepatic
encephalopathy and/ or create conditions for native fiver regeneration of functional
tissue and full recovery (Gregory et al., 2000; Jauregui et al., 1995; Jauregui and
Gann, 1991; Naik et al., 1996). Whilst the precise metabolic functions required of
hepatocytes to treat ALF are unknown, it is likely that a full repertoire of in v/vo-like
differentiated functions including synthetic, detoxifying and metabolic capabilities are
prerequisites ofxenogeneic hepatocytes in order to support the failing liver.
Key factors in achieving such ex vivo maintenance of differentiated PPH
cultures are the most appropriate combination of biomatrix, hepatotrophic support
and medium formulation. However, as mentioned, the use of serum-supplemented
media or biomatrices to maintain retention of liver-specific functions in BAL devices
for 2-4 days, may be unnecessary or even detrimental to cells.
Systematic investigations of the optimal medium requirements for PPH culture
in BAL devices is lacking, probably due to the absence of standardisation and
diversity of culture conditions used by different laboratories as well as the reliance on
extrapolating data from rat hepatocyte studies to evaluating PPH culture systems.
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Moreover, as mentioned, the type of medium formulation appears to modulate gross
hepatocyte morphology, ultrastructure and possibly function.
The objective of this study was to assess the effects of different culture
conditions on differentiated function of PPHs under fully defined conditions.
Hepatocytes were cultured on biomatrix-ffee (unmodified) tissue culture plastic in
four separate serum-free chemically-defined media formulations (WE, HM, Ml 99 and
Ml640) containing equal amounts of hormonal supplements. Because synthetic,
detoxifying and metabolic capabilities of in vitro hepatocyte culture are considered
necessary to fulfil the hepatic replacement function required of the biological
component of BAL systems, we measured the following markers ofdifferentiation: (i)
albumin production as an energy-requiring biosynthetic and secretory function, (ii)
urea production from ammonium chloride as a measure of detoxifying capacity, (iii)
galactose elimination to reflect the integrity of carbohydrate metabolism, and (iv) total
cytochrome P450 content (tP450) as an indicator of biotransformation potential.
Measurement of tP450 would give an overall perspective of the phase 1 potential of
the hepatocytes under the different culture conditions using one assay.
Similar to the biochemical measurements of Chapter 3, this study will entail
examination of multiple comparisons of biochemical functional activity. In order to
define an index of global functional capacity, a scoring system (hepatocyte biological
acitivity index; HBAI) was devised, to simplify comparisons, and as an integrated
measure of overall functional capability. The biochemical data reported in Chapter 3
was used in the generation of the HBAI, whereas parallel morphological observations
were used in the assessment of the comparative scores of the HBAI.
4.1.1 Aims
The specific aim of this study was to assess differential effects of separate, serum-free
chemically-defined medium formulations on differentiated hepatic support functions of
cultured porcine hepatocytes for future BAL devices.
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4.2 Materials and Methods
4.2.1 Reagents
All reagents used were as detailed in Chapters 2 and 3 with the following additions:
Ammonium chloride, D(+)~galactose, 3-N-morpholinopropanesulphonic acid (MOPS
free acid) and MOPS Sodium salt were obtained from Sigma, St Louis, Mo, USA;
Analar grade chemicals for albumin determination were obtained from Life
Technologies (BDH Merck). Albumin blue 580 [2-chloro-3-(2,2-dicyanoethenyl)-2-
cyclohexen-l-ylidene]methylpropanedinitrile potassium salt was from Molecular
Probes (Cambridge Bioscience, UK). Galactose kits were from Roche Diagnostics
Ltd. (UK).
4.2.2 Hepatocyte isolation
Hepatocytes were isolated from weanling piglets (<15kg) using our ex vivo
collagenase perfusion method described in Chapter 2 (Nelson et al., 2000).
4.2.3 Hepatocyte cultures
Hepatocytes were cultured as described in Chapter 3 (Section 3.3.3). Briefly, 107
viable cells were cultured for up to 6 days on 100mm tissue culture plastic (TCP)
dishes in serum-free chemically-defined William's E (WE), Hepatocyte Medium
(HM), Medium 199 (Ml99) and RPMI 1640 (Ml640) media formulations. Unless
indicated, media were changed on days 1, 2, and 4.
4.3 Biochemical and metabolic assessment
4.3.1 General description
For each test medium, hepatocytes were cultured on duplicate TCP dishes and
evaluated for markers of differentiated biochemical function at the time points
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indicated. On the day of isolation (day 0) and on culture days 2, 4 and 6, total
cytochrome P450 (tP450) content and total cellular protein content (TP) of the cell
lysates was measured. Plating efficiency was assessed by measuring TP of day 1
cultures (Section 3.4.3). Cell viability (lactate dehydrogenase (LDH) activity) was
measured in Chapter 3 (Section 3.4.4). Samples of test culture media were analysed
for albumin production and urea synthesis. In addition, both galactose elimination
(GE) and urea synthesis rates (USR) were analysed following culture in test media at
each time point, using HBSS as reference media with either D(+)-galactose or
ammonium chloride challenge. Samples were stored at -70°C until analysis. This was
performed in 10 separate isolations, unless indicated.
4.3.2 Total protein measurements
Total protein (TP) content was determined in fresh cell suspensions and for
hepatocytes cultured in each medium on days 1,2,4 and 6 in duplicate culture dishes,
as described in detail previously (Nelson et al., 2000); see Chapter 2, Sections 2.3.7.1
and 2.3.7.2).
4.3.3 Urea synthesis rate and galactose elimination
4.3.3.1 Urea synthesis of PPHs in test media containing NH4CI
Urea synthesis rates were measured as described in detail in Chapter 2 (Nelson et al.,
2000). Briefly, on days 2, 4 and 6, duplicate cell culture dishes were washed 2x with
HBSS (37°C) and incubated in 8ml of each test medium with 2 mmol/L NH4C1 for 2
hours (Flendrig et al., 1997a) in a humidified incubator at 37°C under an atmosphere
of 95% air / 5% C02. For reference, media controls were treated under otherwise
identical conditions except without cells.
Addendum A preliminary study for day 2 cultures (incubated overnight in each test
medium without NH4CI), showed substantial differences in basal urea production for
WE, HM, Ml99, and Ml640 (67, 234, 79, and 173 nmol/h/ mg TP, respectively).
Thus to permit a more standard methodology which avoids the potential confounding
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factors of different constitution of the test media, such as the variable amino acid
content, urea production was measured in HBSS containing NH4C1, on days 2, 4 and
6 ofculture. This buffered solution does not contain amino acids.
4.3.3.2 Urea synthesis of PPHs in HBSS containing NH4CI
A pilot study was undertaken to confirm that urea production was linear over 2 hours
in HBSS, using the same 2 mmol/L NH4CI concentration utilised in Chapter 2
(Section 2.3.8) for WE cultures. Briefly, cells were cultured in triplicate for 48 hours
in each test medium, washed 2x in HBSS and incubated for 2 hours in HBSS
reference medium containing 2 mmol/L NH4CI. lOOpl samples were taken at 0, 30,
60, 90, and 120 minutes and assayed for urea (see Figure 4.2, page 4-16). Linear
regression analysis confirmed that the urea production rate was linear.
Cells were then cultured in each test medium as described above (Section 4.2.3), and
on days 2, 4, and 6, duplicate culture dishes of each test media were washed 2x in
HBSS. Subsequently, cultures were incubated for 2 hours in HBSS containing 2
mmol/L NH4CI to determine urea production, which was corrected for endogenous
urea production. Samples were taken at to and t2 hours and assayed for urea.
4.3.4 Calculation of urea concentration and urea synthesis rate
Calculations of urea concentration and the urea synthesis rate (USR) were determined
as described in Chapter 2. Briefly, samples taken at the time points indicated were
analysed using a modified colourimetric urea nitrogen kit (Sigma Diagnostics 535-B).
The difference in absorbances (X52s nm in a Pye Unicam spectrophotometer) for the
chromogenic reaction was measured for each time point and both urea concentration
and USR calculated. USR was expressed as nmol/hour/ mg TP. The coefficient of
variation (CV) for this assay was 6% intra-assay CV and 8% inter-assay.
4-6
4.3.5 Galactose elimination
A galactose loading dose of 6 mmol/L was used for GE determination in HBSS
reference medium of all cells pre-cultured in test media. This was because the
galactose content of HM was found to be between 5-6 mmol/L. In addition, this is
close to the value used clinically in liver function tests (Whitington, 1992),
experimentally in BAL systems (Flendrig et al., 1997a), and is close to linear up to
galactose concentrations of 5-6 mmol/L (Figure 4.5, page 4-20). Finally, equimolar
[galactose] allows valid, direct comparisons between the different test medium
formulations.
Hepatocytes were cultured in each test media as described above (Section 4.2.3). On
days 2, 4 and 6, duplicate cell culture dishes for each test medium were washed 2x
with F1BSS (37°C), and incubated in 8ml of HBSS containing 6 mmol/L D(+)-
galactose for 2 hours in a humidified incubator at 37°C under an atmosphere of 95%
air / 5% C02. Galactose elimination (GE) was determined in 0.5ml samples taken at
t=0 and t=2 hours using a modified galactose kit. The difference in absorbances (X340
nm) at each time point (before and after a 40 minute incubation with galactose
dehydrogenase) enabled the galactose concentration to be calculated according to the
manufacturers instructions. Cells were collected from these dishes and analysed for
total protein content as described above. GE was expressed in nmol/hour/mg total
protein. The intra-assay CV was 7% while the inter-assay CV was 10%.
4.3.6 Calculating USR and GE
The USR (Section 2.3.8.3) and GE were both corrected for total protein content and
for pre- and post-incubation volumes for each culture dish according to the equations:
RateusR = C2V2-C1V1/ NT (nmol/hour/ mg TP)
and
RatecE - C1V1 - C2V2 / NT (nmol/hour/ mg TP)
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where: Ci is the initial concentration, Vi is the initial volume prior to sampling, C2 is
the final concentration and V2 is the final volume after sampling; N is the total protein
content and T is the incubation time.
4.3.7 Total cellular cytochrome P450 levels
Total cellular P450 and total protein content were determined in fresh cell suspensions
and for hepatocytes cultured in each medium on days 1, 2, 4 and 6 in duplicate culture
dishes to assess cellular biotransformation potential as described in detail in Chapter 2
(Nelson et al., 2000). Briefly, fresh or cultured hepatocyte samples were solubilised in
ice-cold P450 buffer, sonicated and stored at -80°C until analysis. Total cytochrome
P450 content was determined by carbon monoxide difference spectroscopy of the
sodium hydrosulphite-reduced samples, using a dual-beam Kontron™
spectrophotometer. Results are expressed as pmol/mg protein (corrected for total
cellular protein content as determined by the Bradford assay (Bradford, 1976). The
intra-assay CV 7% while the inter-assay CV was 10%.
4.3.8 Albumin production detected using a fluorimetric albumin blue
580 dye-binding assay
The albumin concentration was determined in duplicate samples of culture
supernatants taken on days 2, 4 and 6 using a fluorimetric albumin blue 580 (AB) dye-
binding assay (Kessler et al., 1997) optimised for measurement in cell culture
supernatants. Cells were cultured as above and 1 ml samples taken from duplicate cell
culture dishes on days 2, 4 and 6 and stored at -80°C until measurement of albumin
content. Quoted literature values for albumin concentrations in PPHs cultures are in
the 20-40 pg/ml range (De Bartolo et al., 2000; Gregory et al., 2000); thus the ratio
of volume of dye to that of albumin standard was chosen so that the fluorescence at
40 pg/ml ofalbumin was maximal.
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4.3.8.1 Reagents
30 mg/L AB 580 dye (Mr = 306.8) stock was prepared by dissolving in 100%
isopropanol. The concentration was measured spectrophotometrically in a Pye-
Unicam spectrophotometer; absorbance at A.5so nm of a ten fold dilution of dye stock
in isopropanol, with isopropanol as blank, was 1.0 ± 0.05 (Kessler et al., 1997)
(Fluorimeter range of absorbance units is 0-2.0). Dye stock was stored at 4°C in the
dark until required. Working buffer (dye solution diluent) was prepared by dissolving
3.0 g MOPS free acid, 9.0 g of MOPS Sodium salt, 12.0 g sodium chloride and 1.0 g
of EDTA disodium salt in 900 ml dH20 / 100 ml isopropanol (pH 7.4). Working dye
solution was prepared by diluting 5.0 ml of dye stock to a total volume of 100 ml with
working buffer. This solution is photosensitive but stable for one month in the dark at
4°C.
4.3.8.2 Standard
Pig albumin (Sigma A1830) dissolved in calibrator diluent was used as the albumin
standard and was prepared fresh for each assay run. Calibrator diluent was prepared
by dissolving 2.7g KH2P04, 0.9g K2HP04, 4.5g of sodium chloride, 0.5g of EDTA
disodium salt and 50 mg of pig gamma immunoglobulins (IgG; Sigma G2512) in 500
ml of dH20 (pH 6.0) and stored at 4°C. Pig IgG was included as a stabilizer to
prevent non-specific absorption of albumin to plastic surfaces.
4.3.8.3 Disposables and equipment
Polypropylene test tubes (5 ml; Sarstedt, FRG) were used for preparing standard and
sample dilutions. The test was performed in 96 well microtitre plates (Dynatech,
USA). Fluorescence was read using a fluorescent plate reader fitted with filters of
bandwidth 20 nm for excitation at A.590 nm and 40 nm for emission at A,645 nm
(Cytofluor 4000, Perseptive Biosystems, USA). The gain was set to 60 V.
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4.3.8.4 Calibration
A standard curve of 0-40 pg/ml of pig albumin in calibrator diluent was prepared. 180
pi of each standard or test sample was added to duplicate wells of a microtitre plate.
Samples (supernatants from pig hepatocytes cultured in each test media) were tested
neat or diluted 1:4 in the appropriate culture medium. Media blanks (which had never
been in contact with cells) were also included. Working dye solution (80 pi) was then
added to all wells. The plate was then shaken for 30 s before reading the fluorescence.
This was performed in 7 separate isolations. Albumin synthesis was expressed as
pg/hour/mg total cellular protein.
4.3.8.5 Quality control
Culture medium (William's E, RPMI 1640 and Medium 199), spiked with pig albumin
at 10 pg/ml and medium blanks were stored in aliquots at -80°C until analysis. The
intra-assay CV 9% while the inter-assay CV was 11%.
4.4 Preliminary studies on immunostaining of albumin in culture
supernatants
Since specific anti-pig albumin antibodies were not commercially available,
preliminary experiments were performed to determine albumin concentrations. Firstly
an immunoturbidimetric microalbumin kit, INCSTAR® (USA), was tried utilising an
anti-human albumin antibody adapted for use on a COBAS FARA centrifugal analyser
(Roche) and compared to an albumin standards calibration curve. Secondly, an
attempt was made to develop an 'in-house' ELISA using an anti-human (sheep)
polyclonal (Dako # A0001) coated to the plate and a second albumin anti-human
(rabbit) albumin-HRP conjugated (Dako # P0356) antibody. Unfortunately, although
minor signals were detected, both these assays were too insensitive for detecting pg
amounts in culture supernatants (data not shown).
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Albumin, with a molecular weight of ^65000 Kda, was initially detected in cell
culture supernatants by Western blotting using BioRad™ Protean Minigels, according
to the manufactures instructions (based on the method of Laemmli et al., 1970). The
first and second antibodies used are described below. To simplify the methodology for
our experiments, a dot blot method was adopted, followed by densitometry (after
addition of a chemiluminescent agent). This method is briefly described. Duplicate
samples of culture supernatants were taken on days 2, 4 and 6 and 5pi spotted onto
nitrocellulosestrips. This was repeated with a pig albumin standard [1 mg/ml] made up
in WE medium, at a range of concentrations (0-100 pg/ml). The nitrocellulose strips
were washed 3x5 minutes in 0.5 % (v/v) Tween-20 PBS solution, and incubated for
2 hours on a rotary shaker at room temperature (RT) with Pierce™ blocking buffer, to
prevent non-specific binding. The first antibody (anti-human albumin (rabbit)) was
titrated to 1:2000 in PBS containing 0.05 % Tween-20 solution with 3 % (w/v) dried
milk (Marvel) and incubated for one hour (RT) on a rotary shaker. This was followed
by 5 x 6 minute washing steps in the PBS 0.5 % Tween-20 solution. The second
antibody (anti-rabbit IgG HRP-conjugated) was titrated to 1:20000 and incubated for
one hour as above, and the washing steps repeated. Controls: i) albumin standard
without the first antibody; and ii) test media (never seen cells) were similarly treated.
A chemiluminescent agent (Supersignal, Pierce™) was added to the nitrocellulose
strips (0.75 ml per strip) for 5 minutes, wrapped in cling-film and either exposed to
photographic film (Kodak™ Omat Film) for 3-4 minutes or subject to densitometry




For each parameter, multiple comparisons were made using ANOVA of:
1) Between-media evaluations on each day of culture, and
2) Between-day evaluations for each single medium formulation.
One-way single factor ANOVA (assuming equal variances) was performed followed
by Post Hoc multiple comparisons tests of least significant differences, using the
SPSS 9.0 statistical software package. The mean difference was considered significant
at the 0.05 level. Results are expressed as mean±SEM (standard error mean of the
mean) and the number n of experiments performed is indicated. Statistically relevant p
values are quoted for the multiple comparisons ofeither or both 1) and 2) above.
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4.6 Results
4.6.1 Cell isolation viability and yield
The hepatocytes were isolated using our ex vivo method described in detail in Chapter
2. For these experiments, cell viability was 87±5% with a yield of 2.2±0.8 x 1010 cells
from 12±1 kg piglets (n=10).
4.6.2 Total cellular protein content
Total protein content was determined as outlined in Chapter 3 as a correction factor
to normalize calculated urea and albumin synthesis rates as well as galactose
elimination and total P450 values.
4.6.3 Urea synthesis
4.6.3.1 Urea synthesis in test media containing NH4CI
Between media comparisons of USR were made on each day of culture (Figure 4.1).
Primary porcine hepatocytes cultured in RPMI 1640 medium on day 2 of culture
showed significantly higher (p<0.05) conversion of ammonium chloride to urea
(511 ±141 nmol/h/mg protein) compared to both WE medium and Ml 99 (292±62;
p=0.044 and 201±50; p=0.015, respectively). By day 4 of culture in RPMI 1640, the
USR had further and significantly increased (608±102 nmol/h/mg protein) compared
to WE (335±79; p=0.01), M199 (248±31; p=0.001) whereas a moderate increase was
observed relative to HM (428±38; p=0.078). RPMI 1640 maintained a significantly
higher USR capacity (847±249) over HM on day 6 (359±77; p=0.031) and a
significantly greater (p<0.05) conversion rate than hepatocytes cultured in WE
(448±90), or M199 (360±125). All other media comparisons and between day
comparisons for each medium formulation were not significantly different at the 5%
level. See Addendum in Section 4.3.3.1, page 4-5.
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4.6.3.2 Urea production in NH4CI-stimulated PPHs cultured in HBSS
Figure 4.2 shows urea production as a function of time. This validates that urea
production is linear for hepatocytes pre-cultured in each test medium and
subsequently assayed in HBSS reference medium with 2mmol/L NH4C1. In the
following experiments, USR was corrected for endogenous urea production (ie urea
production in the absence ofNH4CI).
Between media comparisons of USR were made on each day of culture (Figure 4.3).
This data demonstrates that the urea synthesising capacity of day 2 WE, HM, and
Ml99 pre-cultured cells were not significantly different at 104±11, 126±20, and
115+17 nmol/h/mg protein, respectively. Mean USR for M1640 cells (147+21)
however, was significantly higher than WE pre-cultured cells. By day 4, the USR of
HM pre-cultured cells was similar to Ml 640 grown cells (221+25 vs 176+31,
respectively), although both WE and Ml99 pre-cultured cells, are significantly lower
(93+14 v.v 79+4, respectively; p<0.01) than the former, in their ability to convert
ammonium to urea in HBSS reference medium. HM pre-cultured cells maintained a
significantly higher USR (111+16) than all other test media on day 6. Between day
comparisons for each pre-cultured test media reflected a statistically significant
(p<0.05) increase in USR of day 4 HM cells compared with day2, and a moderate
increase in Ml 640 cells, although the mean values of both were greater than either
WE or Ml99 values. By day 6 USR was attenuated in WE, HM, Ml99 and Ml640
pre-cultured cells (40+15, 111+16, 10+2, and 17+6 nmol/h/mg protein, respectively).
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Figure 4.1 Urea Synthesis Rates of NH4Ci-stimulated Primary Porcine
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Figure 4.1 Urea synthesis rates (USR) of porcine hepatocytes cultured at
107 viable cells per 100mm dish in William's E, HM, M199 and M1640
chemically-defined media for up to 6 days. Following washing the cells twice
with HBSS, 2mM NH4CI was added to each test medium and incubated for 2
hours on days 2, 4, or 6. USR was determined in media samples taken at t=0
and t=2 hours using a modified colourimetric urea nitrogen kit as described
in Materials and Methods. Results are expressed as nmol/hour/ mg total
protein. All values represent the means±SEM of nine experiments in
duplicate.
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Figure 4.2 Urea Production in HBSS / Ammonium Chloride-Stimulated
Primary Porcine Hepatocytes Pre-Cultured for 2 days in Separate
Serum-free Chemically-Defined Medium Formulations
450
Time (minutes)
Figure 4.2 Urea production of ammonium chloride-stimulated porcine
hepatocytes cultured for 2 hours in HBSS. Cells were pre-cultured in test
media for 48 hours as described above (Figure 4.1). On day 2, triplicate
culture dishes of each test media were washed 2x in HBSS and cultures
incubated for 2 hours in 8ml HBSS reference medium containing 2mM
NH4CI. 10Opil samples were taken at 0, 30, 60, 90 and 120 minutes and urea
production determined. Data points were fitted to linear regression curves
using Microsoft Excel 2000 version 9.0. Results are expressed as nmol/mg
total protein.
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Figure 4.3 Urea Production in HBSS / Ammonium Chloride-Stimulated
Primary Porcine Hepatocytes Pre-Cultured for up to 6 days days in
Separate Serum-free Chemically-Defined Medium Formulations
Day of Cell Culture
Figure 4.3 Urea production of ammonium chloride-stimulated porcine
hepatocytes, cultured for 2 hours in HBSS reference medium. Cells were
pre-cultured in each test media as described above (Figure 4.1). On days 2,
4, and 6, duplicate culture dishes of each test media were washed 2x in
HBSS and cultures incubated for 2 hours in HBSS containing 2mM NH4CI.
USR was determined in media samples taken at t=0 and t=2 hours and
corrected for endogenous urea production, using a modified colourimetric
urea nitrogen kit as described in Materials and Methods. Results are
expressed as nmol/hour/mg total protein. All values represent the
means+SEM of 3 experiments in duplicate.
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4.6.4 Galactose elimination
Galactose elimination (GE) for PPHs cultured in HBSS reference medium was
evaluated following spiking of cells (pre-cultured in each test media) with 6 mmol/L
D(+)-galactose in HBSS. For each day of culture, between day comparisons of GE
for each medium formulation were made (Figure 4.4; all mean±SEM, n=3). GE for
WE, HM, M199 and RPMI 1640 on culture day 2 (420+66, 436±54, 416±33, 516±44
nmol/h/mg TP, respectively) was found to be significantly greater (p<0.05) in day 2
cultures compared with both day 4 (266±56, 298±78, 231±41, 277±101) and day 6
cultures (179150, 225+69, 218143, 250174); although no significant difference was
observed between day 4 and day 6. Results are expressed as nmol/hour/mg total
protein. All between medium comparisons for each day of culture were not
significantly different at the 5% level. Figures 4.5 show the relationship of GE as a
function of [galactose] (see Discussion).
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Figure 4.4 Galactose elimination in primary porcine hepatocytes


















Figure 4.4 Galactose elimination (GE) in primary porcine hepatocytes
cultured at 107 viable cells per 100mm dish in William's E, HM, M199 and
M1640 chemically-defined media for up to 6 days. Duplicate cell cultures
were washed 2x in HBSS, then 6mM D(+)-galactose in HBSS was added to
culture dishes of each test media, and incubated for 2 hours on days 2, 4
and 6. GE was determined spectrophotometrically in media samples taken at
t=0 and t=2 hours using a modified galactose kit, as described in Materials
and Methods. Results are expressed as nmol/hour/ mg total protein. All
values represent the means±SEM of 3 experiments in duplicate.
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Figure 4.5 Michaelis-Menten representation of galactose elimination as
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Figure 4.5 Galactose elimination (GE) as a function of galactose
concentration. Primary porcine hepatocytes were incubated in duplicate with
0.5, 1, 2, 4, 8 or 16 mmol/L of galactose in William's medium E for 2 hours,
as described above. The GE was calculated thus: GE = Initial [galactose] t0-
final [galactose] t2 / incubation time. GE is expressed as mmol/L/hour. The
data was fitted to a hyperbolic curve using GraphPad Prism (version 1.03)
software programme.
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4.6.5 Total cytochrome P450 content
4.6.5.1 Between media comparisons for each day of cell culture
Between media evaluations of total cytochrome P450 content were made on each day
of culture (Figure 4.6). Significant differences between cells cultured in each test
media were not observed until culture days 4 and 6. tP450 content of HM medium
grown hepatocytes on day 4 (36±3 pmol/ mg protein) was significantly higher
(p<0.05) than both WE medium (24±3 pmol/ mg protein) and RPMI 1640 medium
(25±5 pmol/ mg protein). The value of tP450 content was significantly lower in WE
medium (17±1 pmol/mg protein) compared to HM (25±1 pmol/mg protein), M199
(28±1 pmol/mg protein; p=0.026), and RPMI 1640 (27±5 pmol/mg protein) cultured
cells.
4.6.5.2 Between day comparisons of each medium formulation
For each medium formulation, between day comparisons of total cytochrome P450
content of freshly isolated (day 0) and cultured hepatocytes were analysed (Figure
4.7). There was a highly significant decrease (p<0.001) in tP450 content, from
120±37 pmol/mg protein for fresh cells, to «40±10 pmoFmg protein by day 2 of
culture in all media formulations. Total cytochrome P450 content remained quite
stable («30±3 pmoFmg protein) up to day 4. However, biotransformation potential
had declined significantly (p<0.05), when comparing day 2 values («40±10 pmoFmg
protein) with day 6 values in WE (17+1 pmoF mg protein), and HM (25±1 pmoFmg
protein) media formulations.
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Figure 4.6 Total cytochrome P450 content in primary porcine
hepatocytes cultured in four separate chemically-defined media























Figure 4.6 Total cytochrome P450 content of porcine hepatocytes cultured
at 107 viable cells per 100mm dish in William's E, HM, M199 and M1640
chemically-defined media for up to 6 days. Cell cultures were scraped from
dishes on days 2, 4 and 6 and total cytochrome P450 content determined by
carbon monoxide difference spectroscopy of the sodium hydrosulphite
reduced samples as described in Materials and Methods. Results are
expressed as pmol/mg total protein. All values represent the means±SEM of
three experiments in duplicate.
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Figure 4.7 Total Cytochrome P450 Content in Primary Porcine
Hepatocytes Cultured in Four Separate Chemically-Defined Media



















Figure 4.7 Total cytochrome P450 content of porcine hepatocytes cultured
at 107 viable cells per 100mm dish in William's E, HM, M199 and M1640
chemically-defined media for up to 6 days. Total cytochrome P450 content in
freshly isolated cells and cell cultures scraped from dishes on days 2, 4 and
6 was determined by carbon monoxide difference spectroscopy of the
sodium hydrosulphite reduced samples as described in Chapter 2. Results
are expressed as pmol/mg total protein. All values represent the
means±SEM of three experiments in duplicate.
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4.6.6 Determination of albumin concentration
The ratio of volume of dye to that of albumin standard was chosen so that the
fluorescence at 40 (ig/ml of albumin was maximal, based on previous literature (De
Bartolo et al., 2000; Gregory et al., 2000). Using these conditions, the standard
deviation of repeated sample blanks (calibrator diluent) was found to be 92
fluorescence units at a mean reading of 1660 unit. The limit of detection was defined
as that test value which exceeds the blank value plus 3 standard deviations, giving a
lower limit of detection at 3.5 pg/ml.
Fluorescence for the zero standard was substracted from the readings for the other
standards prior to construction of the standard curve. The concentration (x) of
albumin in the unknown samples was determined by measuring the fluorescence (y; in
absorbance units) at X5go nm and interpolating the unknown concentration, x from the
albumin standard curve of the form, y = mx + c. Using Graphpad Prism v 1.8, these
data were fitted to a linear regression curve (Figure 4.8).
Solving the equation, y = mx + c for concentration, x gives:
x = y - c / m
Substituting the linear regression equation, y = 346x + 0.9, gives;
x = (y - 0.9) / 346
where:
y is the fluorescence absorbance value (arbitrary units)
m is the slope of the curve giving the unknown albumin concentration
x is the unknown value
c is the x-intercept
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Figure 4.8 Representative Pig Albumin Standard Curve: A Plot of
Fluorescence (Arbitrary Absorbance Units) at Xsso nm Versus [Albumin]
(pg/ml)
pg/ ml
Figure 4.8 Pig albumin standard curve: 0-40 pg/ml of pig albumin in
calibrator diluent was prepared; 180 pi of each standard or test sample was
added to duplicate wells of a microtitre plate. Samples (test media from pig
hepatocyte culture) were measured neat or diluted 1:4 in appropriate culture
medium. Working dye solution (80 pi) was then added to all wells. The plate
was then shaken for 30 s before reading the fluorescence. This was
performed in 7 separate isolations. Albumin synthesis was expressed as
pg/hour/mg total protein. Quality control: Culture medium (William's E, RPMI
1640 and Medium 199) were spiked with pig albumin at 10 pg/ml and stored
in aliquots at -80°C.
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Unknown test concentrations were calculated from the fluorescence readings after
subtracting any background readings.
4.6.6.1 Quality control
Recovery experiments for pig albumin added to pig hepatocyte culture supernatants
were performed. A recovery of 115 % of expected albumin was observed. Medium
was spiked with albumin to concentrations of 2.5 and 20 pg/ml. However, if the total
albumin exceeded 40 pg/ml, albumin recovery was increased to 120 %. Consequently,
culture supernatants giving greater than 40 pg/ml were tested at a dilution of 1:4 in
the same type of medium. Different test dilutions up to a maximum of 1:9 gave results
within 5 % of the previous dilution.
The correlation coefficient (r2) for data fitted using the linear regression equation was
0.998 (Figure 4.8), demonstrating a unique fit that would reliably allow interpolation
ofunknown concentrations from the fluorescence data.
4.6.6.2 Assay performance with culture supernatants
Culture media alone gave background fluorescence readings which were subtracted
from the values for test samples. Repeated testing of the QC samples gave a within
batch and between batch coefficient of variation of 9 % at 10 pg/ml, within acceptable
limits.
4.6.6.3 Albumin synthesis rates
For each medium formulation, between day comparisons were analysed (Figure 4.9).
Albumin secretion by primary porcine hepatocytes cultures (n=7) remained stable up
to day 4 («1.0-1.9 pg/h/ mg protein) but increased significantly thereafter up to day 6
of cell culture in RPMI 1640 medium (2.5±0.5 pg/h/ mg protein; p=0.024); with
substantial increases to 2.3±0.5 pg/h/ mg protein observed in Ml99 (p=0.058) versus
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2±0.4 pg/h/ mg protein in WE medium during the same culture period. All other
between day comparisons for each medium and between media comparisons for each
day of culture, were not significantly different at the 5% level. ASR could not be
measured in HM due to very high background levels in this proprietary medium
formulation.
4.6.6.5 Detection of albumin: Preliminary studies on immunostaining of
albumin in culture supernatants
The presence of albumin was confirmed in each test medium by dot blot analysis (see
Figure 4.1 OA and Section 4.4). As with the other methods briefly described in Section
4.4, densitometric analysis of samples was not reproducible or sensitive enough to
detect pg amounts in culture supernatants (data not shown). However, the dot blots
confirm that the cells produced albumin. Surprisingly, HM medium alone (in the
absence of cells) contained significant amounts of albumin (Figure 4.4.3B). These
findings led the development of the albumin blue 580 fluorimetric dye-binding assay
(see Sections 4.3.9 and Section 4.6.6), in order to accurately quantify albumin
synthesis.
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Figure 4.9 Albumin Synthesis Rates in Primary Porcine Hepatocytes


































Figure 4.9 Albumin synthesis rates (ASR) of porcine hepatocytes seeded at
107 viable cells per 100mm dish in William's E, M199 and M1640 chemically-
defined media for up to 6 days. Samples were taken on days 2, 4 and 6. and
ASR determined for each media using fluorimetric analyses of albumin blue
580 dye binding to albumin as described in Materials and Methods. Results
are expressed as pg/hour/ mg total protein. All values represent the
means±SEM of 7 experiments in duplicate. Note that ASR was not measured
in HM, due to very high background levels (5 % (w/v)) in this proprietary
medium formulation.
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Figure 4./P Dot Blot Analysis of Primary Porcine Hepatocytes Cultured
in Separate Serum-free Chemically-defined Media Formulations Using
Antiserum to Albumin
Albumin was detected in porcine hepatocyte cultures, initially seeded at 107 viable cells per
100mm dish in WE, HM, M199 and M1640 chemically-defined media, for up to 6 days. A)
Duplicate samples of medium supernatant were taken on days 2, 4 and 6, and albumin
determined for each (undiluted) medium sample using dot blot analyses (shown here as
duplicate pairs of blots), as described in Materials and Methods (Section 4.4); B) As controls:
i) Each (neat) medium formulation (HM also diluted 1/20 and 1/10), prior to exposure to
PPHs, and ii) Purified pig albumin (Sigma A1830) at 0, 25, and 50 pg/ml, and 25 pg/ml
without first antibody, were also subject to dot blot as above.
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B) CONTROLS















4.6.7 Assesment of overall performance of test media: The Hepatocyte
Biological Activity Index (HBAI)
In order to define an index of global functional capacity, a scoring system was devised
to simplify multiple comparisons and as an integrated measure of overall functional
capability. Indeed, multiple comparisons of biochemical functional activity for 4 test
media at 3 different time points cannot be analysed using conventional statistical
software programmes. The following assumptions were made: (i) The hepatic-specific
functions measured reflect some of the main synthetic, detoxification, and metabolic
functions cited as prerequisite of their use in an idealised BAL device; (ii) The
associated biochemical measurements of viability and attachment efficiency reflect
cellular integrity in such a device; (iii) Scores were generated for each test medium at
each time point, by assigning an equally weighted arbitary score of 0-10 points, for
the mean values of each biochemical parameter determined from the data in Chapters
3 and 4. Albumun synthesis values were not included because it could not be
determined in HM cultures.
Table 4.1 shows how comparative scores for this hepatocyte biological activity index
(HBAI) were generated. The midpoint values approximate to a range of values
reported in the literature (De Bartolo et al., 2000; Donato et al., 1999; Gregory et al.,
2000; Iwata et al., 1999; Keatch et al., 2002; Lazar et al., 1995a; Nelson et al., 2000;
Olsen et al., 1997). USR data is derived from urea production in HBSS reference
medium (Figure 4.3).
Following from this, Table 4.2 shows a summary of comparative scores; the rank
order of test media accumulated over the 6 day culture period for each parameter and
the overall ranking derived from the total score thus:
M199=HM>WE>M1640
The limitations of deriving these arbitrary values are discussed below.
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Hepatocytes for therapeutic use in BAL devices should retain a full repertoire of
synthetic, detoxifying, metabolic and excretory functions. To achieve this as yet
elusive goal, many studies have focused on in vitro manipulation of the culture
microenvironment, including modulation of ECM components, cocultures, and media
composition (Allen et al., 2001). In rat hepatocyte cultures, the use of a variety of
hormonally-defined media formulations has improved hepatic-specific function,
morphology and survival (LeCluyse et al., 1996a). However, the optimal medium
formulation required for effective support of primary porcine hepatocyte (PPH)
culture in bioartificial liver (BAL) devices remains unclear. The importance of
identifying a culture medium which optimises viability and differentiated function of
PPHs in vitro is well recognised (Flendrig et al., 1997a; Jauregui & Gann, 1991; Naik
et al., 1996; Sielaff et al., 1995b), although no systematic studies have been
undertaken. Direct comparisons of porcine hepatocyte culture conditions designed to
study maintenance of hepatic-specific function are complicated by the number of
culture variables and interdependence on such factors as substratum, medium
formulation, and hormone supplementation. Moreover, comparisons are further
complicated by the by the wide range of endpoints used to assess hepatic function. In
fact, information on metabolic functions in PPHs is still very limited as compared with
primary cultures of human and rat hepatocytes, which have been well characterised
(Donato et al., 1999; LeCluyse, 1996a).
The aim of this study was to examine in vitro conditions for maintenance of
differentiated hepatic-specific functions of porcine hepatocytes under different culture
conditions. Specifically, the effects of William's E, Hepatocyte Medium, Ml99 and
RPMI 1640 serum-free chemically-defined medium formulations on synthetic,
detoxification and metabolic parameters were assessed to determine which medium
was best able to maintain hepatic support functions.
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We have demonstrated that primary porcine hepatocytes can be cultured with
high plating efficiency on biomatrix-free tissue culture plastic in different serum-free,
chemically-defined media formulations whilst maintaining high viability (Chapters 2
and 3) and retention of hepatic-specific function for up to six days (Nelson et al.,
2000; Keatch et al., 2002). The HBAI, as an integrated measure of overall functional
capability, ranked the media as M199=HM>WE>M 1640. The functional data for day
2, which is in the time frame for BAL device usage, showed that USR, ASR, tP450,
and GE functions for test media, were up to 300%, 90%, 20%, and 50%,
respectively, of in vivo values for human liver (Table 4.3). Medium 199 gave the
highest mean values of plating efficiency, viability, and albumin synthesis rates (ASR)
than the other media tested up to day 4, although the differences were not always
statistically significant. By day 4 of culture, both Ml 640 and HM pre-cultured cells
showed significantly greater urea synthesis rates (USR) than both WE and Ml 99
maintained cells. There was a 66% decrease in total cytochrome P450 content (tP450)
in 2-day-old cultures compared with fresh cells, whereas HM maintained cells
preserved significantly higher day 4 tP450 levels than both WE and Ml640
conditioned cells. Galactose elimination (GE) was significantly higher in day 2
cultures in all test media compared with both days 4 and 6 which then remained
relatively stable thereafter. The albumin synthesis rate (ASR) tended to increase in all
media up to day 6. Furthermore, parallel morphological studies indicated that different
medium formulations modulate gross and ultrastructural morphology of hepatocyte
cultures (Chapter 3). These findings may be of relevance when choosing an
appropriate medium for porcine-based BAL devices, which require rapid attachment
of high viability cells with significant ammonia detoxifying capacity whilst maintaining
biotransformation potential and a diverse functional profile.
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Table 4.3 Hepatic-specific functions of porcine hepatocyte cultures compared
with monolayer cultures and in vivo data from several species
Monolayer: USR ASR Total P450 GE References
Day 2 cultures nmol/hr/ pg/hr/mg TP content nmol/hr/ / Comment
unless stated mg TP (pmol/ mg TP) mg TP
Porcine 115 (basal) 0.7 205 (day 0) ND Lazar 1995c;
Sajiki 2000;
Olsen 1997
Porcine 30 (basal) 0.3 ND ND Gregory 2000
90 (2m M H4CI) 1.0 (d6) (Dr P
2.1 (d10) Gregory Pers
Comm.)
Porcine 270 0.034 ND ND Koebe 1996
Porcine BAL ND 0.08 (d21) ND 470 (d21) Gerlach 1994
Porcine 20 (10mM H4CI) ND ND ND Flendrig
Porcine BAL 40 (10mM H4CI) 25 1997; Iwata
Porcine BAL ND 45 1999





Sheep 136 (dO MEM) ND 199 (day 0) ND Watts 1995;
(Day 1 only 51 (d1 WE) 113 (d1 WE) Chee's-
assessed) 70 (d1 WE) 107 (d1 M199) cultured
135 (MEM) 117 (MEM) Cells' non¬
viable
Rat 216 (Day 0) ND 216 (day 0) ND Day 6 rat
(10mM NH4CI) 184 (MEM) 81 (MEM) P450 levels
84 (WE) 31 (WE) unchanged
84 (M199) 49 (M199)
31 (Chee's) 66 (Chee's)
Rat 103 (basal) 2.2 (Day 0) 73 (day O) ND Dich 1987;
300 (3mM NH„CI) 2.2 40 Weymouth's
In vivo values Iwata 1999;
(human liver) 40 2.0 184* 960 Lazar 1995c;
(pig liver) ND ND 204* 410 Gomez-




Pig: 196 (Day 0) ND 120 (Day 0) ND Present data:
WE 104 1.4 35 420 USR / GE
HM 126 ND 48 436 assays in
M199 115 1.9 42 416 HBSS
M1640 147 1.5 41 516 reference
(2m M NH4CI) (6m M gal) medium
Table 4.3 Hepatic-specific functions of porcine hepatocytes cultured in test media compared
with monolayer cultures and in vivo data from different species. Since measured hepatocyte
functions, culture conditions and duration vary greatly between research groups which
makes direct comparisons difficult, each value represents the quoted mean values for day 2
measurements, unless stated, normalised to the total protein content (mg TP). In vivo
values are shown for human, pig, and rat livers. The galactose and NH4CI loading doses'
when cited in literature, are shown in parentheses. Abbreviations: ASR, albumin synthesis
rate; BAL, bioartificial liver bioreactor; Gal, galactose; GE, galactose elimination; USR, urea
synthesis rate; MEM, Modified Earle's Medium; Day 0 (fresh cellls); d1 (Day 1 cultures); ND,
not determined in referenced study.
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Previous studies
Much information is available on differentiated morphology, metabolic function and
long-term survival of rat hepatocyte monolayer cultures. To achieve this, a substratum
of liver-specific extracellular matrix (ECM), such as collagen, fibronectin or Matrigel
is required. Serum is used in media or is required for the initial attachment phase and
cells may be subsequently cultured in serum-free hormonally-defined medium (HDM)
containing known concentrations of growth factors including epidermal growth factor
(EGF), insulin and dexamethasone. Such conditions almost certainly provide the most
physiologically appropriate in v/vo-like environment currently available (Strain, 1994).
In contrast, far fewer studies have evaluated the influence of different media
formulations on rat hepatic functional activity (Enat et al., 1984; Gebhardt et al.,
1978; LeCluyse et al., 1996; Mitaka, 1998; Watts et al., 1995; Williams et al., 1977),
and no data is available for pigs. The data from functional studies of rat hepatocyte
cultures has often been extrapolated to PPHs, which has important implications for
porcine-based cell therapies since distinct species differences are known to exist,
which may invalidate this approach. For example, cell proliferation studies have
shown porcine hepatocytes to have a much greater proliferative potential than rat
hepatocytes cultured on collagen in hormonally-defined medium (Joly et al., 1997;
Wegner et al., 1992). As mentioned, PPHs do not require serum or an attachment
substrate. The latter may however be required for long-term cultures. In addition, pig
hepatocytes reproduced cytochrome P450-dependent oxidative metabolism of human
hepatocytes to greater extent than either rat, rabbit or dog primary cells, or the
HepG2 hepatoma cell line (Donato et al., 1999). Finally, oxygen uptake rates, an
important parameter in BAL design, were significantly higher for PPHs than rat
hepatocyte monolayer cultures (Balis et al., 1999).
These studies highlight the need for species-specific characterisation of hepatic
cellular function to optimise performance for BAL systems.
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Hepatic detoxification capacity
Total cytochrome P450 content
A major complication of ALF is hepatic encephalopathy. Contributory factors include
ammonia toxicity, dysfunctional endogenous benzodiazipine-like substances and
putative toxic compounds released from the injured liver, normally metabolised by the
Cytochrome P450 system (Blei, 1997; Blei, 2000; Desille et al., 1999; Jauregui and
Gann, 1991; Naik et al., 1996). As a result, many studies have focussed on both
ammonia detoxification and P450 system biotransformation in PPHs. In agreement
with previous observations in swine (Monshouwer et al., 1998; Olsen et al., 1997),
our data shows that tP450 levels decreased substantially (55-65%) after 2 days in
culture from 120 pmol/mg TP for freshly isolated cells to 40 pmol/mg TP in all media
tested, remaining relatively stable for the remainder of the culture period (Figure 4.7).
Total P450 content after 48 hours culture of rat, mouse, hamster and human
hepatocytes, in media of 75% MEM/ 25% M199 with 10% FCS or WE or M199 with
5% FCS, was very similar to our values (Chesne et al., 1993; Watts et al., 1995).
However, comparable studies with pig hepatocytes (Monshouwer et al., 1998),
cultured in WE with 4% FBS for 48 hours, showed double the mean tP450 levels (92
pmol/mg TP) of the serum-containing cultures above. This suggests that species
differences might exist in retention of tP450 biotransformation potential under these
conditions (Monshouwer et al., 1998) and that there is a component(s) in serum
which resulted in P450 induction, although this issue was not investigated. Factors
such as age, sex, and strain of the animal can also influence the P450 activity and
tP450 content (Prof JI Mason, University of Edinburgh, personal communication).
The labile nature of total P450 may be explained by observed down-regulation of
P450 mRNA transcripts triggered during the collagenase isolation process (Padgham
et al., 1993; Padgham and Paine, 1993). Total P450 measurements cannot easily be
made in BAL devices due to restricted access during operation. The limitations of
assessing P450 biotransformation of cultured porcine hepatocytes are discussed
below.
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In this study, tP450 levels have been measured as an indicator of the
biotransformation potential of the hepatocytes. Previous reports (Mitaka, 1998;
Nelson et al., 2000; Keatch et al., 2002; Watts et al., 1995) have used tP450 as a
measure of highly differentiated hepatic function. The aim here was to assess, using
carbon monoxide difference spectroscopy, both preservation of a wide range of P450
species and to demonstrate the totality of intact P450 enzymes in the pool using one
assay. However, the values presented here merely gauge the xenobiotic metabolising
activities of all phase I isoenzymes, where high levels of tP450 indicate enhanced
global phase I metabolic capability (as in fresh hepatocytes). The decreased tP450
levels in subsequent cultures suggest a compromise of the phase I metabolising
potential of the hepatocytes, in agreement with previous studies in swine (Donato et
al., 1999; Monshouwer et al., 1998; Olsen et al., 1997). Nevertheless, tP450 does not
provide sufficient information on the type and specificity of phase I activities
representative of particular P450 enzymes. Selection of the most appropriate
functional assay is not straightforward. The metabolic conversion of 7-
ethoxycoumarin to 7-hydroxycoumarin requires both phase I and II reactions and has
been used as a functional assay for PPHs for BAL use (Naik et al., 1996), whilst
metabolism of diazepam has been used as an indicator of both P450 activity and cell
viability (Jauregui and Gann, 1991). Use of the latter is based on the assumption that
dysfunctional endogenous benzodiazipine-like substances are implicated in hepatic
encephalopathy.
Alternatively, cells cultured in each test medium could be evaluated for
cytochrome P450 regioselective testosterone metabolism. This has two main
advantages over tP450 measurement alone: i) the metabolic profile is very similar to
humans; ii) hydroxylated metabolites of testosterone (eg 6|3, 15P; measured by
HPLC) provide information on several P450 activities in a single assay. However, this
approach, in common with other P450 activity assays, would reveal only a very
limited repertoire of P450 species. Moreover, precisely which P450 species are
required to be preserved to treat ALF remains elusive. Another complication in
deciding on a suitable functional P450 activity assay is that some P450 isoforms are
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lacking in certain species. For example, in pig hepatocyte cultures, the P450 2B
related 7-pentoxy-resorufin O-depentylation activity, also involved in testosterone
hydroxylation, was not detectable even after phenobarbital induction, a known inducer
of this P450 isoform (Monshouwer et al., 1998).
Interestingly, Monshouwer et al., (1998) documented that the 50% reduction
in tP450 content paralleled the decline in testosterone 6(i-hydroxylase activity over 48
hours in PPH culture. Likewise, Donato et al., (1999) correlated a decline in
functional phase I (eg ECOD, EROD) and phase II activities in cultured hepatocytes
of different species including pig and human with decreased tP450 levels. In fact, this
study highlighted the lack of information on pig P450 isoen2ymes involved in hepatic
metabolism of a range of common substrates. Finally, due to the importance of phase
II compounds in the detoxification process, it may be beneficial to measure, for
example, cellular glutathione content in future comparative studies.
Urea synthesis
Detoxification of ammonia to urea is considered a prerequisite hepatic support
function of BAL devices. Initial studies showed that cells cultured in each defined test
medium maintained a highly efficient urea synthesising capacity (Figure 4.1), which
was significantly higher than previously reported (De Bartolo et al., 2000; Flendrig et
al., 1997a; Gregory et al., 2000; Lazar et al., 1995a; Lazar et al., 1995b; te Velde et
al., 1995). In these experiments, cells were cultured in each test medium for 2, 4, or 6
days, and then assayed in the same medium containing 2 mmol/L NH4C1. In
retrospect, although producing apparently high USR values, differences between the
media could not be delineated because (a) the 'chronic' effect of the media
conditioning the cells in culture may involve induction or repression of urea cycle
enzymes (see Figure 1.6), and (b) the 'acute' effect of the assay medium may be due
to differences in the amino acid concentrations of the test media (see APPENDIX I),
and (c) a preliminary study for day 2 cultures (incubated overnight in each test
medium without NH4C1), showed substantial differences in endogenous, basal urea
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production for WE, HM, M199, and M1640 cultures (67, 234, 79, and 173 nmol/h/
mg TP, respectively).
Subsequent assays were modified to take account of these differential effects.
Thus to permit a more standard methodology which avoids the potential confounding
factors of different constitution of the test media (such as the variable amino acid
content), cells were pre-cultured in test media and urea production measured in HBSS
reference medium containing NH4CI on days 2, 4 and 6 of culture. This buffered
solution does not contain amino acids. Figure 4.2 confirms that urea production was
linear in cell cultures preconditioned in test media, and subsequently, assayed in HBSS
reference medium containing 2 mmol/L NH4CI. The values obtained for each day of
culture using this protocol, corrected for endogenous urea production, are shown in
Figure 4.3. USR was significantly higher in HM- and M1640-conditioned cells up to
day 4 compared with both WE and Ml99 cultures. USR values in all cultures
conditioned in each test media up to this time point, were comparable with porcine,
human, rat, and sheep hepatocytes under a variety of cultured conditions (Table 4.3),
and 2-5 fold higher than endogenous urea production for human liver in vivo.
These findings support the idea that the ability of cultured pig hepatocytes to
convert NH4CI to urea is in part, influenced by the test medium formulation in pre-
culture. The ammonia concentration in liver cells is about 0.7 mM, about ten times the
upper limit of normal in plasma, whereas at physiological pH, 99% is present as NHL}+
(Ampola, 1994, Meijer, 1990). Considering values in FHF plasma are about 0.16 mM,
depending on the aetiology (Demetriou & Rozga, 1998), the value of 2mM NH4C1
used in our assays is somewhat validated. Under these culture conditions, the high
circulating levels of ammonia, suggested to be involved in the development of cerebral
oedema and herniation in FHF (Plevris et al., 1998), could be lowered in a porcine-
based BAL by compensating the function of the liver, and could, in theory, provide
effective hepatic support and therapy for patients with FHF. In particular, both
Ml640- HM-preconditioned hepatocytes exhibited a greater urea synthesizing
capacity than all other media (Figure 4.3) by day 4, and at least as efficiently as in
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previous reports (Table 4.3), although, since measured hepatocyte functions, culture
conditions and duration vary greatly between research groups, direct comparisons
should be made with caution. Possible physiological reasons for the enhanced urea
synthesis rates observed in these media are discussed later. USR was maintained at
«120 nmol/h/mg TP in both Ml99 and WE conditioned cells on day 2. Considering
that normal in vivo values for human liver are «40 nmol/h/mg TP, these conditions
could potentially deliver BAL support functions, provided there was adequate cell
mass. Hepatic detoxification is considered to assume a critical role in BAL systems.
Whether sufficient P450 detoxification functions would be provided by the same
critical mass of cells, is unknown at present, since different groups have used between
2-33 % of hepatic cell mass in their BAL designs.
The HM formulation is a modification of Leibovitz L-15, which contains
supra-physiological concentrations of certain components, especially amino acids
(APPENDIX I). Conditioning of cells in HM for 4 days probably allow increased
cytosolic concentrations of amino acids by enhanced uptake via amino acid
tansporters, which in turn may upregulate urea cycle enzyme expression. Indeed, a
greater supply of amino acids and NH4+ to the hepatocytes increases urea flux, (1)
through carbamoyl phosphate synthetase upregulation (Meijer et al., 1990), and (2)
by an increase in the supply of substrates (see Figure 1.6), via amino acid catabolism.
Carbamoyl phosphate synthetase controls flux through the cycle and is the key
regulatory enzyme in urea synthesis from ammonia (Meijer et al., 1990). The high
osmolarity of HM may compound these effects by enhancing anabolic reactions and
enzyme expression, as well as amino acid uptake, so USR may approach maximum
velocity.
This would not account for the observation of relatively high USR in Ml640,
compared with WE and Ml99 conditioned hepatocyte cultures. However, the most
potent stimulator of ureogenesis, arginine (Arnpola, 1994, Meijer, 1990) is present in
supraphysiological but varying concentrations in the different media formulations. The
high concentration of arginine in both Ml 640 and HM (4-10 fold greater than WE
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and Ml99 test media; APPENDIX I) may account for the significantly higher urea
synthesis rates in hepatocytes conditioned in these media.
It should be noted that L-15 medium was originally formulated for use in
carbon dioxide free systems for support of cell lines. The extent to which this may
affect, for example, pH homeostasis for HM cultured cells in particular, is unknown.
However, since pH regulation may play an important role in a number of cellular
processes such as glycolysis, cell volume, and urea synthesis (Strazzabosco and
Boyer, 1996), monitoring and maintaining physiological pH to optimise culture
conditions should be considered in future studies.
Our whole liver retrograde perfusion method may isolate parenchymal cells
preferentially from the periportal region (Gumucio et al., 1986; Kano et al., 1998).
Since all five enzymes of the urea cycle are located primarily in periportal hepatocytes
(Meijer et al., 1990), this may partly account for the augmented USR values observed
in this study, compared with some other reports (Table 4.3), which use in vivo
isolation procedures. In addition, unlike labile P450 enzymes, which are rapidly
depleted in culture, expression of urea cycle enzymes are apparently more stable
(Dunn et al., 1991).
An important discrepancy in the urea synthesis data presented here is the lack
of correlation with the ultrastructural observations of Chapter 3 (Section 3.5.3.2, page
3-22). Differences in hepatocyte morphology appeared to be influenced by the culture
medium formulation, since ultrastructural examination of day 2 WE- and Ml 99-
maintained hepatocyte cultures illustrated that the features typical of metabolically
active liver cells were maintained, in contrast to both HM and RPMI 1640 cultures.
Since urea synthesis clearly requires functional and intact mitochondria, it suggests
that alternative mechanisms account for the urea synthesis findings for HM and
Ml640 conditioned cells. Increased lactate concentrations (2mM) can stimulate urea
synthesis from ammonia, at least in rat hepatocyte cultures (Berry et al., 1991). The
morphological appearance (Chapter 3) of Ml 640- and HM-conditioned cells
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hepatocytes show progressive deterioration up to culture day 6 and relatively
decreased viability compared with the other test media, perhaps reflecting an increase
in lactate levels, with a concomitant increase in USR. However, other energy-
requiring synthetic functions, such as albumin synthesis, were relatively well
maintained in these media (see below).
Interestingly, our USR values were at least double those of PPHs grown on a
variety of extracellular matrices (te Velde et al., 1995), including Matrigel™ (50
nmol/h/ mg TP), considered the 'gold standard' attachment substrate with which to
improve differentiated hepatic function. In addition, PPH cultured in a collagen gel-
Matrigel sandwich configuration did not enhance CYP3A metabolic activity compared
with collagen alone (Hosagrahara et al., 2000). Moreover, (Gregory et al., 2000)
demonstrated that culturing porcine hepatocytes on collagen-coated surfaces or single
or double collagen gel layers did not facilitate improved urea (or albumin) synthesis
rates (Table 4.3). Furthermore, our values for albumin synthesis were 100 fold greater
than those achieved using collagen gel entrapped PPHs cultured under serum-free
conditions (Sielaff et al., 1995a; Sielaff et al., 1995b). This reinforces the notion that
exogenous attachment substrates, notwithstanding the expense, may be unnecessary
for porcine-based BAL devices.
Albumin synthesis
Albumin production by hepatocytes is not considered a primary function required of
BAL systems since human albumin can be readily administered in the clinical setting
of ALF (Gregory et al., 2000; Plevris et al., 1998; Riordan et al., 1998; Tsiaoussis et
al., 2001). However albumin is a well established marker of hepatic-specific
differentiation in culture and is the predominant product of hepatic protein synthesis
representing a highly oxygen-dependent (aerobic), energy-requiring (ATP)
biosynthetic function (Seifter and Englard, 1994). Furthermore albumin requires
complex processing and packaging via the endoplasmic reticulum and Golgi
membrane systems prior to secretion, processes which also require cellular energy.
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Taken together, maintenance of albumin synthesis reflects well on both the capacity of
the hepatocytes to synthesise and secrete proteins in general, acting as a surrogate
marker of overall cell fitness.
Albumin production by PPHs was detected in test media using a novel,
sensitive and reproducible method for detecting pig albumin in culture supernatants
(fluorimetric albumin blue 580 dye binding assay). This method is much simpler, more
expedient (samples can be analysed in under 2 hours) and convenient than ELISA,
since there are no antibody incubation steps and the assay is based on a 96-well
microtitre plate format, so enabling up to 40 duplicate samples to be assayed in one
run. The presence of albumin was confirmed by dot blot analysis (Figure 4.4.3). A
major drawback of our comparative study was the inability to measure endogenous
albumin production in HM cultures due to the high background levels in this
formulation. In retrospect, analysis for the presence or absence of albumin in the test
media should have been undertaken, and a more appropriate alternative medium used
in the study. However, conventional methods used for albumin detection in the initial
phase of the study were too insensitive to measure pg quantities in culture
supernatants (Figure 4.10).
Albumin production in WE, Ml99 and Ml640 show good correlation with in vivo
values of human and rat liver (Table 4.3 and Figure 4.9), although with a somewhat
anomalous increase in ASR up to day 6 of culture, despite the observed deterioration
in both gross morphology and ultrastructure noted in Chapter 3 at this time point.
Gregory et al., (2000) reported a similarly increasing trend in ASR throughout the
culture period of PPHs cultured in WE/1% serum on plastic dishes, or as collagen
sandwich cultures, from a relatively high initial ASR value, to values approaching in
vivo production (Table 4.3). This phenomenon could be explained by the observation
that, at least in rat hepatocytes, insulin and dexamethasone have a synergistic effect on
ASR with an initial lag period of several days. Under defined serum-free conditions
insulin initially stabilizes albumin mRNA whereas dexamethasone, after an extended
time-lag, increases the transcription rate of the albumin gene in hepatocyte culture
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(Grunnet et al., 1988; Nawa et al., 1986). It should be noted however that the
influence of insulin, hydrocortisone, glucagons, and serum (of unknown hormonal and
growth factor composition) were included as supplements in these media. The
isolation process itself may account for the initial, relatively low albumin levels
compared with that observed in vivo, since Dunn et al., (1992) showed that
collagenase digestion reduces the average polyribosome size for albumin mRNA
translation within hepatocytes.
9
Between-media comparisons on each culture day did not reveal major
differences. However, ASR in M1640-grown hepatocytes increased significantly
between days 2 and 6. This could not be explained however by the influence ofknown
stimulators of albumin synthesis (Doweiko and Nompleggi, 1991a; Doweiko and
Nompleggi, 1991b) present in the test media. For example, potassium, which
facilitates the release of albumin from the hepatocyte is identical in concentration in
each medium. Moreover, although tryptophan enhances albumin synthesis, the lowest
concentration was present in Ml 640, which paradoxically had the highest mean ASR
value. Remarkably, the urea cycle and albumin synthetic machinery appear
inextricably linked, the same amino acids stimulating both urea and albumin synthesis.
In agreement with Oratz et al., (1973) we have shown that urea synthesis rates and
albumin appear to follow a similar pattern of expression on day 2 of culture (Figures
4.1 and 4.9, respectively).
Galactose elimination
Galactose elimination capacity is used as a quantitative liver function test to study
functional hepatic mass (Baker, 1992). Unlike the caffeine clearance test, which
requires expensive HPLC equipment, galactose levels in culture supernatants (or
plasma) are easily measured using commercial kits requiring standard
spectrophotometry. In humans, plasma [galactose] values are <0.28 mmol/L in adults,
while the range for newborn infants is 0 to 1.11 mmol/L (Painter et al., 1986). The
ability of hepatocytes to metabolise galactose was tested to reflect the integrity of
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carbohydrate metabolism in the BAL setting. A galactose loading dose of 6 mmol/L
was used for GE determination in HBSS reference medium of all cells pre-cultured in
test media, since this is close to the value used clinically in liver function tests
(Whitington, 1992), experimentally in BAL systems (Flendrig et al., 1997a), and is
close to linear at [galactose] of 5-6 mmol/L over a range of concentrations (Figure
4.5). Finally, equimolar [galactose] loading dose allows valid, direct comparisons
between the different test medium formulations, since HM contains 5-6 mmol/L
galactose. The ability of the hepatocytes to uptake and metabolise galactose in each
test medium was significantly higher for day 2 cultures («450 nmol/h/ mg protein)
than days 4 and 6, but remained relatively stable («250 nmol/h/ mg protein)
throughout the culture period (Figure 4.4). These findings are in agreement with
Gerlach et al. (1994) although the GE was maintained at this level up today 21 of
culture in their BAL device. This correlates with the in vivo GE capacity of pig liver
(Table 4.3), and is 50% that of human liver under a 5mM loading dose of galactose.
Moreover, our GE values are 10-20 fold higher than observed in the porcine-based
BAL devices of Flendrig et al., (1997a) and Iwata el al., (1999). The latter study used
DMEM/ 25% heparinised human blood, whereas the former used WE/ 10% FBS in a
3D culture configuration. Whether serum supplementation of the perfusion medium
interferes with this facet ofcarbohydrate metabolism remains to be elucidated.
Thus, taken together with, for example the ASR data above, in vitro markers of
functional activity of PPHs should be compared with documented in vivo levels, when
considering the functional liver cell mass required of BAL systems.
The validity of the GE test in BAL setting remains controversial. Despite its relatively
widespread use as global liver function test, in vitro and animal experiments suggested
it is not a reliable indicator ((Demetriou & Rozga, 1998). However, the efficiency of
galactose elimination in our study reflects both the presence of hexose uptake
transporters in the hepatocyte cultures and the metabolic conversion suggests an
intact Leloir pathway (Leloir, 1951; Figure 1.7). Although the mechanisms by which
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different media formulations impact upon regulation of this facet of carbohydrate
metabolism is unknown, culture age appears to be an important factor.
Overall performance of media formulations: The Hepatocyte Biological
Activity Index (HBAI)
The definition of the most favourable conditions for PPH culture as determined by
measurement of functional capability and identification of a variety of differentiation
markers in optimal culture media is crucial for effective cell-based therapies (Sielaff et
al., 1995b). However, major drawbacks in testing the efficacy of the various BAL
devices under development include the lack of an appropriate animal model of
acetaminophen-induced ALF, discussed in detail in our recent review (Newsome et
al., 2000), and the absence of standardization for assessment of cell function between
laboratories. This may be due to the variable usage of, for example, serum-free or
serum-containing media formulations, biomatrices or culture system modalites.
Such diversity of approach and our limited information of the most important
hepatocyte functions make direct comparisons between research groups very difficult.
Moreover, since the pathophysiology underlying FHF is incomplete, precisely which
hepatic support functions should be preserved in a BAL remains a challenge. Most
investigators therefore evaluate BAL hepatocyte function empirically. It would seem
reasonable to evaluate specific markers of differentiation that cover the spectrum of
synthetic, detoxification and metabolic liver functions, since there is no single global
marker to quantify liver function (Demetriou & Rozga, 1998).
It may therefore be useful to assess and weight all cell functions equally. To
simplify comparisons, we proposed a 'hepatocyte biological activity index' (HBAI),
which normalises each hepatic functional parameter with respect to an equally
weighted scoring system (see Section 4.6.7 and Table 4.1). This would allow direct
comparisons of any hepatocyte-based culture system, provided the same parameters
were used to assess global function. The assumptions made in generating the HBAI
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are outlined in Section 4.6.7, page 4-32. Using these criteria it is evident that both
Ml99 and HM maintained cultures attained the highest HBAI cumulative score by
day 6 (Table 4.2), ranking the media as follows: M199=HM>WE>M1640. However,
the gross and ultrastructural morphological observations, and image analysis data
presented in Chapter 3, suggest Ml99 and WE best preserves the in vivo
characteristics of differentiated hepatocytes up to culture day 4, which is the time
frame for current operational BAL usage, with high viability and attachment
efficiency. Using this utility, HBAI scores for day 2, rank the media as
M199>WE>M1640>HM, whereas the day 4 rankings were, M199>HM>WE>M199.
The morphologica observations, combined with analysis of the HBAI scores, suggest
that Medium 199 may be one of the most suitable synthetic media for preserving
differentiated hepatic function and morphology, under serum-free chemically-defined
conditions for BAL systems.
The HBAI utility presented here provides some measure of global functional
activity of our hepatocyte culture system. There are however, some important
caveats. Firstly, an accord would be necessary between BAL research centres, each
requiring to adopt identical isolation, culture and assay procedures as presented in this
thesis, as the overall quality of the hepatocytes are considered to be interdependent on
these factors (Jauregui, 1991). The HBAI is based on certain empirical assumptions,
and these arbitrary associations cannot take into account, inter alia, that some
functions may be more important than others, or not even be a functional requirement,
per se, for clinical BAL systems. For example, although albumin production is often
cited as a marker of differentiated function, it is unlikely to play an important
therapeutic role for patients with FHF (Gregory et al., 2000). Equal weighting of each
biochemical parameter may in itself distort the final score and outcome of the HBAI,
since an important unmeasured function, or other factor, may be omitted, whereas
random selection of chosen functions may introduce bias. For example, our data
suggests that image analysis data of plating efficiencies may be more discriminatory
than the biochemical measurements of total protein and LDH activity. Therefore,
defining only biochemical measurements as the most important factors in the
generation of the HBAI may be insufficient.
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Also, if a given culture condition significantly enhanced a particular cell
function, say, 10-fold, the scoring systems limited range would not take account of
the relative improvement in function and would skew the final score. Use of only
mean values and omission of SEM statistical data is also problematic. Furthermore,
performance of hepatocytes in our culture system for example, does not guarantee the
same functional efficacy in the BAL environment, since the cells may perform quite
differently in the presence of FHF plasma. Indeed, recent studies have shown that
exposure of ALF serum or plasma to hepatic cell lines has deleterious effects on
important functional parameters including glutathione homeostasis and P450 activity
(Shi et al., 1998; McCloskey et al., 2002). The HBAI may be useful then, in the more
limited, unilateral context ofassessing multiple comparisons.
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Chapter 5
Morphology and Metabolic Function of Primary
Porcine Hepatocytes Cultured in Simulated
Microgravity
5.1 Introduction
Development of therapeutic applications for PPHs may benefit from a culture system
expressing stable levels of liver-specific functions, which exhibit cellular polarity and
morphology that closely resemble that found in vivo. In previous chapters, we have
shown that although PPHs maintain relatively high metabolic activity and normal
phenotype under a variety of culture conditions, cells have a limited life span suitable
for BAL usage of only 2-4 days. One possible reason for this is that conventional
hepatocyte (static) culture on 2-dimensional (2D) surfaces, such as plastic or collagen,
disrupts cell shape and polarity, resulting in retrodifferentiation and loss of hepatic
gene expression and function (Berthiaume et al., 1996). Partial restoration of cell
polarity and differentiated function (Michalopoulos et al., 1999) is achieved using 3-
dimensional (3D) matrices such as Matrigel™ or collagen gel sandwiches (Berthiaume
et al., 1996), in hormonally-defined medium (HDM).
Alternative strategies used to invoke 3D cell culture configurations, include
the formation of porcine hepatocyte spheroids from cell suspensions using spinner
flasks (Lazar et al., 1995a; Lazar et al., 1995c), conventional stirred fermentors
(Unsworth and Lelkes, 1998) and the use of roller bottle culture (RBC) with
microcarrier-attached hepatocytes (Jauregui et al., 1997) or without synthetic support
structures (Michalopoulos et al., 2001). In the latter study, isolated rat hepatocytes
and NPCs in collagen-coated RBCs, formed structured tissue-like formations bearing
resemblance to hepatic histological organization. Hepatocyte aggregation in these
systems, contributes to 3D cellular arrangements and enhanced cell-cell interactions,
which have been reported to prolong and improve hepatocyte function in vitro
compared with traditional 2D cultures (Auth and Ichihara, 1998; Lazar et al., 1995a;
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Lazar et al., 1995b; Lazar et al., 1995c). For example, a significant increase in
albumin synthesis can be induced in engineered liver tissue by hepatocyte aggregation
(Kim and Mooney, 1998; Parsons-Wingerter and Saltzman, 1993). In these dynamic
culture modalities, however, physical forces of high shear stress, which damage the
cells by fluid shear forces and rotationary impeller impacts, and gravity-induced
sedimentation may hinder proper tissue-specific differentiation (Spaulding et al.,
1993; Unsworth and Lelkes, 1998).
Originally to offset the high shear forces of space shuttle launch and re-entry
on biological tissues, NASA developed a novel rotary cell culture system (RCCS),
which promotes growth of fastidious, delicate cells in a simulated microgravity
environment. During space flight, cell suspensions experience microgravity forces of
ltrMO"6 g, preferentially aggregate and yield higher cell densities than at 1 g (unit
gravity) (Unsworth and Lelkes, 1998). Human liver, cartilage, bone marrow, skin
explants and various cell lines and carcinomas have been successfully cultured in the
RCCS into macroscopic, differentiated, tissue-like 3D constructs (Becker et al., 1993;
Goodwin et al., 1993; Jessup et al., 1993; Spaulding et al., 1993). This is facilitated
by a simulated microgravity environment (10 2g), which promotes randomised angular
gravitational vectors on the growing aggregate thus creating a freefall (quasi-
stationary) rotation of the cell aggregate(s) around a horizontal axis within the vessel.
The resultant efficient low-shear mass transfer of nutrients and waste products with
high oxygenation, promotes close apposition (spatial co-location) of single cell
suspensions resulting in the formation ofmicrogravity-induced, 3D cell formations.
Preferential aggregation in microgravity may not only enhance cell-cell
interactions, differentiated function and cell polarity, but may well induce tissue-
specific up-regulation of cell adhesion molecules, extracellular matrix (ECM) proteins
and their respective integrin receptors (Unsworth and Lelkes, 1998). ECM geometry
in concert with adhesive cell-cell and cell-ECM interactions, modulate and maintain
structural and differentiated functional features of hepatocytes in vivo, such as
expression of cell surface adhesion molecules, albumin production and urea synthesis
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(Berthiaume et al., 1996; Bhatia et al., 1999). Such regulatory effects of ECM, are
often mediated by integrins, which comprise a large family of cell surface receptors
that attach cells to ECM proteins and mediate mechanical and chemical signals arising
from ECM. For example, the most abundant hepatocyte integrin, the fibronectin
receptor, a5Pi, is thought to be involved in the coordinated control of cell shape,
growth and survival, important for the establishment and maintenance of tissue
architecture (Giancotti and Ruoslahti, 1999; Stamatoglou et al., 1990; Stamatoglou
and Hughes, 1994). Indeed, antibodies blocking the binding of pi -integrin subunits to
collagen, in collagen-sandwiched hepatocyte cultures, resulted in significant
alterations in hepatic morphogenesis, cell polarity and differentiated function (Moghe
et al., 1997). Using time-lapse microscopy, Peshwa et al., (1996), revealed that cell
movement and reorganization were involved in spheroid formation, implicating a
mechanistic role for integrins. In fact, integrin bridging between cellular cytoskeleton
(CSK) and ECM components allows cells to exert force on their environment, critical
for many cellular processes including efficient cell movement (Holly et al., 2000).
Moreover it has been suggested that cell surface adhesion molecules such as integrins
act as mechanoreceptors, which might sense the microgravity environment and alter
ECM mechanics, cell shape and cytoskeletal organisation and thus tissue-specific
function (Ingber, 1999; Ingber, 1997). Integrins likely play an important role in the
differentiation of the epithelial and endothelial cell populations of the liver (Couvelard
et al., 1998). The present study was designed to investigate the feasibility of using the
RCCS to culture PPHs in a simulated microgravity environment to maintain 3D
aggregate culture formations and differentiated function for an extended period of
time.
5.2 Aims
Using biochemical, histological, ultrastructural and immunocytochemistry studies, we
sought to identify whether spheroid aggregate formation in the unique environment of
simulated microgravity, maintained stable, liver-specific metabolic capacity and
characteristic hepatic morphology for an extended period. The expression of integrin
5-3
a5, as a marker ofhepatic differentiation and structural integrity, was investigated and
the findings compared with conventional static cultures.
5.3 Materials and methods
5.3.1 Reagents
All reagents used were as detailed in previous chapters, with the following additions:
Primary antibody: polyclonal anti-integrin a5 (raised in goat) from Insight
Biotechnology (Middlesex, UK). The secondary antibody, indodicarbocyanine,
Cy3™-conjugated donkey anti-goat IgG and normal donkey serum (NDS; 60 mg/ml)
were supplied by Jackson Immunoresearch (West Grove, PA, USA). Fluorescein
diacetate was obtained from Sigma.
5.3.2 Hepatocyte isolation
Hepatocytes were isolated from weanling piglets (<15kg) using our ex vivo
collagenase perfusion method described in Chapter 2 (Nelson et al., 2000).
5.3.3 Hepatocyte cultures
5.3.3.1 Static cultures
For immuno-staining cells were cultured for up to 6 days on Lab-Tek™ glass
chamber slides in serum-free chemically-defined William's E (WE) Medium. To verify
cell viability, a spheroid sample cultured for 12 days in serum-free chemically-defined
WE medium in the RCCS-HARV, was dispersed by gentle pipetting and transferred
to TCP dishes and cultured for 2 days in the same medium. Otherwise, hepatocytes
were cultured as described in Chapter 2.
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5.3.3.2 Hepatocyte culture in simulated microgravity: The rotary cell
culture system-high aspect ratio vessel (RCCS-HARV)
Microgravity conditions were simulated using two RCCS-HARV configurations: 1)
55 ml capacity single station RCCS-HARV (Figure 5.1) and 2) 10 ml capacity, four
station RCCS-HARV (Figure 5.2).
Preliminary work: In order to optimise, empirically, the consistent formation of cell
aggregates in microgravity, cells were seeded (day 0) in the 10 ml capacity HARVs
(Cellon-Sarl, Luxembourg) at densities of 0.25, 0.5, 1.0 or 2x106 viable cells per ml of
serum-free, chemically-defined William's Medium E at 37°C. Seeding densities of
lxlO6 viable cells per ml gave the most consistent simulated microgravity culture of
aggregates in freefall rotation as defined above (Section 5.1), and were used for all
subsequent experiments.
The HARV was connected to the horizontally rotating axle of the RCCS,
which pumped incubator gas via a central aperture, across a silicon rubber, semi¬
permeable gas exchange membrane within the HARV. The RCCS-HARV assembly
was placed in a humidified incubator under a 95% air: 5% C02 atmosphere. Next day
(day 1), aggregated cells were allowed to sediment, the HARV aspirated, and pre-
warmed, fresh medium added, which was subsequently changed every 2 days. The
optimal rotational speed of the HARV was determined by adjusting the RCCS
rotational speed such that the aggregate(s) maintained a freefall, quasi-stationary orbit
within the culture vessel. The rotational speed varied according to both aggregate size
and the corresponding sedimentation coefficient. However, by day 6 of culture,
rotational speed was set between 10-15 rpm. For changes of supplemented William's
E medium a 0.5 cm fill port was used using a suction aspirator. Medium was
replenished on days 1 and 2, and every 2 days thereafter. When changing the medium,
the cells were covered by a small amount of medium to minimise cell damage. Media
samples were taken at the time points indicated via a syringe attached to one of the
luer-lock syringe ports and stored at -80°C until analysis.
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Incubator
Figure 5.1 The single station high aspect ration vessel (HARV) and
rotary cell culture system (RCCS) set-up.
The power-pack (A) drives the HARV (B) around a horizontal axis which
provides a simulated microgravity environment for the culture of cell
suspensions (see text for details). Medium is replenished via the sample port







Figure 5.2 The four-station high aspect ration vessels (HARVs) and
rotary cell culture system (RCCS) set-up
The power-pack (A, rotator control unit) drives the 4 HARVs (B) around a
horizontal axis, via a pully/belt arrangement, which provides a simulated
microgravity environment for the culture of cell suspensions (see text for
details). Medium is replenished via the sample port (S) and samples taken
via luer locks (L, L) where syringes can be attached. Incubator air is pumped
through the central shaft of each HARV. Gas dissolves in the medium and
induction of air bubbles is eliminated, so minimizing fluid shear stresses.
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5.3.4 Functional parameters
5.3.4.1 Urea synthesis rate and galactose elimination
Freshly isolated hepatocytes (day 0) were inoculated into the 4-station, 10 ml capacity
HARV at a density of 106 cells/ ml in supplemented WE medium containing 2mmol/ L
NH4CI, and rotated at 10 revolutions per minute, in a humidified incubator at 37°C
under an atmosphere of 95% air / 5% CO2. The ammonium chloride challenge was
repeated on culture days 2, 6 and 12; after washing the cells with pre-warmed HBSS.
To allow comparisons with static cultures, galactose elimination (GE) was assayed by
addition of 6 mmol/L D(+)-galactose in HBSS at these time points. The urea synthesis
rate (USR) and GE were determined in t=0 samples (assay medium which had never
been in contact with cells) and at t=2 hours of incubation, using modified commercial
kits, as described in Chapters 2 and 4.
5.3.4.2 Albumin production
The albumin concentration in HARV cultures was determined using the fluorimetric
albumin blue 580 dye-binding assay detailed in Chapter 4, Section 4.3.9. Cells were
cultured as above and 1 ml samples taken from duplicate HARVs on days 2 (24 hours
post medium change), 6 and 12 (48 hours post medium change) and stored at -80°C
until analysis of albumin synthesis.
5.3.5 Morphology
5.3.5.1 Histology of cell aggregates
On days 2, 6, and 12 for HARV-grown aggregates, cell samples were removed and
fixed in 3 % formaldehyde / 0.1M cacodylate buffer. The fixative was aspirated and
the cells washed with PBS; cell aggregates were resuspended in 100 pi of molten
agarose for ease of handling. Histological staining was performed using hematoxylin
and eosin (H&E) to identify hepatocyte nuclei and cytoplasm, respectively. Periodic
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Acid Schiff (PAS) reagent was used to detect the presence of glycogen, whereas
silver nitrate stain was used to identity collagen. Subsequent sample processing and
staining was performed using standard techniques. Morphology was recorded by
photomicrography using an inverted microscope (Zeiss, Germany) under transmitted
light, for each culture modality at each time point.
5.3.5.2 Scanning electron microscopy
Freshly isolated hepatocytes and cell aggregates taken from the HARV-RCCS on
days 6 and 12 were washed in HBSS buffer and subject to low-speed centritugation
(20 g) for 5 minutes. Cell samples were fixed in 3 % gluteraldehyde in 0.1 M sodium
cacodylate buffer (SCB) at pH 7.4 for at least 3 hours. Following washing in 0.1 M
SCB, samples were post-fixed with 1 % osmium tetroxide in 0.1 M SCB for 2 hours
and washed in distilled water. Following dehydration in a graded series of acetone
(50, 70, 90, and 100 % (3 times)), cells were subject to critical point drying with CO2
in a Poleron E3000 SII critical point dryer. For conductive coating, samples were
sputter-coated with 20nm gold / palladium (60/40) in an Emscope sputter coater
(Cohen, 1979; Echlin, 1975; Hayat, 1970; Sabatini et al., 1963). Finally cell
aggregates were viewed in a Philips 505 scanning electron microscope (SEM).
5.3.5.3 Transmission electron microscopy
Cell aggregates taken from the HARV-RCCS on days 6 and 12 were washed in
HBSS buffer and subject to low-speed centrifugation (20 g) for 5 minutes. Cell
samples were fixed in 3 % gluteraldehyde in 0.1 M SCB and processed as described in
Chapter 3, Section 3.3.6.
5.3.5.4 Acridine orange fluorescent dye staining
To assess cell viability, fresh HARV-cultured cell aggregate samples were taken on
day 12 and 100 pM acridine orange in WE medium added for 2 minutes at room
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temperature (RT). Viable (apple green nuclei) and non-viable cells (yellow / orange
nuclei) were visualised using confocal microscopy (see below) and photographed.
5.3.6 Confocal microscopy
The following protocol was modified from Stamatoglou et al., (1990). Adherent
cultures on Lab-Tek™ glass chamber slides or aggregate samples from the HARV at
the time points indicated above, were fixed in formal saline (4% formaldehyde / 4%
paraformaldehyde) / 0.4M sucrose) for 2 hours at room temperature and then washed
in PBS with 0.5 % Triton-X for 30 minutes. RCCS aggregates were transferred to 1.5
ml eppendorf tubes for three cycles of 20 minute washes with 1% donkey serum
albumin (DSA) in PBS on a Spiramix roller bottle tray. For static cultures, slides were
similarly treated and gently shaken on an orbital shaker. Titration of the polyclonal
anti-a5 integrin (goat) primary antibody resulted in an optimal concentration of 1:20
for indirect immuno-fluorescence. 50 pi of primary antibody were added to samples
for 1 hour at RT. After the primary antibody incubation, the cells were washed in PBS
3x for 20 minutes before addition of the secondary antibody. The Cy3™-conjugated
donkey anti-goat IgG secondary antibody was used at a dilution of 1:20 (in 1 % DSA
/ PBS), 50 pi added and incubated for 20 minutes at RT. Unbound antibody was
removed by three 20 minute washes with 1% NDS in PBS. RCCS aggregate samples
were mounted in 50:50 glycerokPBS in wells made by strips of coverslip on standard
glass slides. The wells were sealed with nail-varnish to prevent leakage. The Lab-
Tek™ glass chamber slide cultures were mounted in 50:50 glycerokPBS and covered
with a glass coverslip and sealed as above. Cells were viewed using a Leica TCSNT
confocal microscope system (Heidelberg, Germany) with a lOx objective lens or a 63x
water-corrected lens with the Argon-Krypton laser set at L568 nm. Images were
recorded on computer and stored on CD for future analysis. As controls: 1) Negative
controls: cells were treated as above except that the primary antibodies were omitted;
2) Positive controls: fresh human and pig liver samples were homogenised in SDS /
PBS and dot blot analysis was performed of cell lysates using the above primary
antibody and an HRP-conjugated donkey anti goat IgG secondary revealing high
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(human) and moderate (pig) levels of cross-reactivity (performed courtesy of Drs K
Humphreys and AF Howie, Dept of Clinical Biochemistry, University of Edinburgh).
5.3.7 Fluorescein diacetate metabolism of cultured porcine hepatocytes
Fluorescein diacetate (FDA) metabolism of day 12 cultures was analysed to assess
bile canalicular function. 80pl FDA was added for 30 minutes in a 10 ml capacity
RCCS placed in a C02 incubator at 37°C, according to Mitaka et al., 1999. Cells were
subsequently rinsed 3x with warm PBS following brief centrifugation at low speed
(25g), placed on glass microscope slides and photographed using a Leitz Wetzlar
Ortholux II fluorescent microscope with a 25x water immersion lense.
5.3.8 Statistics
Results are expressed as mean ± standard error of the mean. Student's t-test was used
to compare means of different groups. A p value of < 0.05 was taken as significant
(two tailed test of significance).
5.4 Results
5.4.1 Cell isolation viability and yield
The hepatocytes were isolated using our ex vivo method described in detail in Chapter
2. For these experiments, cell viability was 87±5% with a yield of 2.2±0.8 x 10l0 cells
from 12±1 kg piglets (n=10).
5.4.2 Biochemical measures of functional activity in HARV cultures
5.4.2.1 Urea synthesis rate, galactose elimination and albumin synthesis rates
Figure 5.3 shows that urea synthesis rates (USR) were significantly higher (p<0.05) in
fresh cell cultures (162±40 nmol/hr/106 cells seeded) compared to both day 2 (61+14;
p<0.01) and day 12 (85±20; p<0.05), although not significantly greater than day 6
5-11
HARV cultures (108±38). HARV cultured cells showed enhanced, although not
statistically significant, conversion of ammonia to urea on day 6 (108±38) compared
to day 2 (61±14) cultures and plateaued at this level until day 12 (85±20). USR values
for cells grown in simulated microgravity were approximately one fifth of the values
obtained for static, WE maintained cultures (Chapter 4; Figure 4.1) at each time point,
although the latter became non-viable after one week of culture, following detachment
from TCP dishes.
Figure 5.4 demonstrates that HARV-grown cells had similar day 2 (483±44
nmol/hr/ 106 cells) galactose elimination (GE) capacity as observed for corresponding
static cultures (420±66), assuming TP content of 106 cells ~lmg (Chapter 3). The
mean GE value of HARV cultures remained higher than static cultures up to day 6
(317±57 vs 179±50 %, respectively) and plateaued until termination of the experiment
on day 12. However, GE levels were significantly lower (p<0.05) in both day 6 and
day 12 (277±33) HARV cultures compared with day 2.
Albumin synthesis rates (ASR) displayed a similar upward trend (Figure 5.5)
compared with static cultures (Chapter 4; Figure 4.4.2) for the duration of the
respective experiments. Although the ASR values in HARV cultures on days 2 and 6
of culture were approximately half the values for of comparable static cultures,
HARV environment maintained stable cellular secretion of albumin up to day 12 at
1.4±0.4 pg/hr/106 seeded cells (Figure 5.5).
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Figure 5.3 Urea synthesis rates in primary porcine hepatocytes cultured
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Figure 5.3 Urea synthesis rate (USR) was measured in primary porcine
hepatocytes cultured at 107 viable cells per 10 ml HARV in William's E
chemically-defined medium for up to 12 days in simulated microgravity. 2mM
NH4CI was added to culture vessels and incubated for 2 hours on days 0, 2,
4, 6 and 12. USR was determined in media samples taken at t=0 and t=2
hours using a modified colourimetric urea nitrogen kit as described in
Materials and Methods. Results are expressed as nmol/hour/ 106 seeded
cells. USR is significantly higher in fresh cell cultures compared to day 2
(p<0.01) and day 12 (p<0.05) All values represent the means±SEM of 3
experiments in duplicate. Student's t-test was used to compare means of
different groups. A p value of < 0.05 was taken as significant (two tailed test
of significance).
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Figure 5.4 Galactose elimination of primary porcine hepatocytes

























Figure 5.4 Galactose elimination (GE) of primary porcine hepatocytes pre-
cultured at 107 viable cells per 10 ml HARV in William's E chemically-defined
media for up to 12 days in simulated microgravity. 6mM D(+)-galactose was
subsequently added to HBSS and incubated for 2 hours on days 2, 6 and 12.
and GE determined as described in Materials and Methods. Results are
expressed as nmol/hr/ 106 cells. All values represent the means±SEM of 3
experiments in duplicate. GE is significantly higher in day 2 cultures
compared with both day 6 and day 12 cultures (p<0.05). Student's t-test was
used to compare means of different groups. A p value of < 0.05 was taken as
significant (two tailed test of significance).
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Figure 5.5 Albumin synthesis rates of primary porcine hepatocytes






Figure 5.5 Albumin synthesis rates (ASR) of primary porcine hepatocytes
cultured at 107 viable cells per 10 ml HARV in William's E chemically-defined
medium for up to 12 days in simulated microgravity. Samples were taken on
days 2 (24 hours post medium change), 6 and 12 (48 hours post medium
change) and stored at -80°C until analysis of ASR, determined by fluorimetric
analysis of albumin blue 580 dye binding to albumin as described in
Materials and Methods (Chapter 4, Section 4.3.9). Results are expressed as
pg/hour/ 106 seeded cells. All values represent the means±SEM of 3
experiments in duplicate. ASR is significantly higher in day 12 cultures
compared with day 2 cultures (p<0.05). All values represent the means±SEM
of 3 experiments in duplicate. Student's t-test was used to compare means of
different groups. A p value of < 0.05 was taken as significant (two tailed test
of significance).
5-15
5.4.3 Morphology of freshly isolated primary porcine hepatocytes and
HARV cultured hepatocytes in simulated microgravity
5.4.3.1 Histology
Figure 5.6 shows both freshly isolated hepatocytes (panel A) and day 6 HARV grown
aggregate sections (panels B-C) stained with periodic acid schiff (PAS) glycogen stain
and counterstained with H&E. The eosinophilic cytoplasm of fresh hepatocytes is
stained pink and nuclei are darkly stained. A feature of the fresh cell suspension is the
presence of numerous small clusters of hepatocytes as seen in Chapter 2 (Figure 2.3).
Panel B in Figure 5.6 shows a transverse section of a HARV aggregate with a
distinctive rim ofPAS-positive hepatocytes, 8-10 cells in depth, which circumscribes a
core of dying cells, although the cells in the core region had eosinophilic cytoplasm in
both day 12 (Figure 5.7) and day 6 cultures (not shown). The size of the whole
aggregate was estimated to be 4-5 mm in diameter. At higher magnification (Figure
5.6, panel C) some of the cells in the core appear apoptotic as evidenced by
condensed nuclei and some cells were necrotic as shown by cell fragmentation. In
contrast, the rim of PAS-positive cells appears viable in that the nuclei of individual
cells are large and round with prominent nucleoli with discrete eosinophilic staining of
the cytoplasm up to day 12 (Figure 5.7). The histology of the HARV cultured
aggregates is maintained up to day 12 (Figure 5.8). However, staining for collagen /
reticulin fibres using empiric silver nitrate impregnation of aggregate sections proved
negative.
5.4.3.2 Scanning electron microscopy
Figure 5.9 shows that, following low speed centrifugation, single cells and 5-20 cell
clusters, typical of freshly isolated primary porcine hepatocytes, appear as a densely
packed arrangement at both low (Panel A) and higher magnification (Panel B).
Numerous microvilh are present on the surface of the hepatocytes, which display a
spherical shape upon isolation. By day 6 of culture in simulated microgravity (Figure
5.10), rounded hepatocytes, organized as tight clusters, are clearly distributed on the
aggregate surface suggesting extensive cell-cell contacts. Microvilli are still evident on
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the surface of hepatocytes (Panel A). At low magnification (Figure 5.11, Panel A) the
aggregate is organized as an ellipsoidal, compact cellular structure, although with
more loosely associated rounded parenchymal and, presumably, nonparenchymal cells
present on the aggregate surface. At higher magnification, the smooth appearance on
the aggregate surface (Panel B, open arrow) may be indicative of the compact
morphology. Again, microvilli are present on the surface of hepatocytes (closed
arrows in panel B).
5.4.3.3 Transmission electron microscopy
Transmission electron microscopy of some sections of HARV-RCCS cultured hepatic
aggregates show ultrastructural features of fresh liver tissue (see Chapter 3, Figure
3.3) up to day 12. It should be noted that hepatocytes exhibiting these features are
probably cell formations derived from the rim of (viable) PAS-positive cells which
circumscribe the core of necrotic/apoptotic cells observed above (Figures 5.6 and
5.8). In fact, most of the TEM sections we observed revealed non-viable, damaged
hepatocytes (not shown). After 6 days in culture (Figure 5.12, Panel A) a binucleate
hepatocyte retains characteristic ultrastructural features including prominent round
nuclei and nucleoli, abundant mitochondria and granular endoplasmic reticulum (ER);
interspersed between the mitochondria are numerous dense glycogen particles. Panel
B shows several hepatocytes whose borders are separated by canaliculi-like channels
with distinguishing microvillous processes; at higher magnification (Panel C) part of
the nucleus is shown in close proximity to granular endoplasmic reticulum, adjacent
mitochondria and electron dense glycogen particles. At day 12 cells show bile
canaliculi-like channels with characteristic microvillous processes between several
juxtaposed polygonal hepatocytes (Panel A of Figure 5.13). Ultrastructural features of
fresh liver tissue are evident although there is an asymmetric cytoplasmic distribution
of granular endoplasmic reticulum, mitochondria and other organelles; interspersed
between the mitochondria are numerous electron dense glycogen particles. At higher
magnification (Panel B), ultrastructural features observed in day 6 cultures are
maintained.
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Figure 5.6 Morphology of both freshly isolated primary porcine
hepatocytes and cells cultured for 6 days in the HARV-RCCS simulated
microgravity environment
Representative photographs showing morphology of fresh primary porcine
hepatocytes (A, x100; scale bar 100^m) and of histological sections of PPH
aggregates cultured for 6 days in serum-free chemically-defined WE medium
in the HARV (B, x50; scale bar 100pm) and corresponding higher
magnification photographs of HARV cultures (C, x200; scale bar 50p). Cell
samples (B-C) were stained with periodic acid Schiff glycogen stain and all
samples were counter-stained with haematoxylin. Panel A shows fresh cell
suspension just prior to inoculation into the HARV with eosinophilic
cytoplasm and distinct nuclei present; Panels B and C Part of a HARV
cultured cell aggregate is shown with a distinctive PAS-positive rim of
apparently viable cells (arrows, v-v in panels B and C), some 8-10 cells in
depth with large round nuclei (N; panel C); a necrotic / apoptotic core (n) is
apparent particularly at higher magnification (Panel C) as evidenced by
condensed nuclei (open arrows), and cell degeneration. The area (a), devoid
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Figure 5.7 Morphology of primary porcine hepatocytes cultured for 12
days in the HARV-RCCS simulated microgravity environment
Representative photographs showing overall morphology and histology of
PPH aggregates cultured for 12 days in serum-free chemically-defined WE
medium in the HARV (A, x50; scale bar 200p) and corresponding higher
magnification photographs of HARV cultures (B, x200; scale bar 50p). Cells
were stained with haematoxylin (nuclear) and eosin (cytoplasmic) stains.
Note that the cytoplasm of the inner core of cells is eosinophilic in both
images and condensed nuclei are evident in panel B (open arrows); whereas
only discrete eosin staining of the rim of PAS positive cells (see Figure 5.6)
with large round nuclei is observed here (closed arrows).
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Figure 5.8 Morphology of isolated primary porcine hepatocytes cultured
for 12 days in the HARV-RCCS simulated microgravity environment
Representative photographs showing morphology of primary porcine
hepatocytes aggregates cultured for 12 days in serum-free chemically-
defined WE medium in the HARV (A, x50; scale bar 100p) and corresponding
higher magnification photographs of HARV cultures (B, x200; scale bar 50p).
Cells were stained with periodic acid Schiff glycogen stain and counter-
stained with haematoxylin. Morphology of 12 day old HARV cultures is very
similar to that seen on day 6 (see Figure 5.6). Note the rim of PAS positive
hepatocytes in Panel A (v-v') and Panel B (upper right) with a central core of
dying cells (n) evident in both sections.
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A
Figure 5.9 Scanning electron micrographs of freshly isolated primary porcine
hepatocytes. Following low speed centrifugation, single cells and 5-20 cell clusters
appeared as a densely packed arrangement at both low (Panel A; x250; scale bar
50pm) and higher magnification (Panel B; x460; scale bar 25pm). Note the
presence of numerous microvilli on the surface of hepatocytes, arrows in panel B.
Cells were processed as detailed in Materials and Methods, Section 5.3.5.3.
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A
Figure 5.10 Scanning electron micrographs of primary porcine hepatocytes
cultured for 6 days in simulated microgravity. Panel A (x200; scale bar
100pm) shows rounded hepatocytes organized as tight clusters suggesting
extensive cell-cell contacts and at higher magnification (Panel B; x400; scale
bar 50pm). Note the presence of microvilli on the surface of hepatocytes
(closed arrows in Panel A). Cells were processed as detailed in Materials and
Methods, Section 5.3.5.3.
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Figure 5.11 Scanning electron micrographs of primary porcine
hepatocytes cultured for 12 days in simulated microgravity.
Panel A (x150; scale bar 100pm) shows a tightly packed arrangement of
cells organized as an ellipsoidal, compact structure with more loosely
associated rounded parenchymal and presumably, nonparenchymal cells
present on the aggregate surface. At higher magnification (Panel B; x520;
scale bar 50pm), the smooth appearance on the aggregate surface (open
arrow) may be indicative of the compact morphology. Note the presence of
microvilli on the surface of hepatocytes, closed arrows in panel B. Cells were




Figure 5.12 Transmission electron microscopy of primary porcine
hepatocytes cultured for 6 days in simulated microgravity
Panel A (x8000) shows a binucleate hepatocyte with prominent round nuclei
(N) with nucleoli, abundant mitochondria (Mt) and granular endoplasmic
reticulum (ger); interspersed between the mitochondria are numerous
electron dense glycogen particles (G). Panel B (x6300) shows several
hepatocytes whose borders are separated by canaliculi-like channels (Be)
with characteristic microvillous processes (m) and prominent granular
endoplasmic reticulum present in the cytoplasm. Panel C (x45000) shows
part of a nucleus (top left) in close proximity to granular endoplasmic
reticulum, adjacent mitochondria and glycogen particles. Cells were cultured
and processed as detailed in Materials and Methods, Section 5.3.5.3.
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Figure 5.13 Transmission electron microscopy of primary porcine
hepatocytes cultured for 12 days in simulated microgravity
Panel A (x1800) shows bile canaliculi-like channels (Be) with characteristic
microvillous processes between several juxtaposed polygonal hepatocytes.
Ultrastructural features of fresh liver tissue are evident although there is an
asymmetric cytoplasmic distribution of granular endoplasmic reticulum,
mitochondria (Mt) and other organelles; interspersed between the
mitochondria are numerous electron dense glycogen particles. A possible
nonparenchymal cell (npc) is resident in the center right of this image. Panel
B (x17000) shows part of the hepatocyte nucleus (lower left) in close
proximity to mitochondria and lysosomes and adjacent glycogen particles.
High magnification image (Panel C, x75000) of a bile-canaliculus showing
microvillous processes and adjacent Golgi apparatus (Ga). Cells were




5.4.3.4 Spheroidal viability: Fluorescent acridine orange viability staining of
primary porcine hepatocytes cultured for 12 days in the HARV-RCCS
simulated microgravity environment
Figure 5.14 shows a small cell aggregate (broken off from a larger aggregate during
the staining process), which has stained apple green with the fluorescent dye, acridine
orange, characteristic of viable cells in vitro; non-viable cells are stained orange-
yellow. This demonstrates that at least the outer layer of HARV cultured cellular
aggregates, remain viable up to culture day 12 in simulated microgravity. To verify
cell viability by cell attachment to TCP dishes, a spheroid sample cultured for 12 days
in serum-free chemically-defined WE medium in the RCCS-HARV, was dispersed by
gentle pipetting and transferred to TCP dishes and cultured for 2 days in the same
medium. Figure 5.19 shows a fragment of the spheroid (green asterisk), which readily
attached to the dish surface and formed hepatocyte monolayers, radiating from the
cell aggregate base (white arrows) after 2 days ofculture (xlOO; scale bar 50pm).
5.4.4 Laser Scanning Confocal Imaging Microscopy: Expression of
integrin a5 in fresh, static culture and simulated microgravity HARV-
RCCS cultured primary porcine hepatocytes
5.4.4.1 Expression of integrin a5 in freshly isolated primary porcine
hepatocytes
Figure 5.15 shows the expression of the extracellular matrix counter receptor, integrin
a5, on both a single hepatocyte (panel A) and on a hepatocyte doublet (panel B).
Hepatocytes were placed in fixative and processed for indirect immuno-fluorescent
staining only 2 hours following the initial isolation step (Chapter 2, Section 2.3.4)
suggesting cell surface integrins are not degraded in this time frame. Noteworthy is
the distinct clustering pattern of integrin a5, reminiscent of the configuration adopted
at focal adhesion complexes in native liver in vivo.
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5.4.4.2 Expression of integrin alpha 5 in day 2 static primary porcine
hepatocyte cultures
Figure 5.16 demonstrates that integrin a5 cell surface receptors are retained in static
cultures at least up to culture day 2. However, by day 6, integrin expression was not
detected (not shown).
5.4.4.3 Expression of integrin alpha 5 in day 12 primary porcine hepatocyte
aggregates cultured in the HARV-RCCS simulated microgravity environment
Figure 5.17 shows small cell aggregates (broken off from a larger aggregates during
the staining process), which have stained positive for integrin a5. Panels A-C: Under
low magnification (xlOO; scale bar 200 pm), strong staining of integrin a5 (white
open arrows) is evident in a tight spheroidal aggregate, A; panel B shows the
corresponding light image of A; whereas C is an enlargement of a region of A (dotted
green box). Panels D-E: Note the appearance of integrin 'hotspots' (white closed
arrows) on the surfaces of aggregated cells under higher magnification (x630; scale
bar 50 pm), D, and the corresponding enlarged region of D (dotted green box),
shown in E.
5.4.5 Fluorescein diacetate metabolism of of primary porcine
hepatocytes cultured for 12 days in the HARV-RCCS simulated
microgravity environment
Figure 5.18 shows 2 small cell aggregates (broken off from a larger spheroid during
preparation). Strong staining of the compact spheroid surface is evident with little
demarcation between individual adjacent cells. Hepatocyte nuclei (orange asterisks)
are just visible in cells on the aggregate periphery.
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Figure 5.14 Laser scanning confocal image: Fluorescent acridine
orange viability staining of primary porcine hepatocytes cultured for 12
days in the HARV-RCCS simulated microgravity environment
Laser scanning confocal image (x100) showing staining of viable (apple
green) and non-viable (diffuse orange-yellow) hepatocyte aggregates
cultured in the HARV-RCCS under conditions of simulated microgravity. Cell
aggregates were stained with 100pM of the fluorescent dye, acridine orange
(scale bar 100 pm). Cells were cultured and processed as described in
Materials and Methods.
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Figure 5.13 Integrin alpha 5 expression in freshly isolated primary
porcine hepatocytes (x630)
Panel A: Laser scanning confocal image showing red fluorescent staining of
the cell surface extracellular matrix counter-receptor, integrin a5 on a single
hepatocyte. Note the clusters of integrins apparent on the cell surface (scale
bars 25 |am). Panel B Confocal image of a hepatocyte doublet showing a
similar clustering pattern of integrin a5 expression. Cells were cultured and




Figure 5.16 Integrin alpha 5 expression in primary porcine hepatocytes
on day 2 of static culture (x100)
Panel A: Representative transmitted light image showing gross morphology
of 2 day old primary porcine hepatocyte cultures in serum-free chemically-
defined WE medium (scale bar lOOp.). Panel B is the corresponding laser
scanning confocal image showing red fluorescent staining of the cell surface
extracellular matrix counter-receptor, integrin a5 (scale bar 100p). Cells were
cultured and processed as described in Materials and Methods. Note that




Figure 5.17 Confocal imaging of primary porcine hepatocyte aggregates
cultured for 12 days in the HARV-RCCS simulated microgravity
environment showing integrin alpha 5 expression
A B
C
Laser scanning confocal images showing red fluorescent staining of the cell
surface extracellular matrix counter-receptor, integrin a5 on aggregates of
hepatocytes cultured in the HARV-RCCS under conditions of simulated
microgravity. Panels A-C Under low magnification (x100; scale bar 200 pm),
strong staining of integrin a5 (white open arrows) is evident in a tight
spheroidal aggregate, A; panel B shows the corresponding light image of A;
whereas C is an enlargement of a region of A (dotted green box).
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Panels D-E Note the appearance of integrin 'hotspots' (white closed arrows)
on the surfaces of aggregated cells under higher magnification (x630; scale
bar 50 pm), D, and the corresponding enlarged region of D (dotted green
box), shown in E. Cells were cultured and processed as described in
Materials and Methods.
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Figure 5.18 Fluorescent micrograph of day 12 primary porcine
hepatocyte organoids cultured in a simulated microgravity environment
in the presence of fluorescein diacetate as a marker of bile canalicular
function
Representative fluorescent micrograph showing fluorescein diacetate (FDA)
metabolism of primary porcine hepatocyte spheroid cultures to assess bile
canalicular function (x50; scale bar 50 prn). A small cell aggregate, broken off from a
larger aggregate during the staining process was incubated with 80jul FDA was for
30 minutes in a 10 ml capacity RCCS placed in a C02 incubator at 37°C. Cells were
subsequently rinsed 3x with warm PBS and photographed using a Leitz Wetzlar
Ortholux II fluorescent microscope with a 25x water immersion lens. FDA is actively
taken up across bile canalicular membranes and, following deacetylation, the bright
green fluorescent product (black arrows) is formed, so confirming the presence of
functional bile canaliculae. Strong staining of the compact spheroid surface is
evident with little demarcation between individual, adjacent cells. Hepatocyte nuclei
(orange asterisks) are just visible in cells on the aggregate periphery.
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Figure 5.19 Morphology of primary porcine hepatocytes pre-cultured for
12 days in the HARV-RCCS simulated microgravity environment and
then for 2 days on tissue culture plastic to verify spheroid viability
Figure 5.19 A spheroid sample cultured for 12 days in serum-free
chemically-defined WE medium in the HARV was dispersed by gentle
pipetting and transferred to TCP dishes and cultured for 2 days in the same
medium (x100; scale bar 50p). Fragments of the spheroid (asterisk) readily
attached to the dish surface and formed hepatocyte monolayers radiating
from the cell aggregate base (white arrows) after 2 days of culture.
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5.5 Discussion
Hepatocytes cultured in unit gravity in vitro are limited in their capacity to exhibit
normal functional and morphological characteristics of native liver. Therapeutic
applications, including bioartificial liver devices and xenogeneic hepatocyte
transplantation strategies, would benefit from improved in vitro performance of PPHs.
It has been widely reported that the improved ex vivo maintenance of viability and
differentiated functions of hepatocytes is correlated with the cell-cell contacts and
more ordered cytoarchitecture of cell aggregates, compared with flattened, static
monolayer cultures (Allen et al., 2001; Michalopoulos et al., 2001; Selden et al.,
1999; Strain & Neuberger, 2002). In the latter, the 2-dimensional environment and
rigid substrata alters gene expression and attenuates differentiation. To address these
issues, a large number of liver cell culture techniques have been developed to promote
cell organisation with the ultimate aim of simulating in vivo conditions. These
techniques include gel entrapment, 3D culture on microcarriers or in spinner flasks,
nonwoven fabrics in bioreactors, 3D hollow-fibre membrane networks, and coculture
with NPCs with or without extracellular matrix (ECM) proteins. Simulated
microgravity cultures are hypothesized to support differentiation of cells through
provision of three-dimensionality, low shear and turbulence, and cospatial relation of
dissimilar cell types coupled with high mass transfer and oxygenation capabilities
(Hammond et al., 2000). Recently, RCCS spheroid cultures of human hepatocytes
were shown to retain both ultrastructural characteristics of hepatic tissue-like
structures and albumin mRNA expression for up to 60 days (Khaoustov et al., 1999).
The shortage of human liver tissue, however precludes their use in large-scale clinical
BAL devices. Therefore PPHs are used in most current systems (Strain & Nueberger,
2001). However, there is no information on liver-specific function and morphology of
PPH spheroids cultured in simulated microgravity, which may improve the ex vivo
maintenance of PPHs for future therapeutic applications.
In conventional 3D culture using Matrigel™, Michalopoulos et al. (1999) suggested
integrin mediated reorganization of cell-ECM and cell-cell interactions were involved
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in hepatocyte differentiation. However, Matrigel use in pre-clinical BAL devices or
other therapeutic applications is not desirable due to the potential risks of murine and
/ or tumourigenic proteins entering the patients circulation and is cost-limiting. As
mentioned, the microgravity environment may promote tissue-specific up-regulation
of cell adhesion molecules, ECM proteins and their respective integrin receptors
(Unsworth and Lelkes, 1998).
Given the importance of these factors in the expression of liver-specific functions and
histological architecture (Auth and Ichihara, 1998; Giancotti and Ruoslahti, 1999;
Lazar et al., 1995a; Lazar et al., 1995b, Michalopoulos et al., 1999; Michalopoulos et
al., 2001), the aim of this study was to ascertain whether a simulated microgravity
environment, would promote aggregate formation, maintain hepatocyte-specific
function and be accompanied by more in vz'vo-like morphological characteristics than
is possible using conventional culture methods.
The results of albumin and urea synthesis as well as galactose elimination,
indicate that the HARV-RCCS microgravity spheroid cultures retained extended,
liver-specific functions compared with static cultures, for a pre-determined period of
12 days. Morphological and ultrastructural features, characteristic of differentiated 3D
hepatocyte cultures, were observed including bile canalicula-like structures, capable of
fluorescein diacetate (FDA) metabolism and expression of integrin a5. However,
histological evaluation alone could not confirm the presence of collagen matrix,
whereas large aggregates typically formed a rim of viable cells, which display only
partial restitution of 3D in v/vo-like hepatic architecture, circumscribing a core of
non-viable cells. Khaoustov et al. (1999) observed similar histological phenomena
with a pure population of primary human hepatocytes cultured for up to 60 days in a
RCCS microgravity environment. Under these conditions, spheroids would not be
suitable for use in BAL devices. Further study is required to enhance the viable cell
population, phenotype, polarity and thus functional activity of such liver constructs.
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The vast majority of studies into spheroid culture systems have been
undertaken with rat liver cells (Hamamoto et al., 1998; Ijima et al., 1998; Kawaguchi
et al., 1992; Koide et al., 1989; Koide et al., 1990; Landry et al., 1985; Matsushita et
al., 1991; Peshwa et al., 1996; Sakaguchi et al., 1991; Wu et al., 1999; Yuasa et al.,
1993). Increasingly, the importance of studying spheroid formation, morphology and
function using PPHs for use in BAL systems is recognized (Ijima et al., 1998; Lazar
et al., 1995b; Lazar et al., 1995a; Naruse et al., 1996b; Naruse et al., 1996a; Sajiki et
al., 2000; Sakai et al., 1996c; Sakai et al., 1996a; Sakai et al., 1996b; Sakai et al.,
1999). In contrast, no information is available for these cells grown in the unique
environment of simulated microgravity.
Unlike single cell rat isolates, PPHs naturally form small clusters of 5-20 cells
even after comprehensive collagenase digestion of the liver matrix. Intuitively, this
property of PPHs might be a beneficial attribute for the formation and study of
spheroid cultures. Indeed, freshly isolated PPHs seeded directly into different
bioreactor designs are maintained as quasi, 3 dimensional culture configurations in
several BAL devices, with reportedly improved biological performance (Bader et al.,
2000; De Bartolo et al., 2000; Iwata et al., 1999; Kong et al., 1996). Using a
different approach, Naruse et al., (1996b), pre-cultured PPHs as spheroids for 24
hours in spinner flasks and found 3D cellular formations to be functionally superior to
single cell suspensions immobilized in a non-woven fabric BAL module. Other culture
systems have utilised PPH spheroid cultures (Auth and Ichihara, 1998). PPH
spheroids cultured in defined medium, either entrapped in collagen gel or inert
alginate beads, result in cell-cell contacts which appear to enhance differentiated
function including albumin and urea synthesis, as well as P450 biotransformation and
glucuronidation activity, in comparison with monolayer and dispersed suspension
cultures (Lazar et al., 1995a; Lazar et al., 1995b; Wu et al., 1999). Maintenance of
such cell-cell contacts, as occurs in spheroid cultures, may well contribute to the
enhanced differentiated cell function observed (Bhatia et al., 1999).
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Porcine liver cells, with a mean viability of 87 %, inoculated into the HARV-
RCCS, formed several cellular aggregates approximately 2-5 mm in diameter within
24-48 hours and were successfully maintained in culture for a preset period of 12
days. This contrasts with the 5-day culture period required to form spheroid cultures
using spinner flasks in unit gravity (Lazar et al., 1995c). Scanning electron
microscopy showed a tightly packed arrangement of cells organized as compact
spheroidal or ellipsoidal (see Figure 5.11) structures, often with more loosely
associated rounded parenchymal cells present on the aggregate surface (Figures 5.10-
5.11). Interestingly, Boonstra (1999) demonstrated that EGF-induced cell rounding,
an actin mediated process, was enhanced under simulated microgravity conditions.
Both our study and that of Khaoustov et al (1999) mentioned above, used
chemically-defined medium containing EGF, insulin and dexamethasone. Studies have
demonstrated that both were essential supplements for successful formation of
floating rat hepatocyte spheroids cultures (Kawaguchi et al., 1992; Yuasa et al.,
1993). In contrast, Hsiao et al., (1999) demonstrated that serum promotes
disassembly of rat hepatocyte spheroids cultured in spinner vessels. Using our defined
William's E medium formulation, we have shown that PPHs cultured under simulated
microgravity conditions retain galactose elimination capacity, comparable with the
static cultures studied in Chapter 4, although both albumin and urea synthesis levels,
are only 50% and 20%, respectively of static values. However, on a per (viable) cell
basis, the RCCS cultures may exceed the static values (see below). Importantly,
unlike the latter cultures, functionality was maintained in the microgravity spheroids
up to day 12. Histological evaluation of aggregate transverse sections showed
consistent formation, up to the termination of the experiment on day 12, of cohesive
3D structures reminiscent of poorly organized hepatic architecture with some
hepatocytes arranged in cord-like structures (Figures 5.6 and 5.8), although these
were predominantly in the non-viable cell core. The latter was bounded by a viable
perimeter of glycogen positive cells, about 8-10 cells deep. Recently, Michalopoulos
et al. (2001) showed that isolated hepatocytes and NPCs in collagen-coated RBCs
formed structured histological formations bearing resemblance to characteristic
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hepatic histological organization. Hepatocyte growth factor (HGF), EGF, and
dexamethasone were required for complete histological organisation and phenotypic
maturation of the tissue construct, although functional studies were omitted.
Interestingly, Hamilton et al., (2001) found the HM medium formulation superior to
WE for spheroid formation, and for the maintenance of ultrastructure and albumin
production. The findings of this work and our own histological observations (see
below) and functional data, emphasise the need for additional studies focusing on the
hepatotrophic requirements for building reproducible tissue structures.
Table 5.1 summarises hepatic-specific function and compares our data for porcine
hepatocytes cultured as 3-dimensional spheroids in microgravity with other culture
systems in unit gravity. Since measured hepatocyte functions, culture conditions and
duration vary greatly between research groups which make direct comparisons
difficult, values quoted are for day 6 measurements only, normalised to the number of
cells initially seeded. The biochemical data in our study, is normalised (per million
cells) to the number of cells initially seeded in the RCCS. This is because the
aggregates were required for morphological analysis at the end of each experiment
and destructive biochemical assays, such as total protein (or indeed LDH and
cytochrome tP450 levels) measurements, could not be made. This is an obvious
drawback in RCCS studies and is compounded by the limited number of (HARVs)
culture vessels available using this set-up.
Lazar et al. (1995c) cultured PPHs as spheroids using standard spinner flasks
in serum-free WE containing similar levels of EGF, insulin and dexamethasone as our
study, and reported basal USR of «170 nmol/hr/ 106 seeded cells at day 6 which
declined to «70 nmol/hr/ 106 cells by day 12; ASR was maintained at «2 pg/hr/ 106
cells up to culture day 20. In agreement with others (Dr P Gregory, Organogenesis
USA, personal communication), we found that ammonium chloride-stimulated assays
produce about 3x more urea than in the basal state (not shown). The higher basal
functional values of normal gravity spheroid cultures of Lazar, and enhanced ASR,
suggest smaller spheroids in unit gravity cultures are functionally more efficient than
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Table 5.1 Hepatic-specific functions of 3-dimensional porcine
hepatocyte cultures compared with monolayer cultures and in vivo data
Modality: USR ASR GE References
Day 6 cultures nmol/hr/106 cells pg/hr/106 cells nmol/hr/106 cells
Spheroid (SF) 170 (basal) 2.1 ND Lazar et al.,
Monolayer 70 (basal) 0.6 ND 1995c
Spheroid (CE) 140 (basal) 2.1 ND Lazar et al.,
Dispersed cells 70 (basal) 0.6 ND 1995c
Spheroid (BAL) 200 (1mM NH4CI) 6.0 ND Naruse et al.,
Spheroid (SF) 100 (1mM NH4CI) 4.2 ND 1996a
Cell Aggregates 270 (basal) 0.6 ND Pahernik et
(NWP biomatrix) al., 2001
Spheroids (SF) ND 0.7 ND Sakai et al.,
Spheroids (CE) ND 0.4 ND 1996a
Monolayer ND 0.3 ND
Cell Aggregates ND ND 45 Iwata et al.,
















Spheroid: RCCS 108 0.8 317 Present data:
Monolayer 448 2.0 179
(6mM galactose)
Hepatic-specific functions of porcine hepatocytes cultured as 3-dimensional
spheroids in unit- or micro-gravity, as small cell aggregates or collagen-
entrapment cultures, compared with monolayer cultures and in vivo data.
Since measured hepatocyte functions, culture conditions and duration vary
greatly between research groups which makes direct comparisons difficult,
each value represents the quoted mean values for day 6 measurements,
normalised to the number of cells initially seeded. In vivo values are shown
for human and pig livers. The galactose and NH4CI loading doses' are
shown in parentheses. Abbreviations: ASR, albumin synthesis rate; BAL,
bioartificial liver bioreactor; CE, collagen-entrapment; GE, galactose
elimination; ND, not determined in referenced study; NWP, nonwoven
polyurethane biomatrices in petri dishes; RCCS, rotary cell culture system
microgravity cultures; SF, spinner flasks; USR, urea synthesis rate.
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much larger RCCS spheroid cultures (see Figures 5.3 and 5.5). Moreover, the BAL
module of Naruse et al. (1996a), mentioned above, showed significantly higher
albumin and urea production than RCCS cultures despite using only half the NH4C1
concentration in the latter assay, as was used in our cultures (see Figure 2.5). Finally,
the functionality of monolayer cultures (Chapter 4) was, apart from galactose
elimination capacity, significantly more efficient than microgravity cultures. Taken
together, the RCCS modality does not appear to confer significant advantage over
more conventional spheroid culture systems in terms of hepatic-specific function.
Metabolic activity was nevertheless retained in microgravity cultured cells up to day
12, whereas static cultures had expired after one week in culture on tissue culture
plastic. Functionality of the viable cell population, calculated on a per cell basis, may
however be more efficient in the RCCS (see below). Also, recent work in our
laboratory showed sustained metabolic activity of RCCS cultured cells for a
predetermined period of 21 days (Dabos et al., 2001). Glucose metabolism, glutamine
synthesis and ketogenesis were assessed using 'H nuclear magnetic resonance
spectroscopy of the culture medium. After an initial 10-day period of acclimatisation
cell aggregates formed in the RCCS-HARV switched from the anaerobic to the more
efficient aerobic pattern of metabolism, which was exhibited until the experiments
were terminated. Further experiments require to be undertaken to assess the impact of
these data on hepatic-specific function, as well as in determining the prospective
longevity of cells maintained in this culture system.
The majority of viable hepatocytes most likely reside in the outer rim of
aggregates (Figures 5.6, 5.8 and 5.14), probably as a consequence of mass transfer
constraints. To estimate the fractional volume of viable cells in the aggregate rim, two
diameters (x, y) at right angles to each other were measured for both the external
boundary of viable cells (giving, Total Volume of Spheroid) and for the inner
boundary of viable cells (giving, Volume of Necrotic Core) for typical histological
preparations of aggregates (2-5 mm in diameter), using an eyepiece graticule in an
inverted microscope.
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The Percentage Volume Fraction (PVF) was calculated as:
PVF = (Total Volume of Spheroid - Volume ofNecrotic Core) x 100
Total Volume of Spheroid.
The PVF or proportion of viable cells within an aggregate was calculated as
approximately 5 %. Since these viable cells comprise roughly 1 /20th of the total
number of cells within an aggregate (see Figure 5.6, panel B), the actual value for
urea synthesis and the other functional measurements on a per cell basis may be
considerably greater than the values measured (see Figures 5.3-5.5). However, four to
five aggregates were often observed in the FIARV culture vessels, so reducing the
functional (per cell) value. Also, smaller aggregates frequently rafted together,
forming a macroscopic ensemble of loosely attached aggregates. Upon sampling and
processing for subsequent morphological analysis however, this large assembly broke
up into smaller aggregates, so making a precise determination of the number of
'autonomous' spheroids difficult.
The histological observations presented in our study highlight a significant
limitation of culturing relatively large cellular aggregates under simulated microgravity
conditions. Mass transfer kinetics of oxygen and other nutrients is limited to <200 pm
across multi-cell layers (Kim and Mooney, 1998; McClelland and Coger, 2000),
comparable to the thickness of the viable cell rim in our spheroid aggregates.
Although RCCS microgravity cultures permit formation of much larger 3D structures
than appears to be possible using conventional spheroid culture systems, the downside
is that cells located beyond the 200 pm threshold depth, as observed in our study, do
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show evidence of hypoxia-induced cellular necrosis and apoptosis (Mueller-klieser,
1997; Riva et al., 1998). These results are in conflict with the assertion of a high mass
transfer and oxygenation capacity of the HARV-RCCS modality (Spaulding et al.,
1993; Unsworth and Lelkes, 1998). In comparison though, spheroid formation in unit
gravity achieve a range of spheroid sizes of 50-160 pm in diameter, containing -100
cells, which exhibit good viability throughout the 3D structure (Lazar et al., 1995c;
Sakai et al., 1996a). These studies make it clear that other environmental cues are
certainly required to improve the efficacy of the RCCS (discussed below).
A seeming advantage of the microgravity environment over conventional
culture systems in unit gravity is that the 'ffeefall fluid orbit' of the aggregates
facilitates growth in all directions, since no single gravity vector dictates the direction
of growth. Assuming an average diameter of 25pm for a porcine hepatocyte and cell
compaction in a 5 mm diameter spherical aggregate as evidenced histologically, the
total number of cells per spheroid may be up to 8x106, with in the order of 4x105
viable cells. Considering the inoculum was 107 cells per HARV and several aggregates
were often observed, one may speculate whether ceil proliferation occurs in the viable
cell population under these conditions. Indeed, day 10 RCCS cultures were positive
for the Ki67 proliferation marker (not shown). Interestingly, Yuasa et al., (1993)
showed that rat hepatocytes remained in the quiescent, G0 phase of the cell cycle,
conducive to more differentiated morphology and function compared with subsequent
culture of the spheroids in monolayer in which they flattened, spread and entered Gi
with concomitant reduction in albumin synthesis. We observed similar morphological
phenomena when spheroid fragments were transferred to TCP dishes (Figure 5.19).
Defining the conditions for expansion of the cell population whilst maintaining
differentiated function, remains a major challenge in tissue engineering and would be
an important factor in future studies which seek to optimise spheroid culture systems.
Mass transfer constraints are a common problem with BAL design
configurations. For example, in the hepatocyte gel-entrapment bioreactor module of
Nyberg et al., (1993), where cell suspensions are inoculated intraluminally within
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hollow fibre membranes, both oxygen uptake rates and cell viability (<50 %)
decreased with increasing gel depth (Balis et al., 1999). Similary, Hu et al., (1997)
reported decreased cell viability when the hollow-fibres in the bioreactor, which were
similar in scale to Nyberg's study, incorporated hepatocyte spheroids.
Morphological analysis revealed some conflicting results. Aside from the
histological observations, transmission electron microscopy (TEM) analysis,
presumably of samples derived from the rim of viable hepatocytes, showed some
ultrastructural characteristics of polarized epithelial cells. Intact cytoplasmic
organellar structures and glycogen granules are features reminiscent of fresh fiver
tissue (see also Chapter 3, Figure 3.3). An asymmetric distribution of organelles was
sometimes observed however, which may be a consequence of the centrifugal force
on the cells. Further evidence of cell polarity in the viable cell population comes from
both the ability of these cells to metabolise FDA (Figure5.18) and the expression of
the cell adhesion receptor, integrin a5 (Figure 5.17). The latter is considered to be
important in morphogenesis and maintenance of tissue architecture (Giancotti and
Ruoslahti, 1999; van der Flier and Sonnenberg, 2001). Integrin receptors are normally
present in the sinusoidal or basal domain in vivo where they recognize fibronectin
(integrin a5), and other ECM components including laminin, collagen and
proteoglycans (Desmet et al., 1994). FDA metabolism was demonstrated in day 12
spheroids (Figure 5.18) by the intense green fluorescent staining of the apical (bile
canalicular) domain, although it was difficult to distinguish individual cells in the
multicellular aggregate fragment. These findings are in agreement with Absu-Absi et
al., (2002) and Yumoto et al. (1996) who have demonstrated structural and
functional bile canalicula in rat hepatocyte spheroids. Uptake and metabolism of FDA
is considered a good marker of functional polarity and canalicular function (Strain,
1999), however excretion into the bile canalicular-like channels could not be resolved.
The intensity of fluorescence has been shown also to correlate with cell viability and
hepatic-specific function (Nyberg et al., 1993). As suggested by Mitaka et al., (1999),
the lack of a normal drainage system for bile caused retention of fluorescence and the
observed dilatation (Figure 5.18). Further immunocytochemical studies are required
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to confirm cellular polarity, as in the study of Absu-Absi et al., (2002), using domain-
specific probes, for example to confirm the presence of the apical-specific protein
dipeptidylpeptidase (DPPIV), and E-cadherins in the lateral domain, important in cell-
cell interactions. Bit Plane 3D Imaging software could also allow three dimensional
reconstruction of (0.4|om) optical sections of confocal stacked images, to assess the
precise topology of structural proteins involved in maintenance of polarity and cell-
cell, cell-matrix interactions. For example, if no porcine antibody or cDNA probes
were available, a fluorogenic substrate of DPPIV, Ala-Pro-cresyl violet, could be
utilised since DPPIV cleaves the substrate at the proline residue releasing the
fluorescent cresyl violet molecule, which may be detected using confocal imaging.
Most of the TEM sections we observed however, revealed non-viable,
damaged hepatocytes (not shown) probably originating from the aggregate core.
Khaoustov et al., (1999) observed similar histological phenomena and suggested that
the aggregate's core was composed mainly of necrotic and apoptotic cells. We
observed condensed nuclei and loss of integrity of hepatocyte borders in support of
these findings (Figures 5.6 and 5.8), although the cytoplasm of many core hepatocytes
was found to be eosinophilic (Figures 5.7), suggesting mitochondria and cytoplasmic
proteins may still be present (Junqueira, 1977).
To confirm the viability of aggregates we cultured samples taken at days 6 and
12 (Figure 5.19) from the HARV-RCCS onto tissue culture plastic and observed
attachment and formation of hepatocyte monolayers radiating from the cell aggregate
base which detached from the dish surface after one week, as observed for static
cultures (Chapter 3). In addition, acridine orange fluorescent staining of 12 day old
HARV-RCCS cultured aggregates confirmed viability, at least of the outer, 10 cell
deep PAS positive layer of cells (Figure 5.14).
Given the importance of the ECM, via integrins, in modulating hepatic cell
migration, differentiation and polarity (Selden et al., 1999), reticular staining of
spheroid sections was performed but did not confirm the presence of collagen matrix.
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However, immunocytochemical studies have revealed that the 'reticulin fibres'
demonstrated by empiric silver impregnation correspond to collagen types I and III
(Desmet, 1994). ECM deposition by spheroid cultures has been demonstrated.
Interestingly, spheroid cultures of rat liver cells described by Landry et al., (1985) and
Tong et al., (1990) observed, using immunostaining techniques, the formation of a
thin layer of NPCs encapsulating the spheroid and deposition of ECM containing
fibronectin, laminin and collagen delineating the entire spheroidal structure (LeCluyse
et al., 1996). The presence of type IV collagen or other components of the ECM in
PPH microgravity spheroid needs to be clarified, as soon as suitable antibody or
cDNA probes become commercially available.
Primary porcine hepatocytes express the extracellular matrix (fibronectin)
counter receptor, integrin a5, in freshly isolated cells (Figure 15), static cultures up to
day 2 (Figure 16) but not day 6, while it is expressed in the HARV-RCCS to day 12
(Figure 17). The static WE-maintained cultures ability to express integrin a5
correlated with ultrastructural indicators of differentiated function (see Chapter 3,
Figure 3.5), both of which were lost by day 6. Thus, simulated microgravity
conditions appear to support expression of this integrin class, which may also provide
indirect evidence for the presence of its counter-receptor, fibronectin. Integrin a5 is
part of the fibronectin receptor heterodimer, (X5P1, transmembrane cell surface
receptor. We hypothesized that expression of integrin a5 is important in simulated
microgravity culture, since it is intimately involved in the coordinated control, along
with various growth factors including EGF, of cell shape, growth, movement and
survival, important for the establishment and maintenance of tissue architecture
(Giancotti and Ruoslahti, 1999). This control is achieved by the congress of integrin
clusters. In essence, upon binding of cellular integrins to matrix proteins, assembly of
these components takes place in association with cytoskeletal (CSK) and adaptor
proteins, forming focal adhesion complexes (Berman and Kozlova, 2000) (Figure
5.20). The ECM-integrin-CSK axis thus formed permits bi-directional integrin
signalling allowing mechanical and biochemical signal transduction and the
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Figure 5.20 The ECM-Integrin-Cytoskeletal Axis (large 3D-arrow). Binding of
ECM components, such as fibronectin, to integrin receptors (ap heterodimers)
promotes integrin clustering (closed arrows) forming supramolecular complexes
called focal adhesion sites, comprised of adaptor proteins such as focal adhesion
kinases (FAK), which are associated with cytoskeletal elements (eg B-tubulin and/or
actin). Activation of the intracellular signalling pathways can activate cell regulatory
processes such as nuclear gene expression (open arrow), cell attachment, movement,
and survival (Figure adapted from; Giancotti and Ruoslahti, 1999; Holly et al.,
2000;Sastry and Burridge, 2000).
5-53
It is suggested that the ECM-integrin-CSK axis is, in effect, 'hard-wired' for
mechanotransduction (Ingber, 1999; Ingber, 1997). Demonstrating the presence of
this signal transduction axis in simulated microgravity cultured aggregates, may
provide evidence of the role of focal adhesion complexes in cellular sensing of the
microgravity environment.
In preliminary studies, we attempted to demonstrate the presence of key
components of this axis using immuno-fluorescent staining and confocal microscopy.
We used speculative antibodies (ie not specific, pig antisera) directed against
fibronectin, integrins a5 and a3, B-tubulin, and focal adhesion kinase as
representative of the ECM, integrin, cytoskeletal, and signal transduction elements,
respectively. Following single, double or triple immuno-fluorescent staining and
confocal microscopy analysis, only integrin a5 stained positive in RCCS-grown cell
aggregates. Indeed, only integrin a5 showed cross-reactivity following dot blotting
(Section 5.3.6). Clarification of the presence of these components would require in-
house development of specific anti-porcine antibodies.
As mentioned, Peshwa et al., (1996), demonstrated that cell movement and
reorganization were involved in spheroid formation, implicating a mechanistic role for
integrins. Given that PPHs readily attach to plastic culture surfaces without
exogenous matrix proteins and that the fibronectin counter receptor, integrin a5 is
expressed in RCCS cultures and day 2 static WE cultures, may suggest that PPEls (or
'contaminating' NPCs) can synthesize fibronectin locally, although this could not be
confirmed by immunostaining. In fact, rat and human hepatocytes, which have an
absolute requirement for exogenous matrix proteins for attachment, can synthesize
and secrete cellular fibronectin in vitro (Christiansen et al., 1988; Odenthal et al.,
1992).
Deposition of fibronectin may be beneficial in promoting 3D cytoarchitecture.
Sanchez et al., (2000) demonstrated that this matrix protein facilitated the formation
of liver plate-like structures and expression of liver-specific genes in foetal rat
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hepatocytes suggesting fibronectin partakes in polarization of hepatic tissue.
Furthermore, the a5pi integrin, induces expression of the anti-apoptotic protein Bcl-2
(Giancotti and Ruoslahti, 1999), protecting cells from apoptosis from a variety of cell
stresses. Of course, further studies are required to identify the presence of fibronectin
or other components of both ECM and corresponding focal adhesion complexes,
using western immunoblotting or confocal microscopy. Unfortunately, specific
antibodies directed against porcine-derived cellular components are not commercially
available at present.
The findings presented here recommend that many improvements are required
to prove the microgravity spheroid cultures beneficial for clinical BAL use. Utilising
strategies which have been employed to improve the hepatic culture environment in
both unit gravity and microgravity, it may be possible to reduce the relative size of the
necrotic core, improve overall viability and metabolic function of 3D cell aggregates
cultured in simulated microgravity. While the present study provides some evidence in
the viable cell population of rather poorly organized hepatic proto-tissues in RCCS-
grown aggregates, they clearly do not recapitulate the phenotypic diversity of parental
tissues. Important components are absent, including the correct ratio of parenchymal
cells (PC) to non-parenchymal (NPC) cells, tissue-specific autologous matrices and
vascularization of the engineered tissue. Heterotypic coculture between PC and NPC
cells in conventional cultures, provide for cell-cell interactions which have been
demonstrated to preserve liver-specific functions and phenotype in vitro (Bader et al.,
1996; Bhatia et al., 1998b; Bhatia et al., 1998a; Bhatia et al., 1999; Duray et al.,
1997; Gerlach et al., 1995; Glicklis et al., 2000; Yuasa et al., 1993). For example,
Michalopoulos et al., (1999) used roller bottles to maintain phenotypically stable 3D
cultures of a mixture of rat PC (hepatocytes) and a 'contaminating' NPC population
of 5 % which attached to collagen coated polystyrene beads. Expression of both
albumin and cytochrome P450 species, and structures reminiscent of hepatic
architecture, such as formation of hepatocyte guided plates, was retained for up to 2
months. However, we found that attachment of PPHs using identical microcarrier
beads and a similar PC:NPC ratio as in the former study, was very poor in the HARV-
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RCCS (data not shown). Mitaka et al., (1999) on the other hand, cultured a 50 %
NPC:PC (containing both small and mature rat hepatocytes) mix of rat hepatic cells
on collagen coated static culture dishes which showed proliferation, synthesis of ECM
proteins and formed 3D colonies ofacinar-like structures.
In the context of simulated microgravity cultures, provision of the necessary
cues for organotypic reconstruction of native liver is a formidable task, requiring,
amongst other considerations, a systematic assessment of the precise ratio ofPC:NPC
cells which may optimise phenotypic and functional stability as well as defining the
most favourable biochemical environment of both the culture medium and biomatrix
components. Coculture of rat or porcine hepatocytes with murine 3T3 cells have been
shown to induce the highest levels of albumin production by hepatocytes (4.2 to 15
pg/h/ 106 cells (Bhatia et al., 1999; Gregory et al., 2001). However, the latter study
by Gregory et al., (2001) found no effect on urea synthesis or P450 activity compared
with standard control cultures.
Primary human liver cells (PHLC) cocultured with an NPC fraction
(containing fibroblasts, Kupffer cells, endothelial cells and bile duct epithlelial cells)
under simulated microgravity conditions formed 3D liver tissue-like structures with a
markedly reduced non-viable core of cells compared to homotypic hepatocyte cultures
(Khaoustov et al., 1999; Yoffe et al., 1999). However, neither the PC:NPC ratio nor
functional activity of the spheroids were documented. The quality of PHLC cocultures
was further enhanced by the use of polyglycolic acid (PGA), a non-toxic
biodegradable synthetic polymer scaffold, resulting in more efficient cell assembly,
much larger viable cell aggregates of up to 3 cm with, albeit limited, formation of
nascent vascular 'sprouts'. Scaffolding is considered to be a critical component in
tissue engineering since it provides 3D cues for cell seeding, migration, growth, and
morphogenesis (Sundback and Vacanti, 2000).
Due to the inherent limits of nutrient diffusion mentioned above,
vascularization of engineered tissue seems critical for the formation and maintenance
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of large cellular constructs to facilitate metabolic transport of oxygen and nutrients
and removal of waste products (Kim and Mooney, 1998; Unsworth and Lelkes,
1998). This could be achieved in the microgravity bioreactor by incorporating the
appropriate levels of angiogenic factors such as vascular endothelial factor,
hyaluronidase, and migration stimulating factor (Prof. SL Schor, University of
Dundee, personal communicatin), as well as sinusoidal endothelial cells and
bioengineered tubular scaffolds with which to form such blood vessel conduits,
perhaps incorporated into the PGA scaffolds mentioned above.
Delineation of the optimal conditions under simulated microgravity, necessary
for the in vitro replication of in vivo liver architecture, phenotype and function
remains a major challenge. Preliminary results using the HARV-RCCS modality
suggest determination of the appropriate seeding density, coculture ratios and
interactions, matrix component(s) and angiogenic factors, alluded to above, will allow
appropriate design criteria for more efficient BAL devices. In engineering terms scale-
up of the RCCS utility for provision of adequate cell mass is not problematic
(Synthecon, Technical Services), whereas incorporation of optimised spheroids into
current BAL devices is feasible (Allen et al., 2001) Ultimately, success in this
endeavour would result in bioreactors that require less hepatocellular mass, have




6.1 Bioartificial liver devices
Bioartificial liver support systems incorporating primary porcine hepatocytes are a
promising modality with which to treat acute liver failure. Many BAL device
configurations are under development around the world. In fact, clinical trials are
already underway, using the HepatAssist 2000 developed by Circe Biomedical
(Watanabe et al., 1997). However, despite the use of PPHs as the principal
xenogeneic source for BAL devices, published data characterising both porcine
hepatocyte biochemical functionality and morphology under defined culture
conditions is very limited. Moreover, it is difficult to make direct comparisons of
bioreactor efficacy because each research group uses different culture media and
supplements, biomatrices and bioreactor design configurations to maintain cell
function in vitro. Given that the pathophysiology of acute liver failure is not well
defined, clinically effective PPH-based BAL designs should maintain a range of
differentiated hepatic support functions. Notwithstanding this, many issues relating
to optimisation of bioreactor device configuration to maximize hepatocyte function
remain unresolved. The ability to maximize porcine hepatic support functions would
contribute significantly to the development of ergonomic BAL designs, which
provide the required cell mass for optimal performance. The work presented in this
thesis addresses some of these issues.
6.2 Thesis aims
The principal aims of this thesis were to develop a high viability, high yield,
reproducible ex vivo method for obtaining PPHs and to characterise different PPH
culture conditions, under defined conditions, using functional and morphological
criteria for use in BAL devices.
6-1
6.3 Summary of experimental results
In this study, our method provides a high viability, high yield and rapid isolation
technique, which is easy to perform in a standard research laboratory. Outcome is
similar to most in vivo protocols reported, although improved yield and viabilities are
attainable with the latter. Nevertheless, the method obviates the need for relatively
complex, in vivo surgical techniques and facilities, which are time-consuming and
require highly trained, licensed personnel. Cells can be deployed in a variety of in
vitro liver model systems in under two hours, whilst maintaining viability and
hepatocyte functionality. In this study, yield, viability and function of isolated
hepatocytes compare favourably with results obtained using in vivo techniques.
Primary porcine hepatocytes were cultured in separate medium formulations
(commonly used in BAL systems) with serum-free, chemically-defined supplements.
It was demonstrated that high plating efficiencies and viability on biomatrix-free
(unmodified) tissue culture plastic can be maintained in the absence of serum or
sophisticated substrate for attachment, up to day 6. Image analysis data proved more
discriminatory, in assessment of cell attachment efficiencies, than assessment of total
protein, or viability using LDH activity. Cellular biomass, compatible with retention
of functional activity, is maintained up to culture day 6. Hepatocytes maintained in
Ml99 and WE media formulations preserve ultrastructural and gross morphological
features of healthy cells up to culture day 4. In contrast, HM- and M1640-grown
hepatocytes, exhibit features of damaged or unhealthy cells even on day 2.
Morphological observations suggest that 6 day old hepatocyte cultures may not be
compatible for use in cell based therapies. Thus, selection of the most appropriate
medium formulation may be a significant factor in experimental liver culture
systems, as it appears to modulate gross hepatocyte morphology, ultrastructure and
possibly function.
In this culture environment, hepatocytes show variable effects on functional
activity depending on the medium formulation and / or culture age. The HBAI utility
for multiple comparisons, reinforced by morphological observations, ranked the
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media on day 2 as: M199>WE>M1640>HM, with M199 retaining primacy up to day
6. The gross and ultrastructural morphological observations, and image analysis data
presented in Chapter 3, suggest Ml99 best preserves characteristics of differentiated
hepatocytes in vivo up to culture day 4, which is the time frame for current
operational BAL usage, with high attachment efficiency. Using this utility, it is
concluded that Medium 199 may be one of the most suitable synthetic media for
culturing PPHs under serum-free chemically-defined conditions for BAL systems.
The HBAI presented here provides some measure of global functional activity of our
hepatocyte culture system, with important caveats. The HBAI may be only useful in
the limited context of assessing multiple comparisons.
The functional data for day 2, which is in the time frame for BAL device
implementation, showed that USR, ASR, tP450, and GE functions for test media,
were up to 300%, 90%, 20%, and 50%, respectively, of in vivo values for human
liver. Medium 199 gave the highest mean values of plating efficiency, viability, and
albumin synthesis rates than the other media tested up to day 4, although the
differences were not always statistically significant. By day 4 of culture, both Ml640
and HM pre-cultured cells showed significantly greater urea synthesis rates than both
WE and Ml99 maintained cells. There was a 66% decrease in total cytochrome P450
content in 2-day-old cultures compared with fresh cells, whereas HQV1 maintained
cells preserved significantly higher day 4 tP450 levels than both WE and M1640
conditioned cells. Galactose elimination (GE) was significantly higher in day 2
cultures in all test media compared with both days 4 and 6, which then remained
relatively stable thereafter. The albumin synthesis rate tended to increase in all media
up to day 6. Furthermore, parallel morphological studies indicated that different
medium formulations modulate gross and ultrastructural morphology of hepatocyte
cultures. These findings may be of relevance when choosing an appropriate medium
for porcine-based BAL devices, which require rapid attachment of high viability
cells with significant ammonia detoxifying capacity, whilst maintaining
biotransformation potential and a diverse functional profile.
Cells cultured in the HARV-RCCS, simulated microgravity environment,
formed cellular aggregates approximately 2-5 mm in diameter within 24-48 hours
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and were successfully maintained in culture for a preset period of 12 days. The
HARV-RCCS modality retains stable, liver-specific synthetic, detoxification and
metabolic functions of PPHs over a 12 day culture period. Morphological and
ultrastructural features characteristic of 3D hepatocyte cultures were observed
throughout the culture period. The presence of bile canalicular-like structures, and
integrin a5expression, suggest the viable cell population maintained a differentiated,
3D cytoarchitecture with evidence of polarity. Under these conditions, large
aggregates formed a rim of viable cells circumscribing a core of non-viable cells,
which displayed only partial restitution of in vivo hepatic architecture. Further study
is required to enhance the viable cell population, phenotype, polarity and thus
functional activity of such liver constructs, for future therapeutic use.
6.4 Future work and perspectives
From a practical point of view, rapid deployment of freshly isolated PPHs into a
BAL device would be the ideal scenario, since these cells are superior to cultured
hepatocytes both metabolically and in terms of differentiated function (Guillouzo et
al., 1997). Microcarrier-attached PPHs, obtained using an in vivo procedure and
cryopreserved, have been used in BAL devices (inoculated with 5 x 109 cells) to treat
FHF (Demetriou, 1998; Rozga et al., 1993a; Watanabe et al., 1997). However, since
cryopreservation of large numbers of high viability PPHs for on-demand usage has,
historically, proven difficult (Darr and Hubel, 1997; Strain, 1994), the fact that our
simplified procedure takes less than 2 hours from animal sacrifice to the isolation of
purified cells, and could accommodate any scaled-up BAL currently under
development, is highly advantageous.
Although freshly isolated cells showed high viability, improvements in this
technique are desirable to achieve optimal BAL function. Wang et al., (2000)
investigated 21 multivariables including pig body and liver weight, collagenase
digestion times, a range of concentrations of Na+ and CF, as well as pH in perfusates.
Viabilities >90% and increased P450IA1 activity were consistently achieved by
strictly controlling the Na+ and CI" perfusate concentrations. Further refinement of
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the isolation technique, ongoing in our laboratory, using digitonin-collagenase
perfusion, can allow differential isolation of perivenous and periportal hepatocytes
for use in studies of heterogeneous hepatocyte function pertaining to BAL and other
applications, including hepatocyte transplantation.
Further work is required to establish precisely how long PPHs should be
cultured in a bioreactor for optimal BAL support. Flendrig et al., (1998b)
demonstrated that prolonging culture recovery time of freshly seeded PPHs from 14
to 38 hours improved cell performance and BAL efficacy. Unger et al., (2000)
concluded that hepatocyte nutrition with WE medium during this 'standby' period,
influenced the metabolic functional profile and efficacy of their bioreactor, when
compared with human plasma-perfused cells. It is assumed hepatocytes undergo a
'consolidation phase' during the first 24-48 hours of culture, whereby cells can repair
membranes, partially restore polarity and cell-cell interactions (Berry et al., 1991c),
and undergo proliferation (Wegner etal., 1992). The morphological observations and
functional data presented here suggest cells are most suitable for application in BAL
systems between days 2 and 4 of culture.
Related to this, is the question of the duration of BAL therapy. How long are
hepatocytes able to function effectively in their optimised state, in the presence of
'toxic' human plasma? Most PPH-based BAL devices are designed to be operational
for 4-8 hours of perfusion with heterologous plasma (Stefanovich et al., 1996;
Demetriou et al., 1998). Follow-up studies should be undertaken to assess PPH
performance in 'toxic' human plasma within this timeframe and beyond. Uchino et
al., (1991) reported that pig hepatocytes cultured for 3 days in human ALF plasma
maintained gluconeogenesis and ureogenesis equal to that of cells cultured in normal
human plasma or Leibovitz medium. However, Kawazoe et al., (1999) showed that
the viability of PPHs cultured in normal human plasma decreased to 37%, while
albumin synthesis was one third of that in DMEM controls. Moreover, nafamostat
mesilate, a protease inhibitor, had a favourable effect on these parameters. Washizu
et al., (2000) found that amino acid supplementation improves cell-specific functions
of rat hepatocytes exposed to human plasma. Elucidation of the potentially toxic
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effects of ALF plasma and mechanisms of cells death may allow for BAL
cytoprotective strategies to be developed.
Clearly, a systematic study of PPH attachment efficiency and function on the
many and varied hollow-fibre biomembrane materials used in BAL devices is
warranted. In terms of the biological component of BAL systems, there is evidence
that isolated hepatocytes arranged into multi-cellular formations, establish cell-cell
and cell-matrix contacts which result in improved differentiation and liver-specific
function, when compared with single cell culture monolayers (Ben-Ze'ev et al., 1988;
Bhatia et al., 1999; Khaoustov et al., 1999). Indeed Gerlach et al., (1995) have
demonstrated that PPHs readily attached to uncoated hollow fibre membranes
constructed of polypropylene, a synthetic material similar to that used in TCP dish
manufacture. Formation of cell aggregates may be achieved by culturing cells in a
simulated microgravity environment (Dabos et al., 2001; Khaoustov et al., 1999;
Yoffe et al., 1999) or as hepatospheroids on Primaria™ dishes (Koide et al., 1990),
providing an in v/vo-like liver micro-architecture promoting maintenance of viability
and differentiated functions. The use of serum-supplemented medium in this context
is controversial. Hsiao et al., (1999) demonstrated foetal bovine serum caused
disassembly of hepatospheroids and a decrease in cytochrome P450 1A/2 activity.
On the other hand, Sakai et al (Sakai et al., 1996a; Sakai et al., 1996b) showed that
culturing spheroids in suspension within rotating dishes or entrapped in collagen gel
in 100% porcine or human plasma could enhance ammonia detoxification compared
to conventional monolayer cultures. The use of bio-degradable scaffolds (see below)
optimised for cell-cell, cell-matrix geometry and heterogeneous functional activity
promises to be a major advance in promoting and sustaining vital differentiated
function required of a liver support device (Glicklis et al., 2000).
The precise reasons for the observed marked differences in morphology and
function up to culture day 4 between different media formulations are unclear. An
explanation proposed for this pattern may lie in the individual medium compositions.
Medium 199, and to a lesser extent WE, are media formulations which contain a
greater range of constituents (including inorganic salts, vitamins, cofactors and
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amino acids) with which to support hepatocyte culture compared with the other test
media. Although the hormone levels are the same for each test medium, a greater
pool of amino acids, in the presence of insulin, may enhance utilisation of this pool
and favour anabolic protein metabolism (Berry et al., 1991a). This could influence
cell attachment, membrane integrity and survival as well as favouring better
preservation of cell ultrastructure and hence differentiated functions. These effects
may be synergistic, acting in concert with the other hormonal supplements,
dexamethasone and L-EGF. Another possibility is that a broader spectrum of amino
acid concentrations are a requirement of the high density cultures used in our
experiments. High cell density, not only delays the loss of some differentiated
functions, but may well lead to a relatively more cuboidal, less flattened cell shape
(Ben-Ze'ev et al., 1988; Berry et al., 1991a). Hepatocytes with this topology display
ultrastructural characteristics of both cell aggregates and liver cells in situ (Berry et
al., 1991b; Gerlach et al., 1995; Sajiki et al., 2000), as do both M199 and WE
maintained cultures described here (see Figures 3.3, 3.5 and 3.7). Of course, other
hepatocyte culture media are commercially available and routinely used including:
DMEM, Chee's, and Modified Earl's Medium. (Berry et al., 199b, 1991d). Testing
all media formulations and all combinations with the numerous, potentially
beneficial supplements available, would require a major research undertaking.
In Chapters 3 and 4, it was shown that PPHs readily attached to biomatrix-
ftee TCP whilst maintaining viability and functional activity, as well as
morphological characteristics of differentiated cells up to day 4 of culture, at least in
WE and Ml99. Considering the wealth of evidence in other species, particularly rat,
it would be prudent to assess whether autologous ECM might enhance these criteria
of hepatic support functions for BAL systems. Equally, tissue engineered PPH
culture systems may allow for functional living tissue to be fabricated using
hepatocytes and NPCs seeded on highly porous, synthetic, biodegradable polymer
scaffolds, and permanently implanted to restore hepatic function (Sundback and
Vacanti, 2000). Important liver functions cannot be enabled by use of purified,
homotypic hepatocyte cultures (Busse et al., 1999; Bhatia et al., 1999). Potential
benefits of NPC inclusion in cocultures (discussed below) include bile excretion and
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the phagocytic function of Kupffer cells. However, the possibility of antigenicity
from the NPC coculture fraction should not be underestimated (Demetriou, 1998a),
and needs to be investigated further.
Since the liver serves as the primary site of detoxification of an enormous
range of natural, synthetic, and toxic substances in the systemic circulation, any BAL
system must be capable of dealing with this complex metabolism. Parallel
diminution in tP450 levels (Chapter 4) and functional activity is observed in swine
and other mammals (Donato et al., 1999; LeCluyse et al., 1996; Monshouwer et al.,
1998; Olsen et al., 1997). Determination of tP450 by CO-binding capacity does not
distinguish between the many P450 isoforms. Species differences in xenobiotic
metabolism are also well recognised (LeCluyse et al., 1996). Future studies would
characterise a much wider spectrum of porcine P450 species utilising both
'speculative' antibody homologues or, ideally, pure anti-porcine antibodies could be
developed via protein purification through expression vectors, as the pig genome
project unfolds (Professor JI Mason, Personal Communication). Moreover, as the
requirements ofBAL system detoxification are more clearly identified, P450 enzyme
induction could be tailored accordingly.
Hepatocye functional activity can be augmented in vitro. Cytochrome P450
isoenzymes can be induced using a variety of inducers including phenobarbital or
dexamethasone. This results in both increased tP450 content and P450-mediated
enzyme activities including testosterone hydroxylation, caffeine demethylation, and
induction of the pig CYP3A4 isoform, an important inducible enzyme involved in
the metabolism of many drugs in humans (Desille et al., 1999; Li et al., 1995;
Monshouwer et al., 1998; Olsen et al., 1997). Suprisingly, few intervention strategies
have been designed to manipulate pig liver in vivo or in vitro, in order to condition
cells which may enhance bioreactor efficacy. Porcine xenobiotic metabolism could
be further characterised by establishing whether in vivo and/or in vitro intervention
with high dose dexamethasone or phenobarbital enhances hepatic Phase I and II
isoenzyme expression and function in vitro under defined conditions. In our culture
system, use of the P450 inducer, dexamethasone could be confounding when
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assessing either tP450 or functional activity, since, precisely which individual
enzymes are present in pig liver, or are modulated by induction remains unclear.
Alternative approaches to enhance the hepatic culture environment should
also be investigated. Supplementation of optimal media with DMSO (combined with
dexamethasone) or retinoic acid, can maintain or re-establish hepatocyte culture
morphology, differentiated morphology and function (Arterburn et al., 1995; Mitaka
et al., 1998; Falasca et al., 1998) Nicotinamide could also be used to maintain the
capability of cell growth (Mitaka et al., 1998), required during the attachment and
growth phase for pre-clinical BAL devices.
Culture of hepatocytes as hepatospheroids offers great potential for
improving culture longevity, morphology and function. In retrospect, parallel spinner
flask or roller bottle cultures, using cells from the same pig isolation, would have
permitted a more direct comparison of differences in biochemical functionality and
morphology between RCCS-grown and conventional rotational cultures in unit
gravity. If we consider that the sinusoidal surface of liver is about 150 m2 and current
dialysers offer an exchange surface of 0.5-2 m2 (Busse et al., 1999), and their are
inherent limits to nutrient diffusion, vascularization of engineered tissue appears a
critical step. The formation and maintenance of large, vascularized cellular
constructs, would facilitate metabolic transport of oxygen and nutrients and removal
of waste products (Kim and Mooney, 1998; Sundback and Vacanti, 2000; Unsworth
and Lelkes, 1998). This could be achieved in the microgravity bioreactor by
incorporating the appropriate levels of angiogenic factors, sinusoidal endothelial
cells and bioengineered tubular scaffolds with which to form such blood vessel
conduits, perhaps incorporated into PGA scaffolds.
6-9
6.4.1 Potential disadvantages of xenogeneic cells in bioartifcial liver devices
Immunogenicity, zoonoses and biocompatibility are potential disadvantages of
xenogeneic cells for therapeutic use (Tsiaoussis et al., 2001):
Immunogenicity. Pre-formed IgM antibodies against porcine hepatocytes have been
reported in almost 7% of the healthy population leading to hyper-acute rejection in
xenogeneic organ transplantation. Consequently immuno-isolation using semi¬
permeable hollow-fibre membranes with 100 KDa molecular weight cut-off, have
been incorporated into many systems to prevent extensive porcine hepatocyte
necrosis and consequent flux of necro-inflammatory chemicals back into the patient.
The membranes may also protect against possible immunological compounds
escaping from xenogeneic tissue into the patient's circulation, although despite their
usage elevated titers of anti-pig IgM and IgG xeno-antibodies (primarily against A-
Gal epitope on pig hepatocytes) have been found following two or more treatments
with porcine- based BAL systems indicating that host exposure to porcine antigens
still occurs. The promising developments of transgenic animals with knock-outs for
Gal-epitope, and addition of nafamostat mesilate (a synthetic serine protease
inhibitor of complement with cytoprotective properties) to BAL systems, may
mitigate the problem of hyperacute rejection and human serum cytotoxicity
(Kawazoe et al., 1999) As yet, no adverse immunological reactions have been
reported with repeated usage of these systems over a prolonged period of several
days, but this may be due to the fact that patients with ALF are relatively
immunosuppressed and are unable to mount significant immune responses.
Zoonoses'. Standard health screening protocols are available to ensure that animals
are free of various pathogens. Of greater importance is the issue of Porcine
Endogenous Retroviruses (PERVs), which are incorporated into the porcine genome
itself. At present, it has not proven possible to remove PERVs from such
hepatocytes. There is no evidence to indicate any pathogenic role of PERVs in pigs,
but there has been concern that this may not be the case if human cells become
infected. Consequently, experiments have focused on transmission of PERVs to
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human cells and possible pathological sequelae. Demonstration that PERV particles
can be transmitted from porcine to human cells appear to confirm this. However, a
series of large studies has subsequently not demonstrated any evidence for the
transmission of viable virus with replicative potential. The distinction between
'simple' uptake of viral particles and the successful migration of PERVs and
potential adverse effects is of paramount importance in combating difficulties that
may arise. Whilst there is therefore no evidence of successful transmission of active
PERV from pig to human or even evidence of pathogenicity the issue is far from
resolved. Some countries have consequently implemented xenotransplantation
moratoria before permitting the usage of xenogeneic tissue. Ongoing studies are in
place to develop PERV-free pigs, although the possibility of transmitting hitherto
unknown zoonotic (or human) viruses will always remain a concern.
Biocompatibility. Whilst porcine hepatocytes may detoxify human toxins there are
concerns that products from different species such as coagulation factors, albumin,
growth factors and cytokines may not exert a similar biological response in humans.
It is worth noting however that porcine tissue, such as heart valves, pancreas
transplants and insulin have been used to good effect in human diseases for many
years now.
6.4.2 Key logistical and technical considerations
There are still key logistical and technical issues to be resolved in terms of
the ready availability of PPHs for on-demand usage, cryopreservation of cells, and
the critical functional liver cell mass required for effective support. Ongoing
hepatocyte culture within the bioreactor has the disadvantage of high costs (labour,
materials and time), as well as the limited 'shelf-life' of the hepatocytes. Several
bioreactors would have to be maintained concurrently if, for example the 6-hour
multiple treatment regime was adopted. Quality control tests of biochemical
functionality and microbial screening would be limited also. Cryopreserved liver
cells would have obvious advantages. However, despite their use in the
HepatAssist™ device, there is evidence that upon thawing, only 50 % of cells attach
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to plastic (compared to 80-90 % for freshly isolated cells (Chapter 3)), suggesting
compromised function (Darr and Hubel, 1998; Loretz et al., 1989). Further advances
in freezing protocols and optimisation of function, post-thaw, are required
(Tsiaoussis et al., 2001). The critical cell mass for effective BAL support is not
known. Current estimates from clinical studies of partial hepatectomy and treatment
of animal models of ALF with BAL systems (Busse et al., 1999; Demetriou, 1998;
Tsiaoussiss et al., 2001) suggest 20-40 % is required, corresponding to about 150 to
300 g of liver tissue for a 70 kg patient. Of the three bioartificial liver support
systems for which clinical data are available (see Table 6.1), there are also significant
• *9 9\
differences in the number of cells used to load the bioreactor (6 xlO to 100x10 )
which corresponds to 2-33% of normal liver mass (Sundback and Vacanti, 2000).
Specifically, the HepatAssist BAL device (Rozga et al., 1993a) contains
approximately 6xl09 cryopreserved porcine hepatocytes (30g; 2% of normal
hepatocyte mass), whilst the ELAD (Sussman et al., 1994) contains 40xl09
transformed C3A cells (200g; 15% of normal hepatocyte mass). A more complex
device (Gerlach et al., 1994b) contains lOOxlO9 porcine hepatocytes (500g; 33% of
normal hepatocyte mass). Other devices which are at a developmental stage contain
similar numbers of hepatocytes, for example, Bader's bioreactor (DeBartolo et al.,
2000) contains lOxlO9 porcine hepatocytes.
Table 6-1 Criltical Hepatic Cell Mass for BAL Systems
BAL System Cell Type No. of Weight Liver Mass Phase of
Cells (g) (%) Development
1
HepatAssist Porcine 6 x 109 30 2 Clinical
2ELAD C3A 40 x 109 200 15 Clinical
3Gerlach Porcine 100 x 109 500 33 Clinical
4Bader Porcine 10 x 109 50 3.3 Experimental
Notes: The number of hepatocytes varies significantly from as low as 2% to
33%. The Percentage of liver cell mass is derived from a value of a human
liver of 1.5 kg. References: 1 Rozga et al., (1993a); 2Sussman et al., 1994;
3Gerlach et al., 1994b; 4DeBartolo et al., 2000.
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Human hepatocytes are considered the ideal cellular component to fulfil
hepatic support functions for BAL systems. However, the growing disparity between
the numbers of donor organs and patients requiring OLT precludes their use in this
setting. The development of genetically-engineered immortalized human cell lines,
with fully differentiated normal hepatic support functions, would alleviate both the
logistical constraints and disadvantages associated with using xenogeneic cell
sources. As an alternative to tumour-derived lines such as C3 A or HepG2, mentioned
previously, reversibly immortalized cell lines have been developed. For example, the
NKNT-3 line, has been heralded as a breakthrough for hepatocyte transplantation.
Produced by retroviral transfection of normal primary human hepatocytes with the
Simian Virus 40 large T antigen, NKNT-3 cells have been shown to express key
genes of liver metabolism and produced significant biochemical and clinical
improvements in 90 % hepatectomy rats when infused into the spleen (Kobayashi et
al., 2000). The utility of this and other cell lines under development are exciting
prospects for the field of BAL support.
The work presented in this thesis provides information on the use of primary porcine
hepatocytes as a model culture system for functional and morphological
characterisation under fully-defined conditions, appropriate for BAL support
systems. Evidence has been presented that media formulation can have significant
modulatory effects on hepatocyte morphology and function, which may impact upon
bioreactor efficacy. Also, a simulated microgravity environment was investigated as
a novel system to study the cytoarchitecture and biochemical functionality of three-
dimensional liver cell cultures over an extended period of time. These findings could
be important in highlighting the need for both species-specific characterisation of
porcine hepatocytes, and the ongoing requirement for a more comprehensive
approach to culture optimisation for BAL applications. Several areas where progress
needs to be made have been outlined above. Refinements of existing technology and
the rapid advancements in the new areas of tissue engineering and stem cell biology
suggest the promise of clinically effective BAL support will become realised.
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APPENDIX I
Amino-acid composition of the four media used. HM is a modification based on










Alanine 0.09 0.45 0.05 —
Arginine 0.05 0.5 0.07 0.2
Asparagine 0.02 0.25 - 0.05
Aspartate 0.03 - 0.06 0.02
Cysteine 0.04 0.12 0.00011 —
Cystine 0.02 - 0.026 0.0652
Glutamate 0.0445 - 0.1336 0.02
Glutamine - - - 0.3
Glycine 0.05 0.2 0.05 0.01




Isoleucine 0.05 0.25 0.04 0.05
Leucine 0.075 0.125 0.12 0.05
Lysine 0.08746 0.075 0.07 0.04
Methionine 0.015 0.15 0.03 0.015
Phenylalanine 0.025 0.25 0.05 0.015
Proline 0.03 - 0.04 0.02
Serine 0.01 0.2 0.05 0.03
Threonine 0.04 0.6 0.06 0.02
Tryptophan 0.01 0.02 0.02 0.005
Tyrosine 0.05045 0.3 0.05766 0.02883
Valine 0.05 0.2 0.05 0.02
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An improved ex vivo method of primary porcine hepatocyte
isolation for use in bioartificial liver systems
Leonard J. Nelson3, Philip N. Newsome3, A. Forbes Howieb,
Patrick W. F. Hadoke3, Konstantinos J. Dabos3, Simon W. Walkerb,
Peter C. Hayes3 and John N. Plevris3
Introduction Primary porcine hepatocytes are commonly
used in bioartificial liver devices and for in vitro studies of
hepatocyte function. Although in vivo isolation of porcine
hepatocytes can give high yield and viability, such methods
are time-consuming and expensive, requiring specialist
surgical facilities.
Aim To develop a simple, low-cost, high viability, high
yield, reproducible ex vivo method for obtaining functional
porcine hepatocytes for use in bioartificial liver systems.
Methods Weanling piglets (12 kg) were killed with
pentobarbitone sodium, the infra-hepatic inferior vena cava
was clamped and the supra-hepatic inferior vena cava
cannulated. The whole liver was retrogradely perfused in
situ with cold saline and excised, followed by an ex vivo
open-loop and re-circulating perfusion method (at 37°C) in
five steps. The liver was disrupted, sequentially filtered in
washing buffer, purified by centrifugation and
resuspended in Williams E medium. Viability and cell
number were assessed using trypan blue exclusion. The
cells were subsequently cultured in serum-free chemically-
defined medium and function was assessed.
Results The time interval from when the animals were
killed to the final cell wash was 105 ± 5 min (n = 20). Cell
viability was 85 ± 6% with a yield of (2.4 ± 0.5) x 1010 from
12 ± 1 kg piglets using 0.03% (w/v) collagenase (n = 20).
Hepatocytes from all isolations were successfully plated
and grown in monolayer culture. In freshly isolated
hepatocytes (day 0) total protein content (TP) was
1.2 ± 0.1 mg/106 cells (n = 5) and 1.2 ± 0.3 mg/106 cells
(n = 5) for day 2 monolayer cultures, corresponding to
approximately 9 x 106 hepatocytes per dish. The
percentage of total LDH released into the medium was
13 ± 4% for day 0 and 8 ± 4% at day 2; conversely,
intracellular LDH activities were 87 ± 4% and 92 ± 4% of
the total, respectively. The urea synthesis rate was
196 ± 36 nmol/h/mg total protein at day 0 (n = 5) and
292 ± 62 nmol/h/mg protein (n = 9) at day 2. The total
P450 content was 99 ± 11 pmol/mg total protein for fresh
cells (n = 5) and maintained at 89 ± 35 pmol/mg total
protein in day 2 cultures.
Conclusions This ex vivo method provides a high viability,
high yield, cost-effective and rapid technique for isolating
functional porcine hepatocytes with high plating efficiency,
which compares favourably with results obtained using
complex in vivo techniques. Eur J Gastroenterol Hepatol
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Introduction
There is an increasing demand for hepatocytes for use
in studies of gene therapy, hepato-toxicology, hepato¬
cyte transplantation and incorporation into bioartificial
liver (BAL) devices for treatment of fulminant hepatic
failure (FHF) [1,2]. Immortalized human hepatocyte
cell lines, such as Hep G2, can theoretically provide an
unlimited resource for use in BAL systems [3], but
problems associated with possible transfer of tumori-
genic proteins to the patient via the BAL, and the
dedifferentiated metabolic profile of such cells, have
limited the use of cell lines in BAL devices [4-7],
3954-691X © 2000 Lippincott Williams & Wilkins
Inadequate yields from rat livers and other small
mammals prohibits direct scale-up to clinical BAL
application. Hepatocyte viability from standard rat liver
perfusions is similar to that obtained from pigs [8] but
yields of 108 hepatocytes are not sufficient to be
incorporated into a scaled-up clinical device for use in
humans. Since primary human hepatocytes are not
readily available [7] and large yields of functional
hepatocytes are required for a clinically effective BAL,
primary porcine hepatocytes (PPHs) are the cells of
choice for most BAL devices. They have similar
physiology and metabolic functions to human hepato-
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cytes, differentiated function and can be obtained with Fig. 1
good viability and yield [4,5,9-13,29].
Conventional in vivo isolation of PPHs involves ante¬
grade perfusion of the portal vein, sometimes in
combination with perfusion of the hepatic artery. How¬
ever, although producing excellent cell viability and
yield, this technique requires large perfusion volumes
and high collagenase costs with increased perfusion
times [12-18]. Moreover, in vivo techniques involve
anaesthetic maintenance regimens and extensive surgi¬
cal facilities requiring expert licensed personnel. These
requirements may preclude many laboratories from
obtaining and utilizing the considerable research poten¬
tial of porcine hepatocytes.
Ex vivo isolation of PPHs from livers of abattoir origin
can attain acceptable viabilities [19,20] but with several
disadvantages, including insufficient yield for BAL
devices, availability and locality constraints of the
abattoir source, high collagenase costs and potential
infection problems with abattoir-derived organisms.
The aim of this study was to develop a rapid, low-cost,
high viability, high yield and reproducible ex vivo
method for obtaining functional primary hepatocytes




The animals were treated in accordance with UK
Home Office Guidelines (Scientific Procedures Act,
1986). Following euthanasia, all procedures were per¬
formed post-mortem. Piglets (Large White; < 15 kg)
were obtained from the Roslin Institute (Roslin, UK)
on the day of isolation and maintained on standard feed
and water ad libitum up to the time when they were
killed. Animals were anaesthetized with 30 mg/kg body
weight of pentobarbitone sodium via the auricular vein
and then killed with an i.v. bolus dose of 150 mg/kg
body weight. The abdominal cavity and lower chest
were opened with a midline incision exposing the
viscera and the supra-hepatic IVC was clamped just
below the heart, cannulated with a Foley catheter and
secured with a ligature. The infra-hepatic IVC was also
clamped (Fig. 1).
Reagents
Type IV collagenase (from Clostridium histolyticum),
ethylene glycol-bis[|3-aminoethyl ether}-N,N,N',N'-tet-
raacetic acid (EGTA), /V-2-hydroxyethylpiperazine-//'-
2-ethanesulfonic acid (HEPES), albumin (Fraction V),
long epidermal growth factor (L-EGF), Triton X-100
and Williams E (WE) medium were obtained from
Sigma (St Louis, MO, USA); and penicillin-streptomy¬
cin, gentamicin, fungizone (Amphotericin), L-gluta-
mine, phosphate-buffered saline (PBS, pH 7.4) and
Hanks' Balanced Salt Solution (HBSS; Ca and Mg free,
pH 7.4), supplied by Gibco (Paisley, UK), were of cell
culture grade. Analar grade chemicals for the perfusion
solutions and P450 buffer were obtained from Life
Technologies (BDH Merck). Other reagents were:
dexamethasone (David Bull Labs, England), aprotinin
(Trasylol1M, Bayer) and porcine insulin (Pork
Velosulin1M, Novo Nordisk, Denmark).
Perfusion and washing buffers
A stock solution (stock PB) was prepared, consisting of
21 of perfusion buffer (PB) containing 154 mmol/1
NaCl, 5.6 mmol/1 KC1, 5 mmol/l glucose, 25 mmol/1
NaHCO.i and 20 mmol/1 HEPES, made up with dis¬
tilled H2O, adjusted to pH 7.4 and sterile filtered.
Solution PB1 consisted of 500 ml stock PB supplemen¬
ted with 1 mmol/1 EGTA, 20 mg dexamethasone and
1.4 mg aprotinin. Solution PB2 contained 500 ml stock
PB with 1 mmol/1 EGTA. Solution PB3 contained
100 ml PB stock alone. Solution PB4 was 500 ml stock
PB with 5 mmol/1 CaCl2 and 0.03-0.05% (w/v) Type
IV collagenase. Solution PB5 was 200 ml Williams E
medium only. Two litres of washing buffer (WB)
containing 120 mmol/1 NaCl, 6.2 mmol/1 KC1, 0.9 mmol/
Diagram showing the Foley catheter assembly in the supra-hepatic
inferior vena cava (i.v.c.) and positioning of tie clamps for retrograde
perfusion of whole piglet liver (not to scale). Perfusate enters the liver
through the supra-hepatic i.v.c., while clamping the infra-hepatic i.v.c.
shunts the perfusate to exit via the porta hepatis; (h.a.) hepatic artery,
(b.d.) bile duct, (p.v.) portal vein. Broken lines with arrow heads depict
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CaCl2, 10mmol/l HEPES and 0.2% (w/v) albumin,
as made up with distilled H2O, adjusted to pH 7.4
id sterile filtered [19]. All equipment was sterilized by
itoclaving.
srfusion steps
he liver was retro-gradely perfused in situ with 250 ml
iS at 4 °C, via the Foley catheter which was coupled
a VygonIM connector and 50 ml syringe with luer
:ks (Fig. 1). The whole liver was excised and subse-
lently exsanguinated with a further 250 ml of PBS,
nfirmed by a clear perfusate emerging from the porta
pans (leaving the Foley assembly and infra-hepatic
C clamp in place), rinsed with PBS, placed in a
ilythene bag with 200 ml PBS on ice, and transported
the laboratory.
e-warmed perfusion buffers (PB1-4) were saturated
th 95% 02/5% CO2 and the liver was transferred to a
linless-steel bowl and placed in a 37 °C water bath,
rfusion was either open loop (non-re-circulated; PB
3, PB5) or closed loop (re-circulated; PB4). The liver
is sequentially perfused via the Foley catheter con-
cted to a peristaltic pump (Watson-Marlow, USA)
: at 65 ml/min via silastic tubing thus: PB1 (8 min),
12 (8 min), PB3 (2 min), PB4 (16 min) and PB5 at
'C (3 min). Perfusate was removed following steps
>1 and PB2.
patocyte isolation
llowing perfusion the whole liver was dissected
:ptically with sharp scissors into pieces of approx.
m3 and the disrupted tissue placed in an orbital
iker at moderate speed for 5 min at 37 °C in the
;sence of PB4 and PB5. The resulting cell suspen-
n was transferred to a laminar flow hood and
juentially filtered through a stainless-steel collander
i meshes of grid sizes 200, then 150 and then
) pm into collection bottles placed on ice. Collage -
;e activity was neutralized by adding 500 ml WB at
C (containing 0.2% albumin) to the filtered suspen-
n to achieve a final volume of 1200 ml. The parench-
al cell fraction was allowed to sediment on ice and
■ non-parenchymal fraction aspirated. The hepato-
es were then washed using three centrifuge-wash
:les at 25 g (4 °C) for 5 min. Finally, the hepatocyte
lets were resuspended in Williams F medium at
C. Cell number and viability were initially deter-
aed by the trypan blue exclusion test using a
ubauer cytometer. Aliquots of fresh cell suspension
re analysed for total protein content, total cyto-
ome P450 content, lactate dehydrogenase (LDH)
ivity and for urea synthesis rate following ammo-
m chloride challenge.
Datocyte cultures
lis were seeded at a density of 8 X 106 viable cells
per 90 mm culture dish (Dow Corning, USA) in 8 ml
WE medium at 37 °C. The culture medium consisted
of serum-free, chemically-defined Williams E media
(WE+) supplemented with 50 ng/ml L-EGF, 10 pg/ml
porcine insulin, 1 pmol/1 dexamethasone, 2 mmol/1 L-
glutamine, 50 mg/ml gentamicin, 50 mg/ml penicillin-
streptomycin and 2.5 pg/ml fungizone. The culture
dishes were shaken gently to aid dispersal of cells for
attachment and placed in a humidified incubator under
a 95% air:5% CO2 atmosphere. For the initial cell
attachment phase, the incubator was gassed with 30%
02/5% CO2 for 2 h [21]. Next day (day 1), the culture
dishes were aspirated and fresh WE+ medium was
added.
Assays
On the day of isolation (day 0) and on day 2, total
protein (TP) content, LDH activity, urea synthesis rate
(USR) and total cytochrome P450 content of the cells
were measured. The above assays were performed in at
least five separate isolations.
Treatment of fresh cell suspension for total protein and
LDH measurements
On day 0, 10 ml (5 X 107) fresh cell suspension in WE
medium was centrifuged at 25 g (4 °C) for 5 min and 1-
ml samples of the supernatant taken (F1 fraction) and
stored at —70 °C until analysis of extracellular LDH
activity. The cell pellet was resuspended in 10 ml
0.25% Triton X-100 in HBSS and frozen to —70 °C,
thawed, centrifuged at 200 g (4 °C) for 5 min and 1-ml
samples of supernatant (F2 fraction) taken as above for
analysis of cytosolic LDH and total protein (TP). TP
was analysed using the Bradford assay [22,30] modified
for a GOBAS FARA multi-analyser (Roche Diagnos¬
tics); results are expressed as mg protein/106 cells.
LDH activity was determined in the F1 and F2
fractions by following the rate at which NADH is
converted to NAD+ at ^340 nm in the presence of
pyruvate (Sigma Diagnostics LDH kit DG1340-K)
using the COBAS FARA. The percentage of total
extracellular LDH released into the medium is calcu¬
lated as follows: %LDH = (Fl/Fl + F2) X 100 whereas
the percentage of total cellular (cytosolic) LDH =
100 — (Fl/Fl + F2) X 100. The coefficient of variation
of this assay was less than 5%.
Treatment of day 2 monolayer cell cultures for total protein
and LDH [23,24] measurements
On day 2, 1-ml samples of medium (F1 fraction) were
taken from duplicate dishes and stored at -70 °C until
analysis for extracellular LDH. The medium was then
aspirated completely, the cell monolayer washed twice
with HBSS (4 °C) and 5 ml 0.25% Triton-X 100 in
HBSS added. Dishes were freeze-thawed and cells
scraped from the dish using a pastette. Residual cells
were rinsed from the dish with 5 ml HBSS, added to
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the lysed cell homogenate and centrifuged at 200 g
(4 °C) for 5 min, and 2 X 1-ml samples of supernatant
(F2 fraction) were stored at —70 °C until analysis for
TP and LDH activity (as above).
Treatment of fresh cell suspension and day 2 monolayer
cultures for total cellular P450 levels [27,28]
On day 0, 2 X 107 freshly isolated cells in WE medium
were centrifuged at 25 g (4 °C) for 5 min and the
supernatant was aspirated; 2 ml of ice-cold P450 buffer
[28] (containing 0.1 M sodium phosphate buffer pH 7.6
(87 ml 0.2M Na2HP04 + 13 ml 0.2 M NaH2P04),
0.02% Nonidet P-40, 20% glycerol, 1 mM EGTA and
1 mM dithiothreitol) was added to the cell pellet and
the crude suspension homogenized using seven strokes
of a Teflon-glass Dounce homogenizer and stored at
— 70 °C until analysis. Day 2 monolayer cultures were
washed twice with HBSS (4 °C) and 2 ml P450 buffer
was added; the crude homogenate was collected and
treated as above. Following assay of the TP content as
above, both fresh and cultured cells were diluted with
P450 buffer to 4 mg protein/ml and 1 ml of sample was
placed into each of two 1-cm quartz glass sample and
reference cuvettes; 1 mg sodium hydrosulphite was
added to both cuvettes; 2 min later the sample cuvette
was bubbled for 20 s with 99% pure CO gas. The P450
content was assessed by carbon monoxide-difference
spectroscopy [27] of the sodium hydrosulphite-reduced
samples using a Kontron dual beam spectrophotometer
scanning between Lroo and X500 nm. The difference in
absorbance between A450 and X490 nm was recorded
using an extinction coefficient, £ = 91mM cm"1 to
calculate the P450 concentration thus: [P450] = Absor-
bance/£. Results are expressed as pmol/mg protein
(corrected for total cellular protein content). The coef¬
ficient of variation for this assay was less than 7%.
Urea synthesis rate
Freshly isolated hepatocytes (day 0) were inoculated at
a density of 8 X 107 in 55 ml WE+ medium with
2 mmol/1 NH4C1, into a rotary cell culture vessel (high
aspect ratio vessel; Cellon-Sarl, Luxembourg) and
rotated at 10 revolutions per minute for 2 h in a
humidified incubator at 37 °C under an atmosphere of
95% air/5% C02. The urea synthesis rate (USR) was
determined in 0.5 ml samples taken at t = 0 and t = 2 h
using a modified colorimetric urea nitrogen kit (Sigma
kit 535-B). The difference in absorbances for the
chromogenic reaction was measured at each time point
at 7.S25 nm in a Pye Unicam spectrophotometer and
USR calculated. Cells were collected and analysed for
total protein content as above. The coefficient of
variation for this assay was less than 5%.
On day 2, duplicate cell culture dishes were washed
twice with HBSS (37 °C) and incubated in 8 ml WE+
with 2 mmol/1 NH4C1 for 2 h at 37 °C as above. The
USR was determined as above and corrected for total
protein content for each culture modality.
Morphology
Morphology was assessed using a Zeiss inverted micro¬
scope (Zeiss, Germany) under phase-contrast on both
day 0 and day 2 of culture. Photomicrographs recorded
hepatocytes in suspension and monolayer culture. He-
patocyte purity was determined by cytospin (X 200 g,
5 min) of 5 X 10s freshly isolated cells and staining
with haematoxylin + eosin/periodic acid Schiff (PAS),
followed by counting cells in three separate fields for
three separate isolations.
Statistics
Results are expressed as mean ± standard error. Stu¬
dent's /-test was used to compare means of different
groups. A P value of <0.05 was taken as significant
(two-tailed test of significance).
Results
The time intervals from when the animals were killed
to the initial PBS flush and PBS flush to cold storage
were 12 ±4 and 16 ± 6 min respectively. Transport
time to the laboratory was 12 ± 3 min, while hepatocyte
isolation time (PB1 to final cell wash) was 65 ± 6 min
(« = 20). Total isolation time (from the time the ani¬
mals were killed to final cell wash) was 105 ±5 min
(n = 20).
The common Large White strain of pig (< 15 kg;
costing $25 each) was used in the hepatocyte isolation
experiments. A reduction of the collagenase concentra¬
tion ($200 per g) from 0.05 to 0.03% (w/v) produced a
five-fold increase in cell yield (Table 1), and signifi¬
cantly reduced the cost of the isolation.
Table 1 Hepatocyte isolation from whole livers of weanling piglets showing the influence
of collagenase concentration on cell viability and yield
Cell isolation Body weight Collagenase Yield
group (kg) % (w/v) % Viability (X 10'°)
1 (n — 5) 12.8 J: 1.3 0.05 82 ± 9 0.43 ± 0.22
2 (/? = 5) 14.1 ± 0.6 0.04 76 ±6 0.70 ± 0.20
3 (n = 20) 12 ± 1 0.03 85 ± 6 2.4 ± 0.5
Results are expressed as mean ± standard error. The number, n, of hepatocyte isolations performed is in
parentheses.
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Cell viability was 85 ± 6% with a yield of (2.4 ±
0.5) X 1010 cells from 12 ± 1 kg piglets using 0.03% (w/
v) collagenase (» = 20; Table 1). Hepatocytes from all
isolations were successfully plated and grown in mono¬
layer culture. Microbiological sensitivity tests of cell
cultures showed no evidence of infection.
In freshly isolated hepatocytes (n= 5) (day 0) total
protein content (TP) was 1.2 ± 0.1 mg/106 cells and
1.17 ±0.27 mg/106 cells for day 2 monolayer cultures,
corresponding to approximately 9 X 106 hepatocytes
per dish (Table 2). The percentage of total LDH
released into the medium was 13 ±4% for day 0 and
8 ± 4% at day 2; conversely, intracellular LDH activ¬
ities were 87 ± 4% and 92 ± 4% of total, respectively.
Urea synthesis rate was 196 ± 36 nmol/h/mg of protein
at day 0 (« = 5) and significantly increased to
292 ± 62 nmol/h/mg of protein («= 9) at day 2
(P < 0.01, Table 2).
Total P450 content was 99 ±11 pmol/mg of protein for
fresh cells (« = 5) and maintained at 89 ± 35 pmol/ mg
of protein in day 2 cultures.
The cell suspension was composed of single cells and
small aggregates of between five and 20 cells showing
bright cytoplasm, sharply defined borders, commonly
with round or polygonal shape and little physical
damage (blebbing) under phase contrast microscopy
(Fig. 2a). In monolayer culture, hepatocytes showed a
flattened morphology with typical trabecular arrange¬
ment, sharp refractile borders and dark cytoplasm with
a pronounced nucleus often with two or more nucleoli.
Bi-nucleated hepatocytes were also present (Fig. 2b).
Hepatocyte purity for day 0 cells was 95 ± 3% (n = 3)
(Fig. 2c). PAS staining revealed a high hepatocyte
glycogen content (not shown).
Discussion
Hepatocyte based BAL systems as used in the treat¬
ment of liver failure require large numbers of viable
hepatocytes that have preserved synthetic, metabolic
and detoxifying functions. The most common source
for such cells has been porcine liver tissue. Whilst
several methods have been described for isolating
porcine hepatocytes, there have been technical pro¬
blems which have restricted their use. These include
the requirements of prolonged anaesthesia and surgical
expertise with in vivo techniques and low yield in
current ex vivo techniques [1,4,5,11-17,21,31]. Our aim
was to establish a simple, time- and cost-effective
method to isolate PPHs with a high yield and viability.
Comparative yields and viabilities of differing methods
of PPH isolation are outlined in Table 3. With a mean
cell viability of 85% and a viable cell yield of
2.4 X 1010corresponding to 108 cells/g wet weight liver,
our data compare favourably with in vivo techniques
[1,5,11-16] and outperform yields obtained using com¬
parable ex vivo isolation methods by an order of
magnitude [19,20], The theoretical functional liver
mass required for a clinically effective BAL is
between 20 and 40% of total liver mass correspond¬
ing to approximately (20-40) X 109 hepatocytes
[1,5,15,16,26,32,33], which is obtainable using our ex
vivo method.
The hepatocytes show good morphology in both sus¬
pension and day 2 cultures (Fig. 2a and b) and have
high intracellular LDH activity (Table 2), indicating
high viability and preservation of membrane integrity
[23,24]. Microscopic analysis of fresh cell suspensions
shows a tendency of the hepatocytes to aggregate into
small clusters of 5-20 cells (Fig. 2a). This may be
advantageous for cells expediently seeded into a bio-
artificial liver device. Indeed, there is evidence that
isolated hepatocytes arranged into multi-cellular forma¬
tion establish cell-cell and cell-matrix contacts which
result in improved differentiation and liver-specific
function, when compared with single cell culture
monolayers [25,37,38], It is thought that formation of
Table 2 Biochemical parameters of freshly Isolated hepatocytes (day 0) and day 2
hepatocyte monolayer cultures (n = 5)
Biochemical parameter Fresh cells (day 0) Cultured cells (day 2) P-value
% LDH in medium (F1) 13 ±4 8 ± 4 NS
% LDH retained in cells (F2) 87 ±4 92 ±4 NS
Total protein 1.2 ± 0.10 1.17 ± 0.27 NS
(mg/106 cells)
Urea synthesis rate 196 ± 36 292 ± 62 < 0.01
(nmol h"1/mg protein) (n = 9)
Total P450 99 ± 11 89 ± 35 NS
(pmol/mg protein)
Cell viability was assessed as a function of percentage total lactate dehydrogenase (LDH) released into the
medium (F1) and retained as cytosolic LDH (F2); total protein (TP) approximates to cell number and urea
synthesis rate (USR) to detoxification capacity; total P450 content indicates cellular bio-transformatory
potential. Results are means (± standard error) from at least five separate hepatocyte isolations measured in
duplicate for each parameter.
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Fig. 2
(b)
cell aggregates may provide an in two-like liver micro¬
architecture promoting maintenance of viability and
differentiated functions [5,17,39-41].
For hepatocyte cultures, we used serum-free, chemi¬
cally-defined medium containing long-EGF and insu¬
lin. Porcine hepatocytes cultured this way showed
much greater growth potential than rat hepatocytes
cultured under the same conditions [37]. Indeed den¬
sity-dependent inhibition of cell growth was less pro¬
nounced with the porcine hepatocytes even after
reaching confluency [42,43], Morphologically, we have
observed overgrowth of pig hepatocytes even after
reaching confluence on day 2 and up to day 6 (not
shown). This may be important in terms of maintaining
differentiated, multi-cellular formations in BAL devices
as discussed above.
(a) Freshly isolated porcine hepatocyte suspension following the final
washing step. Under phase contrast microscopy, hepatocytes show
bright cytoplasm, sharply defined borders with round or polygonal
shape and little physical damage (blebbing). Original magnification
X 200. (b) Hepatocytes in confluent monolayer culture show a
flattened morphology with typical trabecular arrangement, sharp
retractile borders and dark cytoplasm with pronounced nucleus often
with two or more nucleoli, (c) Haematoxylin + eosin staining showing a
pure hepatocyte population.
The hepatocytes isolated by our method showed a high
level of ammonia detoxification (Table 2). Ammonia is
a putative neurotoxin in the development of hepatic
encephalopathy and brain oedema in FHF, so NHj
detoxification is considered essential for an effective
BAL device in clinical usage [4,21,35,43], In addition,
we have shown that these cells retain P450 activity and
thus maintain a significant metabolic bio-transformation
potential (Table 2). Although cellular P450 content is
known to decline with culture age in most species, it
can be enhanced by modulating culture conditions [28]
or by administration of phenobarbital prior to cell
isolation. Recently, pig hepatocytes have been shown
to outperform both rodent and dog hepatocytes in
maintenance of phase 1 and phase 2 activities, whilst
high metabolic similarities were found between pig and
human hepatocytes [29], These attributes of pig hepa¬
tocytes support their use as the cells of choice for the
biological component of BAL devices.
The main factors we have adopted for the successful ex
vivo isolation of porcine hepatocytes, without compro¬
mising yield and viability are as follows:
1. The use of weanling piglets with a mean body
weight of 12 kg. Viability and yield have been shown
to decline with increasing pig weight (Table 3) [36],
possibly as a result of increased fibrous tissue
content in the more mature pig liver.
2. Retrograde perfusion via the large supra-hepatic IVC
allows easy access to the liver (Fig. 1) and rapid
removal of blood following the initial in situ flush
with PBS.
3. Reduced collagenase concentrations to 0.03% (w/v)
thereby minimizing cost (Table 1).
4. Reduced perfusion volumes and time.
5. Use of a simple, cheap liver storage solution (PBS).
6. Perfusion with cooled hepatocyte medium (Williams
E) as a cytoprotectant (after the collagenase re-
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Table 3 Comparative data of various techniques employed to isolate primary porcine hepatocytes with high yield and viability
Body weight % Collagenase
Method Mean yield Mean viability (kg) (w/v) References
In vim 10'°-10n 70-95 5-40 0.05-1.0 [11, [5], (13-18),
[211,(361
Ex vivo 1 2X10® 84 35-115 0.05 [191,(20]
Ex vivo 2 3X109 71 60 0.05 unpublished data
Ex vivo 3 >2X10'° 85 12 0.03 present method
circulation step) prior to disruption and mechanical
handling of the digested liver [14].
7. Avoidance of PercollIM purification [19,20] to en¬
hance viability (by up to 10%) as it is known to
reduce yield by 40-50%.
Furthermore the whole procedure can be performed in
approximately 2 h, a benefit which may be of impor¬
tance in the provision of an on-demand supply of
hepatocytes for a BAL device. Such cells are, at
present, only available on demand by thawing supplies
of cryopreserved cells. This situation is not ideal given
the loss of metabolic function seen in cryopreserved
hepatocytes [34,35].
In conclusion, our method provides a simple, high
viability, high yield, rapid isolation technique which is
easy to perform in a standard research laboratory. Cells
can be deployed in a variety of in vitro liver model
systems in less than 2 h, whilst maintaining viability
and hepatocyte functionality.
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REVIEW ARTICLE
Which Hepatocyte Will It Be? Hepatocyte Choice for
Bioartificial Liver Support Systems
John Tsiaoussis, Philip Noel Newsome, LeonardJoseph Nelson, Peter Clive Hayes,
andJohn Nicholas Plevris
Liver failure, notwithstanding advances in medical man¬
agement, remains a cause of considerable morbidity and
mortality in the developed world. Although bioartificial
liver (BAL) support systems offer the potential of signifi¬
cant therapeutic benefit for such patients, many issues
relating to their use are still to be resolved. In this review,
these issues are examined in terms of the functions re¬
quired, the cells of choice in such a system, and the most
appropriate environment to optimize the function ofsuch
cells. The major functions identified to date for a BAL are
ammonia detoxification and biotransformation of toxic
compounds, although this somewhat belies the complex¬
ity of the functions required. Two practical choices for cell
type within such a system are xenogenic hepatocytes and
immortalized human hepatocyte lines. Both these choices
have drawbacks, such as the transmission ofzoonoses and
malignant infiltration, respectively. Finally, improve¬
ments in culture conditions, such as supplemented media,
biodegradable scaffolds, and coculture, offer the possibil¬
ity of prolonging the differentiated function of hepato¬
cytes in a BAL. (Liver Transpl 2001;7:2-10.)
The development of nonbiological systems to sup¬port critically ill patients with acute liver failure
(ALF) that incorporate plasmapheresis,1 charcoal hemo-
perfusion,2 and ultrafiltration techniques3 has not had a
significant impact on survival. Consequendy, hepatocyte-
based biological systems have attracted intense interest
worldwide but have also generated most of the contro¬
versy. Uncertainty exists about the most suitable biological
component and the risk for zoonoses and immune rejec¬
tion in the host. In addition, the optimization of culture
conditions and thus metabolic function of the biological
component have not been systematically studied, al¬
though continuing improvements in these areas have ren¬
dered this therapeutic avenue in ALF more promising. To
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compound matters, the question of which aspects of
hepatocyte metabolism in an artificial liver are required to
sustain life and promote recovery remains largely un¬
answered, further limiting development. In this review,
the biological substrate of such systems is critically ex¬
amined and insights are provided into the ideal system.
Essential Metabolic Functions
A major cause of death in ALF is hepatic coma, but
because of controversy about its exact cause, it is un¬
clear which specific hepatocyte functions are re¬
quired in a bioartificial liver (BAL) system. The the¬
ories of the pathogenesis of hepatic coma in ALF are
not discussed here except to list those most widely
accepted.4 These include ammonia accumulation (with
depletion of brain glutamate),5'6 endogenous benzodi¬
azepine accumulation (leading to neural inhibition
through y-aminobutyric acid type A-receptor acti¬
vation),78 and generation of false neurotransmitters
from gut-derived amines (again leading to neural in¬
hibition).9
Thus, removal of nitrogenous waste and the abil¬
ity to perform a number of biotransformatory func¬
tions with regard to ammonia metabolism can be
considered important functions of a BAL. Removal
of nitrogenous waste can occur through 3 main path¬
ways: (1) incorporation of ammonia into the urea
cycle, (2) conversion ofammonia into glutamine, and
(3) conversion of ammonia into glutamate. Conse¬
quently, urea cycle enzyme activities must be well
maintained in a BAL system to facilitate the elimina¬
tion of ammonia.10 The biotransforming properties
of hepatocytes can be divided into phase I (oxidation
by P-450 enzymes) and phase II (conjugation with
glutathione, glucuronidation, and sulfation) activi¬
ties. Appropriate laboratory tests (Table 1) can be
used for the relevant enzymes to ensure that their
levels are suitably maintained.10
Other functions, such as gluconeogenesis, albumin
synthesis, and coagulation factor synthesis, are valu¬
able, but not of paramount importance because most
can be administered exogenously without the need
for a BAL.
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Table 1. BAL Quality Control
Test Required Criteria
Cellular appearance and number Cell number















>5 /xg/h/million cells! (or 0.083 /xmol)
>50 /xg/h/million cells!
NOTE. Suggested checks to be performed before using a BAL in a clinical treatment.
* This figure reflects the realistic cellular viabilities that can be obtained after hepatocyte isolation.86
t These values represent the metabolic function that can be obtained from a BAL system that contains healthy hepatocytes.87,88 Due to
uncertainty about the desired function of BAL systems, it is not clear whether these values are sufficient or even required.
Choice of Cells
Human Hepatocytes
Although on first inspection, human hepatocytes may
appear to be the natural cellular choice for an artificial
liver system, further scrutiny shows many difficulties.
One of their major drawbacks, their relative scarcity, is
further compounded by the competing demands of
whole-organ liver transplantation and, to a lesser ex¬
tent, hepatocyte transplantation. In addition, the lack
of a regular supply of human tissue makes it difficult to
plan for its appropriate clinical use. Attempts to over¬
come this difficulty by maintaining long-term cultures
of hepatocytes have been hindered by both cost and the
rapid loss of differentiated metabolic function."12 As
with whole-organ transplantation, immune rejection is
also a problem, although hyperacute rejection, which
often applies in xenotransplantation, is generally not
seen." Finally, the use of human hepatocytes isolated
from liver tissue from partial hepatectomy and/or
hepatocellular carcinoma surgery has raised concerns
about the transmission of malignancy or infection to
the patient. Consequently, human hepatocytes have
not been widely used in artificial livers, and attention
has turned to immortalized human hepatocyte lines or
xenogenic hepatocytes.
Human Hepatocyte Cell Lines
Immortalized human hepatocyte cell lines can provide
an unlimited resource for BAL systems,14'15 although
concerns exist about their metabolic function and the
transmission of immortalized cells or tumorigenic
products to the patient's circulation.16 This concern is
heightened by the knowledge that patients with liver
failure are immunocompromised for long periods of
their lifetime, either acutely or posttransplantation,
thus decreasing their ability to remove such malignant
cells from the circulation. However, this still remains a
theoretical concern because no evidence exists of trans¬
mission in trials performed to date.17
The 2 basic types of human hepatocyte lines are
those derived from human tumors18'19 and those cre¬
ated by immortalizing human hepatocytes.20"22
Tumor-derived line. One of the most developed BAL
systems currently under trial, the ELAD system23'24
(VTTAGEN Inc, La Jolla, CA), uses the C3A cell line, a
clonal derivative of the hepatoblastoma-based HepG2
cell line, which is reported to have a more highly differ¬
entiated hepatic phenotype than the HepG2 line.25
Metabolic studies of the C3A line have shown greater
levels of such synthetic function as albumin and alpha-
fetoprotein production, as well as nitrogen-metaboliz¬
ing activity similar to that of perfused rat livers.26 How¬
ever, compared with primary porcine hepatocytes, the
C3A cell line has lower levels of P-450 IA1 activity,
ammonia removal, and amino-acid metabolism.19 In¬
creasing evidence shows that continuous human liver
cell lines derived from liver cancers may not conserve all
aspects of drug metabolism found in normal cells, fur¬
ther limiting their efficacy.27
Immortalized cell lines. Human hepatocyte lines de¬
rived from normal liver and immortalized by coculture
with rat epithelial cells, such as HHO1, HH02, HH09,
and HH2521 cells, show viability in continuous culture
for several years and express a spectrum ofdifferentiated
hepatocyte functions. This admixture of nonhuman
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and human cells may prove to be a disadvantage in
subsequent clinical application.
Attempts to develop new transfected cell lines with
decreased malignant potential include the OUMS-2920
and HepZ.28 The OUMS-29 is derived from human
fetal hepatocytes transfected with the pSV3neo plasmid
and contains the genes encoding simian virus 40 large
T antigen (SV40T) and neomycin phosphotransferase.
The OUMS-29 cells express genes of many liver-spe¬
cific functions, including albumin, asialoglycoprotein
receptor, glutamine synthetase, glutathione-.?-trans¬
ferase-/;, and human blood coagulation factor X.20 In¬
jected into 90% hepatectomy rats, these cells resulted
in significant clinical improvement in terms of blood
ammonia level, hepatic encephalopathy grade, and sur¬
vival.20 Furthermore, preliminary data with the
OUMS-29 line did not show tumorigenic features
when transplanted into athymic nude mice29 compared
with the HepG2 line, which caused multiple tumor
nodules within 2 weeks of infusion into similar mice.15
Although reassuring that OUMS-29 cells may not
represent as important a malignant risk as HepG2 cells,
there still remains concern about the use of irreversibly
immortalized cells in immunosuppressed patients.
The recent development of a reversibly immortal¬
ized cell line, NKNT-3,22 has been heralded as a break¬
through for hepatocyte transplantation. The NKNT-3
line is produced by the retroviral transfection ofnormal
primary human hepatocytes with SV40T flanked by
LoxP recombination targets. In addition, there is con¬
current expression of a protein fusion (Hygro-TK) that
confers cellular sensitivity to ganciclovir. The NKNT-3
line can be successfully remortalized by transduction
with a replication-deficient recombinant adenovirus
that expresses the Cre recombinase, which permanently
excises both the SV40T and Hygro-TK genes by acting
at the LoxP recombination targets. Although the im¬
mortalized (nonreverted NKNT-3) line maintains ex¬
pression of key genes of liver metabolism (glutamine
synthetase, hepatic bilirubin-uridine diphosphate-glu-
coronyltransferase, and glutathione-S-transferase-/>),
the levels of expression increase dramatically after exci¬
sion of the SV40T gene, and albumin and human blood
coagulation factor X messenger RNA were only de¬
tected after the SV40T gene had been removed. Never¬
theless, both forms of NKNT-3 produced significant
biochemical and clinical improvement in 90% hepatec¬
tomy rats when infused into the spleen.22 To further
mitigate against the transmission of malignancy, this
line remains sensitive to ganciclovir, which, together
with the host immune response, should remove such
cells from the patient's circulation when needed. Al¬
though the investigators present data that describe the
successful removal of such cells from the rat model,
more work is required to confirm that this line can be
used for hepatocyte transplantation. Nonetheless, for
the purposes of BAL systems, this line offers the possi¬
bility of treating and then removing cells that have
escaped from the BAL into the patient's circulation.
Xenogenic Hepatocytes
Because of the previously mentioned concerns about
metabolic function and/or malignant risk with immor¬
talized cell lines, xenogenic hepatocytes have been
widely used in BAL systems.30 Although rat hepatocytes
are metabolically active, the relatively small size of the
animal has made it difficult to obtain a sufficiently high
yield to load a BAL system for use in human liver
failure. Conversely, porcine hepatocytes have remark¬
ably similar physiological characteristics and metabolic
functions to human hepatocytes, with high expression
ofmixed-function oxidases (cytochrome P-450 system)
that are essential for detoxification of chemicals found
in liver failure,31 as well as relative size compatibility
with humans.32'33 Although considerable expertise has
been gained in the use of xenogenic hepatocyte-driven
BALs, as with immortalized hepatocyte lines, serious
concerns exist about their use. Xenogenic cells have the
following 3 main recognized disadvantages.
Immunogenicity. Preformed immunoglobulin M (IgM)
antibodies against porcine hepatocytes have been reported
in almost 7% of the healthy population,34 leading to
hyperacute rejection in xenogenic organ transplanta¬
tion. Consequently, immunoisolation using semiper¬
meable membranes has been incorporated into many
systems to prevent extensive porcine hepatocyte necro¬
sis and the consequent flux of necroinflammatory
chemicals back into the patient. The membranes also
might protect against possible immunologic com¬
pounds escaping from xenogenic tissue into the pa¬
tient's circulation. However, despite their use, elevated
titers ofantipig IgM and IgG xenoantibodies (primarily
against A-Gal epitope on pig hepatocytes) have been
found after 2 or more treatments with porcine-based
BAL systems, indicating that host exposure to porcine
antigens still occurs.35-36 The promising development
of animals with knockouts for Gal-epitope may miti¬
gate the problem of hyperacute rejection, although this
has yet to be achieved in the pig and may cause further
problems with porcine endogenous retroviral (PERV)
transmission, described next. To date, no adverse im¬
munologic reactions have been reported with repeated
use of these systems over a prolonged period of several
days, possibly because patients with ALF are relatively
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immunosuppressed and are unable to mount significant
immune responses.37
Zoonoses. Standard health-screening protocols are
available to ensure that animals are free of various
pathogens. Of greater importance is the issue of such
ubiquitous organisms as PERVs,38,39 which at present
are not removable from such hepatocytes. Although
there is no evidence to date to indicate a pathogenic role
of PERVs in pigs or other species, much concern re¬
mains about cross-species transmission of these viruses.
Consequently, experiments have focused on the possi¬
ble transmission ofPERVs to human cells and the study
of the subsequent events. Although PERV particles can
be transmitted from porcine to human cells when
cocultured in vitro,1739 only recently has evidence
come to light that indicates the transmitted virus has
the potential to replicate in its new host. Coculture of
the human kidney epithelial cell (U293) with either
PK-15 or pig islets showed that the U293 line was
positive for PERV pol DNA after 18 and 28 days of
culture.40 However, in the context of BAL treatment,
coculture is not the most suitable comparison, and Ny-
berg et al41 showed that exposure of human HEK 293
cells with fulminant serum incubated with porcine
hepatocytes does not lead to PERV infection. Although
it is known that some cells escape from a BAL and enter
the patient's circulation, inclusion of a 150-nm mesh
bioreactor membrane reduces PERV infectivity by
100,000-fold.42
Ofgreater concern is the finding that pancreatic islet
transplantation into severe combined immunodefi¬
ciency (SCID) mice causes widespread infection with
PERV, showing for the first time evidence of in vivo
transmission.40 Although a large study of human recip¬
ients of porcine tissue and/or BAL treatments did not
show evidence of transmission, this may reflect several
important differences between the 2 reports. Although
some of the human recipients were immunosuppressed,
it is unlikely they were as suppressed as SCID mice. In
addition, mice do not have natural immunity against
galactose a(l-3)-galactose terminal sugars.43 Signifi¬
cantly, the majority of immunosuppressed human re¬
cipients did not show long-term survival and function
of their grafts, raising concerns about long-term safety
of xenografts.40 Consequently, many countries have
implemented xenotransplantation moratoria before
permitting the further use ofxenogenic tissue. Ongoing
studies are in place to develop PERV-free pigs,44 al¬
though the possibility of transmitting as yet unknown
viruses will always remain a potential concern.
Biocompatibility. Although porcine hepatocytes may
detoxify human toxins, there are concerns that products
from different species, such as coagulation factors or
albumin, may not exert a similar biological response in
humans,13 although porcine tissues, such as pancreas
transplants and/or insulin, have been used to good ef¬
fect in human diseases.
Critical Cell Mass
Animal studies have suggested between 20% and 40%
of host liver mass is required for effective support
(Table 1), which would correspond to approximately
150 to 300 g of liver tissue for a 70-kg patient (3 to 6 X
1010 hepatocytes).45 Animal models have shown that as
little as 2% of normal liver mass reduced the levels of
transforming growth factor-/? 1, an inhibitor of hepatic
regeneration.46 Of the 3 BAL support systems for which
clinical data are available (Table 2), significant differ¬
ences exist in the number of cells used to load the
bioreactor (6 X 109 to 1 X 10"), which corresponds to
2% to 33% of normal liver mass.47 Specifically, the
BAL device, HepatAssist, contains approximately 6 X
109 cryopreserved porcine hepatocytes (30 g; 2% of
normal hepatocyte mass),48 whereas the ELAD con¬
tains 4 X 10'° transformed C3A cells (200 g; 15% of
normal hepatocyte mass).49 A more complex device,
Gerlach's device contains 1 X 10" porcine hepatocytes
Table 2. Critical Cell Mass of BAL Systems
Weight Liver Mass Phase of
BAL System Cell Type No. of Cells (g) (%) Development
HepatAssist89 (Circe Biomedical Inc, Lexington, MA) Porcine 6 X 109 30 2 Clinical
ELAD49 C3A line 4 X 10'° 200 15 Clinical
Gerlach90 (University of Berlin, Berlin, Germany) Porcine 1 X 10" 500 33 Clinical
Bader51 Porcine 1 X 10'° 50 3.3 Experimental
NOTE. The number of hepatocytes in the BAL systems varies significantly from as low as 2% to 33%. The percentage of liver mass is
derived from a value of a human liver of 1.5 kg.
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(500 g; 33% of normal hepatocyte mass).50 Other de¬
vices at a developmental stage contain similar numbers
ofhepatocytes; for example, Bader's bioreactor contains
1 X 1010 porcine hepatocytes.51
Modulation of Function
With a view to augmenting the function of the hepato¬
cyte load in BALs, other approaches to enhance the
culture environment have been undertaken. The main
strategies used to enhance performance in vitro are
(1) media supplementation, (2) use of biomatrices,
(3) preferential cell isolation, (4) novel culture modali¬
ties, and (5) cocultures.
Media Supplementation
Culture media containing nonautologous serum intro¬
duce unknown factors, such as selective cytoinhibitors,
bacterial endotoxins, and lipids, that may contribute to
the observed cytostatic and cytotoxic effects ofserum.52
Serum has been shown to inhibit the expression of
differentiated liver-specific functions and be selective
for the growth of nonparenchymal cells.53 For these
reasons, the use ofserum-free chemically defined media
with potent mitogenic supplements is preferred. Such
supplements include long-epidermal growth factor, a
synthetic recombinant analogue of endogenous epider¬
mal growth factor that has stimulatory effects on DNA
synthesis, cell growth, amino acid transport, and pro¬
tein synthesis.54 Insulin has been shown to enhance
initial cell attachment and may be important for seed¬
ing cells onto tissue culture plastic or BAL hollow-fiber
membranes. Both hormones contribute to the preser¬
vation ofhepatocyte morphological characteristics, sur¬
vival, and such tissue-specific functions as albumin syn¬
thesis. This is also true of dexamethasone, which
stimulates protein synthesis and suppresses fibroblast
growth.53
Biomatrices
Engelbreth-Holm-Sarcoma gel (Matrigel; Becton Dickin¬
son & Co, Franklin Lakes, NJ)55'58 and collagen gel
sandwiches5*1 have been shown to maintain differenti¬
ated function and improve cellular polarity of rat hepa¬
tocytes.60 Matrigel, unlike collagen gels acquired from
nontumor sources, is a laminin-rich protein obtained
from Engelbreth-Holm-Sarcoma cells. Thus, a theoret¬
ical concern exists about the transmission of tumor
particles from Matrigel biomatrices, although this has
not been shown to date.58 Uniquely, porcine hepato¬
cytes appear able to maintain these functions without
the aid of exogenous substrates.61,62 For these reasons,
the use of biomatrices to enhance liver-specific func¬
tions in BAL devices remains controversial.
Maintenance and enhancement of the biological
component of BAL systems without resort to a bioma-
trix environment is theoretically achievable. The perox¬
isome proliferators, methylclofenapate and nafenopin,
as well as phenobarbital barbiturate, can induce DNA
synthesis and provide a survival signal for cultured rat
hepatocytes by suppressing apoptotic cell death.63
However, such pharmacological interventions are
largely experimental at present.
Preferential Cell Isolation
Preferential zonal isolation ofhepatocytes using the dig-
itonin/collagenase perfusion technique can be used to
isolate periportal or perivenous hepatocytes that have
differing metabolic profiles. Both urea synthesis and
glutathione replenishment capacities are enhanced in
the periportal (acinar zone 1) region, whereas P-450
activity is greater in the perivenous areas. Thus, the
potential exists to load a BAL selectively with zone 3
hepatocytes to augment P-450 function and improve
biotransformation, although there is no evidence to
suggest that such cells can function optimally in isola¬
tion.6466
Novel Culture Modalities
Formation of hepatospheroids using a rotary cell cul¬
ture system (inducing a simulated microgravity envi¬
ronment), roller bottles, or nonadherent positively
charged surfaces may facilitate the development ofcell-
cell cell-matrix interactions, thus promoting cellular
polarity and enhanced differentiated function. Again,
such modalities are at an experimental stage, and their
applicability remains to be confirmed.67"72
Hepatocyte Coculture With Nonparenchymal
Cells
The number of required hepatocytes may be reduced if
their function can be enhanced by coculturing hepato¬
cytes with such nonparenchymal cells as fibroblasts.
The murine embryonic fibroblast cell line, 3T3-J2, can
induce a 3- to 15-fold increase in albumin secretion per
rat hepatocyte,68 thus decreasing the need for a large
number of hepatocytes. The optimum ratio of non¬
parenchymal to parenchymal cells in cocuhures has
been studied, and it appears that a ratio near 6:1 maxi¬
mizes the effectiveness of nonparenchymal cells.68
BALs incorporating nonparenchymal cells with a bio¬
degradable polymer scaffold obtained impressive results
in terms of both survival and function of hepatocytes.73
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The possibility of further antigenicity from the cocul-
ture cells should not be underestimated74 and needs to
be investigated further. When the HHY475 cell line was
encapsulated in 1% alginate, cytochrome P-450 1A1
activity increased 3- to 4-fold compared with mono¬
layer cultures, and urea production was detected for the
first time.76 Currently, this approach remains very
promising, and further studies will determine their fu¬
ture role in BALs.
Availability
The ready availability of hepatocytes to load a bioreac-
tor at short notice has been a major issue in the devel¬
opment of BAL support systems for the treatment of
patients with ALF. Different approaches to this prob¬
lem have been adopted.
Ongoing Hepatocyte Culture
Within the Bioreactor
This has the disadvantage of high costs and a limited
shelf life because of rapid deterioration of the biological
function of the hepatocytes. Although groups77 have
claimed that improved bioreactor design may be impor¬
tant in maintaining viability and metabolic activity,
even with these improved bioreactor configurations,
cells are unlikely to maintain significant function be¬
yond 3 weeks." Another approach is to identify the
optimum medium for culturing hepatocytes before and
during seeding of a BAL, an area that requires further
work, although it is unclear which metabolic function is
of most value. Regular microbial screening could be
incorporated into such a system.
Fresh Isolation of Hepatocytes From Readily
Available Sources and Loading the Bioreactor
as Required
This approach requires a team to be on standby on a
24-hour basis to be able to prepare a bioreactor but has
the advantage of using fresh cells near the peak of their
metabolic activity. Given that patients often present
with ALF before requiring treatment, there may be
adequate time for bedding hepatocytes into a BAL to
ensure optimal function.
Cryopreservation of Hepatocytes
This has been explored as a means of maintaining their
ready availability and is an approach adopted by the
HepatAssist system, currently under clinical evaluation
(phase III multicenter trial).48 This system uses porcine
hepatocytes that are attached to dextran microcarriers
and cryopreserved. In general, the viability of primary
porcine hepatocytes after cryopreservation is decreased
by 10% to 25%,78,79 although Percoll (Pharmacia,
Uppsala, Sweden) separation can remove these dead
cells before their use in BAL systems. There is concern
that simple measures of viability may be inadequate;
however, in testing, the true health and function of
cryopreserved hepatocytes and, consequently, cell at¬
tachment to plastic has been suggested as a more accu¬
rate marker ofsuch functions. Only 50% of cells retain
their ability to attach on plastic after thawing,80 con¬
firming that the metabolic function and/or health of
these hepatocytes deteriorates at a greater extent than
suspected by simple measurement of viability. Work
has therefore focused on ways of improving the func¬
tionality of cryopreserved cells by changing the cryo-
preservative solutions and the freezing protocols. Di¬
methyl sulfoxide reduces ice formation and osmotic
changes during freezing by interacting electrostatically
with phospholipid membranes81 and is considered the
most suitable cryoprotectant.82 Several cryopreserva¬
tion protocols have been used, such as slow-freezing
protocols, quick-freezing protocols, and stepwise pro¬
tocols.83,84 To date, computer-controlled stepwise
freezing with rapid thawing has given the most satisfac¬
tory results.82 A high cellular energy status has been
recognized as an important factor in maintaining suffi¬
cient metabolic function during cryopreservation;
therefore, isolated hepatocytes have been incubated in a
well-oxygenated buffer containing 15 mmol/L of glu¬
cose for 30 minutes at 37°C before freezing process,
with improvement in postthawing results.85
Although cryopreservation has much to offer for the
use of primary hepatocyte-based BAL therapy, further
advances are required to optimize the function of the
cryopreserved hepatocytes.
Conclusion
Extensive progress has been made in the field of hepa¬
tocyte biology for BAL systems over the past 10 years,
but many questions remain. Although such functions as
ammonia detoxification and compound biotransforma¬
tion are important for BAL efficacy, additional func¬
tions required for the treatment of liver failure remain
unclear. This is primarily because of uncertainty about
the pathological processes underlying ALF, which must
be explored further if BAL advances are to be made.
When choosing the hepatocyte for use in a BAL system,
it is important to be aware that a balance of risks exists.
The practical choices are xenogenic (porcine) hepato¬
cytes or transformed human hepatocyte lines. Although
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porcine hepatocytes confer greater biological functions,
there is the unknown risk for PERV transmission.
However, transformed human lines offer slightly
poorer biological function, with the risk for malignant
infiltration. Increasingly, a body of literature suggests
that transformed lines are becoming safer in this re¬
spect, and their biological function appears to improve
with each successive development. Consequently, both
cell types have been used in human trials with no major
ill effects to date. To complicate decision making fur¬
ther, the possibility ofusing human hepatocytes derived
from human adult and/or embryonic stem cells has
been added to the list of possibilities. Of equal impor¬
tance will be developments in the housing and culture
ofcells within the reactor to maintain these cells at their
optimal function. When considering the use of BALs,
whichever cell type they contain, it is imperative that
their suggested risks are balanced with the urgency of
the clinical condition. A patient with ALF who requires
treatment with a BAL is seriously ill and still has a
depressingly high mortality rate without liver trans¬
plantation.
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